April 3, 2009
GENERAL INSTRUCTIONS FOR COMPLETING THE DATABASE
Each question in the database is preceded by the relevant LCME accreditation standard. In some cases
two standards are closely related, and the questions are germane for documenting compliance with each
of the two standards. Additional related information is sometimes contained in the responses to questions
that deal with other standards; in those cases, cross-references to the additional information are included
in italics. The cross-references are intended to help self-study groups and the survey team identify all
relevant data for assessing compliance with standards.
For comprehensive instructions regarding database completion, please refer to the document “Background
and Instructions for Completing the LCME Medical Education Database and Institutional Self-Study,”
available on the LCME web site at: http://www.lcme.org/database.htm.

The school should maintain a master database that contains all of the information used for the selfstudy. When it becomes necessary to update database sections after the self-study report is complete
but prior to the survey visit, the school should create separate database pages containing the updated
information only.

Most questions require a narrative answer or completion of a table; in some cases, it will be necessary
to duplicate a blank table (for example, to summarize each of the school’s clinical teaching sites).
Use as much space as necessary to answer each question completely, or to complete the tables. The
tables may be modified to fit the circumstances specific to the school.

Any supporting documents that are requested in the database (e.g., bylaws, organizational charts,
policy documents) should be compiled in a separate (red) binder, divided by tabs for each section of
the database; do not include such appended materials in the individual database sections.

The header on each page should indicate the most recent academic year for which information is
available at the time of the self-study, not the academic year in which the database is being
completed; in most cases, the year for which information is available will be the 2008-2009 academic
year (July 1, 2008- June 30, 2009) for self-studies concluding in 2009-2010. When the requested data
are for a different time period than that indicated in the header, the applicable time period should be
included in the response to the question.
If database information is updated after completion of the self-study, the academic year listed in the
header should be changed accordingly, and marked with the word “Update” in the header along with
the year shown (e.g., “Update 2009-10”). Note that changing the header will affect all pages of a
database section; therefore, a fresh (blank) copy of the database section should be used for updates.

If requested information is available from the school’s web site, make sure to print a copy of the web
site information for the master database maintained by the school. Changes to such documents after
completion of the self-study should be printed and stamped “Updated” to indicate that they have
changed, and included in the updated database. In addition, database pages that list URLs of modified
web pages should indicate that the web site information has been altered from the original data
available to the self-study groups.

The database copies sent to the LCME Secretariat should include printed copies of any information
referred to by website URL. If the document is long, please include the table of contents and only the
relevant sections. The Secretariat is required to maintain complete print records of all database
information.
LCME Medical Education Database 2009-10
I. Institutional Setting

For US schools, most of the Key Quantitative Indicators (Part A of each database section) can be
completed using information contained in the Longitudinal Statistical Summary Report. This report
is prepared annually by the AAMC Section for Institutional, Faculty, and Student Studies, and sent
directly to the dean.
SPECIAL INSTRUCTIONS FOR SECTION I: INSTITUTIONAL SETTING
No special instructions are included for this section.
LCME Medical Education Database 2009-10
I. Institutional Setting
BACKGROUND INFORMATION ABOUT THE SCHOOL
a. Insert a copy of the school’s current entry in the AAMC Directory of American Medical Education.
b. Indicate on a separate page any changes in administrative positions or personnel that have taken place
since the directory was published.
Changes to AAMC Directory of American Medical Education since last publication:
Las sentence of the overview should read “The School of Medicine is one of six professional
schools………”
Clinical facilities: Interim LSU Public Hospital (Medical Center of Louisiana in New Orleans); Children’s
Hospital; University Medical Center – Lafayette; Earl K. Long Medical Center – Baton Rouge; East
Jefferson General Hospital; New Orleans Adolescent Hospital; LSU Hospital – Depaul Campus; Ochsner
Medical Center; Ochsner – Kenner; Ochsner – Baptist; Touro Infirmary; West Jefferson Medical Center;
Our Lady of the Lake; Baton Rouge General Hospital; Lake Charles Memorial; LSU – Bogalusa Medical
Center; LSU Baton Rouge Mid-City Clinic.
Medical School Administrative Staff
 Coordinator, Office for Research and Vivarium Director should be listed under University
Officials
 Director, Library should be listed under University Officials
 Personnel changes:
- Associate Dean for Healthcare Quality and Safety: Dwayne Thomas, MD
- Associate Dean for Alumni Affairs and Development: Cathi Fontenot, MD
- Associate Dean for Clinical Affairs: Thomas E. Nolan, MD, MBA
- Director of Clinical Science Curriculum: Robin English, MD
 New positions:
- Director of Research: Jean Jacob, PhD
- Director of Faculty Development: Paula Gregory, PhD
Department and Division or Section Chairs
Basic Sciences
Genetics
 New department head: Jay K. Kolls, MD
Clinical Sciences
Medicine
 New section chiefs:
- Endocrinology and Metabolism: William T. Cefalu, MD (pending University approval)
- Gastroenterology: Daniel Raines, MD (Interim)
LCME Medical Education Database 2009-10
I. Institutional Setting

- Pulmonary and Critical Care: Judd Shellito, MD
Section of Nutrition and Metabolism not a separate section any longer
Obstetrics and Gynecology
 New section chief:
- General Gynecology: Martha Brewer, MD
Orthopaedics
 New department head: Andrew King, MBBCh
Pathology
 Epidemiology not a section in the department any longer
Pediatrics
 New section chiefs:
- Cardiology: Robert J. Ascuitto, MD
- Gastroenterology and Nutrition: Paul E. Hyman, MD
Psychiatry
 New section chiefs:
- Psychology: Phillip T. Griffin, PhD
- Social Work: Michelle M. Many, MSW, LCSW
Surgery
 New section chiefs:
- Pediatric Surgery: Evans P. Valerie, MD
 Sections closed:
- Bariatric
- Transplant
 Correction to Department Head: Dr. Baker not interim head
 Correction to name of Trauma section: should be Trauma/Critical Care
c. Provide a brief history of the medical school, noting any key points in the school’s historical
development.
The Louisiana State University School of Medicine was authorized by Legislative Act 145 of 1877
and founded formally by the LSU Board of Supervisors on 3 January 1931. The School officially opened
on 1 October 1931 in a nine story building at 1542 Tulane Avenue adjacent to the 2200 bed Charity
Hospital of Louisiana at New Orleans. This location for the medical school was selected primarily
because Charity Hospital provided the patients and medical facilities necessary for the development of
outstanding programs in medical education and research. There have been several reorganizations of
the administrative structure of the School of Medicine and changes to its name; it now is known as the
LSUHSC School of Medicine in New Orleans. Founded as a small school with a mission of educating
physicians for the State of Louisiana and caring for the indigent patients of the New Orleans region, it
has grown dramatically into a robust, resilient institution known for training excellent physicians, its
commitment to the medically under-served, and notable research programs. Like many public medical
schools, it is not state supported, but rather state assisted; nonetheless, the state support has been
constant as demonstrated by the investments it has made in our campus and our faculty since inception.
LCME Medical Education Database 2009-10
I. Institutional Setting
Since its creation, the School of Medicine has graduated over 7850 physicians. The majority of
practicing physicians in Louisiana are alumni of the School of Medicine or have trained in its residency or
fellowship programs.
The first 28 matriculants, graduating in 1933, were third year transfer students. The first four
year class graduated in 1935. Class size was increased incrementally from 100 in 1949 to approximately
165 in 1975 and it remained at this level until recently. With the entering class of 2007, the base number
of students accepted was raised to 180; this increase accommodates the successes of the Rural Scholars
Track and the small, but significant, number of non-resident MD/PhD candidates, and non-resident
alumni children who matriculate in the first year class.
With growth of the student body, faculty, and research activities, additional space was needed.
Hence, in 1954, a nine story addition to the original building (now known as the Clinical Education
Building) was completed. Another five story expansion to the Clinical Education Building was completed
in 1964 and included parking facilities. In the same general timeframe an 11 story residence hall and
student center was built nearby across Claiborne Avenue. This latter project sparked the dramatic
western expansion of the campus in proximity to then-named Hotel Dieu Hospital which provided inpatient and limited out-patient facilities for the private faculty practice that took place outside of Charity
Hospital.
Since these changes to the original medical school building, we have experienced a succession of
building projects to support our educational and research missions. The Medical Education Building
(MEB)(1901 Perdido Street) was completed in 1981; it provides space for much of the teaching for the
pre-clinical curriculum, most of the Basic Science Departments, the Department of Pathology, and the
Section of Pulmonary Medicine and Critical Care. It is located adjacent and connected to the Residence
Hall. The MEB has benefited from recent updates to the roof, the morgue for the anatomy labs, the
multi-disciplinary teaching labs, the cafeteria, the main lecture rooms, and many support spaces and a
major project on the air handling system is also underway.
A facility housing an outpatient ambulatory clinic, research laboratories, and teaching space
(2020 Gravier Street) was completed in 1986 using principally self-generated funds. A key donation from
the Lions Foundation anchored construction funding, which explains in part the informal moniker, The
Lions Building. This building and its upper floor expansion continue to accommodate the Department of
Ophthalmology and the Neuroscience Center. The Student Learning Center was constructed in 2001 on
the ground floor of the Lions Building, but it was destroyed in the flooding that occurred following
Hurricane Katrina. The Student Learning Center is being relocated to the sixth floor of the same building
(expected completion Spring 2009), in proximity to the recently completed Center for Advanced Practice
(completed in 2008), a high-technology simulation and learning center used by students, residents and
fellows, practicing physicians, and other constituents. No clinical activities have taken place in the Lions
Building since Hurricane Katrina. This building connects with the Nursing and Allied Health Professions
Schools Building which opened in 1985.
In 1988, construction was completed on the Resource Center, providing space for the Ische’
Medical Library, Computer Enterprises, the bookstore, the credit union, the Chancellor’s Office, and key
operations for the campus administration, including human resources, accounting, payroll, grants and
contracts, and the LSUHSC Office of Research.
LCME Medical Education Database 2009-10
I. Institutional Setting
The final major construction project supporting the School of Medicine, the Clinical Sciences
Research Building, was completed in 2000. This building has replaced the research laboratory facilities in
the original medical school building and is a state-of-the-art facility with a vivarium and high technology
equipment. It houses the Departments of Genetics and Otorhinolaryngology, the Alcohol Research
Center, the Gene Therapy Program, the Stanley S. Scott Cancer Center, and the laboratory activities of
several of the clinical science departments. While not “new” construction, other enhancements to the
campus have, however, continued, and in 2004 a new residence facility, Stanislaus Hall, was completed
in a renovated nursing school building. A full service fitness center (opened in 2006) is also located
within Stanislaus Hall.
In 1965, the Louisiana Legislature authorized the creation of a second LSU medical school in
Shreveport and the LSU Medical Center (later renamed as the LSU Health Sciences Center) was formally
created for the two medical campuses. In approximately the same period, the School of Medicine in
New Orleans was given expanded responsibility for developing teaching programs and staffing indigent
patient care at the public hospitals in Baton Rouge, Lafayette, Lake Charles, and Bogalusa. (The LSU
medical school at Shreveport shared a common Chancellor with the LSUHSC School of Medicine in New
Orleans until late 2000 when the governance of the two LSUHSC campuses was separated and a
Chancellor for LSUHSC Shreveport was named.)
The downturn in the state’s economy in the late 1980s and early 1990s led to a dramatic
reduction in the size of Charity Hospital. Reductions in bed capacity in the outlying Charity Hospitals in
smaller Louisiana cities forced closure of many of their residency programs. In 1993 with the state
economy rebounding, more change to the clinical resources occurred when the state acquired Hotel
Dieu and renamed it University Hospital; initially this facility was administered by the Louisiana Health
Care Authority and, subsequently, with the passage of state legislation in 1997, by the LSU Health Care
Services Division. The LSU Health Care Services Division continues to manage and operate the state
public hospitals in Baton Rouge, Lafayette, Bogalusa, and several other cities. University Hospital
formally became part of the Medical Center of Louisiana in New Orleans (MCLNO) and the two
campuses were the major teaching sites for the medical school for over a decade. The “Old Charity”
campus has remained closed since Hurricane Katrina and the University Hospital facility has been
renovated and reopened as the Interim LSU Public Hospital.
While much of the clinical training experiences for our students remain focused in the state
public hospital facilities, largely in New Orleans, Baton Rouge, and Lafayette, and on treating the
medically under-served patients that seek care there, the School has many cooperative training
agreements with private community hospitals and clinics and with a large number of volunteer faculty
members and preceptors. These internal and external relationships form the core of our clinical
teaching of medical students, residents and fellows. Planning is underway for the replacement facility
for MCLNO in a large adjacent plot of land where both the New Orleans Veterans Medical Center and
the LSU teaching hospital will be located; land acquisition for these facilities is underway.
Of course, the history of the School of Medicine would not be complete without a brief account
of the remarkable events of the 2005-2006 academic year. Hurricane Katrina made landfall slightly east
of New Orleans early on 29 August 2005. The storm and its surge breached more than 50 canal levees
and over the next two days 80% of the City of New Orleans was flooded with up to 15 feet of water.
Much of the city remained under water for weeks and, as a consequence, the flooding devastated the
city and its infrastructure, the LSUHSC New Orleans campus, Charity Hospital, and many of the other
community hospitals used for teaching. Overcoming enormous obstacles of physical dislocation and in
communication, and also in the context of tremendous personal losses on the part of many of our
LCME Medical Education Database 2009-10
I. Institutional Setting
students, house officers, and faculty and staff, School of Medicine operations were restored quickly.
Clinical clerkships resumed no later than three weeks after the storm for individual students, mainly in
Baton Rouge and Lafayette, and preclinical classes resumed within four weeks of the storm, on 26
September 2005. A revised pre-clinical curriculum and course schedule was implemented at the
Pennington Biomedical Research Center in Baton Rouge. By May 2006 most of the administrative
functions of the medical school had resumed in New Orleans and by August 2006 preclinical classes
resumed in the Medical Education Building. Extensive renovations have been completed or are under
way for all School of Medicine buildings damaged by Hurricane Katrina. University Hospital (now Interim
LSU Public Hospital) has been upgraded and functions as a primary training site while plans for a
replacement for Charity Hospital proceed.
There have been sixteen (16) Deans of the School of Medicine since its inception, including
fourteen (14) permanent and two interim or acting deans. Dr. Larry H. Hollier was the dean, appointed
in January 2004, at the time of Hurricane Katrina and he served as Dean and Chancellor for slightly less
than two years when Dr. Steve Nelson was named Dean in September 2007. Dr. Hollier continues to
serve as Chancellor of the LSUHSC New Orleans and he is the seventh permanent Chancellor for the New
Orleans campus.
As Louisiana State University School of Medicine in New Orleans prepares to celebrate the 80th
Anniversary of its establishment, it continues to provide excellent undergraduate, graduate, and
postgraduate medical education and patient care, and foster innovative biomedical research. The
students, house officers, faculty and staff of the school not only survived the recent adverse events
related to Hurricane Katrina, but they responded with renewed vigor and loyalty. The School of
Medicine looks forward to the future with optimism, as it continues to have excellent applicants and
graduates, supportive and dedicated faculty, strong alumni support, and a renewed campus.
LCME Medical Education Database 2009-10
I. Institutional Setting
SECTION I. INSTITUTIONAL SETTING
Part A: Key Quantitative Indicators
Please provide the following information, using your school’s copy of the Longitudinal Statistical
Summary Report as the data source unless indicated otherwise.
a. Number of vacant department chair positions
2002-03
0
2003-04
2
2004-05 2005-06
0
0
2006-07 2007-08 2008-09
3
0
1
b. Total numbers of enrolled master’s and doctoral students in graduate programs in the biomedical
sciences
2002-03
Master’s 61
Doctoral 70
2003-04
44
84
2004-05
51
85
2005-06
30
103
2006-07
30
89
2007-08
16
109
2008-09
15
102
c. Total numbers of residents and clinical fellows on duty in ACGME-approved programs that are the
responsibility of the medical school faculty
2002-03
Residents 518
Fellows
94
2003-04
514
76
2004-05
525
110
2005-06* 2006-07
545
426
94
49
2007-08
439
57
2008-09
464
77
* The institution lost about 110 trainees due to Hurricane Katrina during this year.
d. Percentage of graduating students who participated in a research project with a faculty member
(source: AAMC Graduation Questionnaire)
2002-03
2003-04
2004-05
2005-06
2006-07
2007-08
2008-09
43.8
42.7
41.1
36.9
30.4
38.7
NA*
*March 19, 2009
____________________________________________________________________________________
LCME Medical Education Database 2009-10
I. Institutional Setting
SECTION I. INSTITUTIONAL SETTING
Part B: Narrative Data and Tables
IS-1. Each medical school must engage in a planning process that sets the direction for the
institution and results in measurable outcomes.
To assure ongoing vitality and successful adaptation to the rapidly changing environment of academic
medicine, schools need to establish periodic or cyclical institutional planning processes and activities.
Planning efforts that have proven successful in medical schools and other professional or business
milieus typically involve the definition and periodic reassessment of both short-term and long-range goals
for the successful accomplishment of institutional missions. By framing goals in terms of measurable
outcomes wherever circumstances permit, a school can more readily track progress toward their
achievement. The manner in which a school engages in institutional planning will vary according to
available resources and local circumstances, but all schools should be able to document their vision,
mission, and goals; evidence indicating their achievement; and strategies for periodic or ongoing
assessment of successes and unmet challenges.
__________________________________________________________________________________
a. Provide a brief statement of the mission and goals of the medical school. When were these last
reviewed?
Louisiana State University School of Medicine - New Orleans trains physicians and scientists in health
care disciplines. The Medical School strives for excellence in medical education, research, and service
through the following objectives:
Medical Education Mission Objectives
The undergraduate curriculum contains programs of study that enable students to become competent,
caring physicians who can function in any healthcare system, continue self education, and appreciate
and evaluate medical research. Graduate Medical Education programs and their support are important
components of the educational mission. Graduates of specialty training programs will be skilled and
knowledgeable in their chosen discipline and able to assume the responsibilities of a practicing
physician. Training programs of the school assess and adjust to changing physician work force needs of
the state.
Research Mission Objectives
Medical education and research are related pursuits. Academic excellence in research heightens the
intellectual atmosphere, develops new knowledge, and transmits current information for the benefit of
all constituencies. The Medical School provides adequate facilities for trainee and faculty research
including support areas such as the library, animal care, and computer services. Long term planning and
acquisition of research funds are vigorously pursued to ensure research growth.
Service Mission Objectives
The school provides a model of excellence in public and private medical care and community oriented
programs. The school remains responsive to changing health care systems and trends. Patient care
activities are important to all school missions. Personal practice supports and maintains the clinical skills
of faculty and expands opportunities for undergraduate and graduate teaching and research. The school
develops community outreach programs that provide educational and service opportunities and
enhance the quality of life of constituent communities.
LCME Medical Education Database 2009-10
I. Institutional Setting
The most recent comprehensive review was December, 2008
b. Provide an executive summary of the current medical school strategic plan, if any.
Consistent with its mission, and building on its historical role and traditional strengths, the LSUHSC
School of Medicine - New Orleans strives to be a regional and national leader, recognized for its
commitment to excellence and its passion for innovation, and defined by:

A competency-based approach to medical education that links undergraduate, graduate and
continuing education in an integrated statewide system that blends modern technology with
hands-on learning experiences and draws upon the strengths of regional partners to create a
center of educational excellence that contributes to the recruitment and retention of physicians,
representative of the diversity of our communities, well-prepared for practice in the State of
Louisiana.

A research enterprise that fosters collaboration across disciplines, spans the continuum from
basic science to the bedside, and promotes the discovery and application of new scientific and
clinical knowledge, with an emphasis on addressing the health care issues and challenges that
are of greatest import to the citizens of Louisiana.

An approach to patient care that is characterized by the existence of a fully integrated multispecialty academic group practice that excels as a regional referral resource for complex tertiary
care and demonstrates an ongoing commitment to improvement of the health status of citizens
of Louisiana through the provision of care that is accessible, patient-centered, quality-focused
and safety-oriented.

A strong commitment to diversity and community outreach that builds on, leverages and
promotes the school’s patient care, research and educational strengths by seeking partnerships
with city, state and regional groups and organizations, both public and private, to develop
programs that benefit the citizens of Louisiana.
The “Overarching Goals” listed below serve as the core components that are requisite to fulfilling the
goals of the Strategic Plan.








Promote excellence and innovation in all School of Medicine educational programs
Foster a culture of academic and investigative excellence
Structure existing and new clinical programs to fulfill short and long term goals while strategically
positioning SOM and LSU HealthCare Network for the completion of new University Hospital
Align goals and missions of core clinical entities
Develop a cohesive mechanism for faculty orientation, development, and evaluation, including
those for SOM leadership
Establish a clear and standardized process for annual reporting and Periodic Academic Unit Review
Refine budget principles for resource allocation, particularly as they relate to educational and
clinical programs
Promote diversity and expand community outreach programs, building in large part on existing
relationships with our strategic partners (School of Public Health and Southeast Louisiana Area
Health Education Center and others)
LCME Medical Education Database 2009-10
I. Institutional Setting


Enhance electronic web-based tools for all School operations
Better communicate internally and externally on all SOM activities and those of its support
organizations
c. Date of most recent review or revision of the strategic plan:
December, 2008
d. How often is the plan reviewed or revised?
The last time that the School of Medicine developed a comprehensive strategic plan was in 1987, and
this resulted in a long-range plan for the years 1988-1992. Subsequent to this, a Research Strategic Plan
was developed in June/July of 1999 (which included a retreat), and this was followed up by the
generation of another Research Strategic Plan (with associated retreat) in January, 2001. These latter
two plans dealt only with research issues (both basic and clinical science). Strategic planning for the
medical school curriculum was undertaken in 2000, and the curriculum was dramatically revised and
renewed as a consequence of the retreat, its recommendations, and their implementation. A focused
retreat and strategic planning for the clinical operation was undertaken in 2001. Plans are for
comprehensive strategic planning to be undertaken at least every five years; however, updating and
review of implementation of the strategic plan is planned at shorter intervals.
e. Briefly summarize or outline the planning process, including the main participants and the names or
titles of individuals or groups whose approval is required to finalize the plan.
Under the direction of Dean Nelson, Associate Dean Janis Letourneau announced plans for the School of
Medicine Strategic Planning Retreat on May 5, 2008. Invited participants included individuals identified
as leaders from across the LSUHSC School of Medicine-New Orleans and several of its affiliated
organizations. This group included Basic Science Department Heads, Clinical Science Department Heads,
Center Directors, Associate and Assistant Deans, and selected faculty at various levels of appointment
and rank who had demonstrated certain skills valuable to the planning process and a dedication and
loyalty to the goals and success of the School of Medicine and LSUHSC. Other invitees included
community and hospital partners, alumni, residents, and students. The retreat was held on June 7,
2008, and over 70 individuals attended the retreat. Alan Burgener, MHA, helped to facilitate the retreat
and served as a key consultant. Institutional leadership personnel involved in facilitating the retreat
were:
Steve Nelson, MD (Dean, School of Medicine)
Janis G. Letourneau, MD (Associate Dean for Faculty and Institutional Affairs)
Wayne Backes, PhD (Associate Dean for Research)
Keith Schroth, MBA (Associate Dean for Fiscal Affairs)
During the retreat, the following areas were identified for development in the strategic plan, and,
subsequently, workgroups were formed to develop the core priorities and goals defined in each of the
following areas:
The names of the workgroup leaders are given in parentheses:
LCME Medical Education Database 2009-10
I. Institutional Setting






Educational Enhancement (Richard DiCarlo, MD)
Research Infrastructure and Core Facilities (Alistair Ramsay, PhD)
Community Outreach and Engagement (Robert Maupin, MD)
Faculty Development and Mentoring (Peter Winsauer, PhD)
Clinical Centers of Excellence (Christopher Baker, MD)
Communication Strategies (Patricia Molina, MD, PhD)
The workgroup leaders met with Dean Nelson and Associate Dean Letourneau, along with additional
senior leadership within the SOM and members of the administration on July 9, 2008, to review the
specific work group charges, define expectations and set working timelines. Over 100 faculty members,
strategic partners in health care and in the community, alumni, house officers, and students participated
actively in the Work Groups, which met frequently to satisfy a demanding deadline. The faculty Work
Group members were broadly representative of the school, incorporating the array of basic and clinical
science disciplines, academic ranks and tracks, geographic site of activity, and specialized expertise or
interest. The composition of the Work Groups reflected the diversity of the school and included elected
Faculty Assembly representatives.
Formal recommendations on strategic initiatives, focused on the previously mentioned Work Group
charges, were made to the Dean and abstracted into an integrated comprehensive plan. The plan is
structured around ten broad overarching goals (see above) that reflect the traditional elements of
activities within a School of Medicine - education, research, clinical service, and community service and
outreach. Specific initiatives are outlined for each of the ten goals.
The roster of Strategic Work Group Committee Contributors is found in the attached appendix.
Finalization of the Strategic Plan document requires the approval of the Chancellor.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-2. A medical school should be, or be part of, a not-for profit institution legally authorized under
applicable law to provide medical education leading to the MD degree.
___________________________________________________________________________________
a. Year of initial chartering:
1877
b. Type of charter (check one):
X Not-for-profit
Commercial, for profit
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-3.
If not a component of a regionally accredited institution, a U.S. medical school must achieve
institutional accreditation from the appropriate regional accrediting body.
The LCME is recognized by the U.S. Department of Education as an accrediting agency
for the educational programs, more specifically for the accreditation of medical
education programs leading to the M.D. degree. Because the LCME is not recognized as
an institutional accrediting agency, it lacks standing to accredit stand-alone medical
schools as institutions of higher education.
Institutional accreditation is granted by a regional accrediting agency, and is required to
qualify for federal financial assistance programs authorized under Title IV of the Higher
Education Act. Some regional accrediting bodies grant “pre-accreditation” as a first
step to achieving full accreditation. In such circumstances the attainment of preaccreditation status would meet the requirements of this standard.
___________________________________________________________________________________
a. Regional accrediting body (check one):
Middle States Association of Colleges and Schools
New England Association of Colleges and Schools
North Central Association of Colleges and Schools
Northwest Association of Schools and Colleges
X
Southern Association of Colleges and Schools
Western Association of Schools and Colleges
b. Current institutional accreditation status:
Accredited
c. Year of next regional accreditation survey:
2015
Documentation for the accreditation status of LSUHSC can be found at:
http://www.sacscoc.org/details.asp?instid=44400
LCME Medical Education Database 2009-10
I. Institutional Setting
IS- 4. The manner in which the medical school is organized, including the responsibilities and
privileges of administrative officers, faculty, students and committees must be promulgated in
medical school or university bylaws.
___________________________________________________________________________________
a. Provide a copy of the faculty bylaws that apply to the medical school, or the URL of the web site
where they can be viewed.
The School of Medicine faculty does not have its own specific set of bylaws. Louisiana State University
Health Sciences Center in New Orleans (LSUHSC-NO) is part of the Louisiana State System. Thus the
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College serves as the
Management Board for LSUHSC-NO. The Bylaws and Regulations of the LSU Board of Supervisors can be
viewed at www.lsusystem.edu/policies/bylaws_regulations/ or
www.lsuhsc.edu/no/Administration/bylaws/. Of particular pertinence to the medical school faculty is
Article VII (Rights, Duties and Responsibilities of Principal Administrative Officers of the University
System) and Chapter II (Appointments, Promotions and Tenure). The other documents that define the
framework for the activities of the LSUHSC-NO faculty are the following: the LSUHSC-NO Faculty Senate
Constitution and Bylaws (www.lsuhsc.edu/no/schools/facultysenate/), the LSUHSC-NO School of
Medicine Faculty Assembly Bylaws (www.medschool.lsuhsc.edu/faculty_assembly/bylaws.aspx),
the LSU System Permanent Memoranda (www.lsuhsc.edu/no/administration/pm/) , the LSUHSC-NO
Faculty Handbook (www.lsuhsc.edu/no/administration/academic/FacultyHandbook.pdf) and the
LSUHSC-NO Chancellor’s Memoranda (www.lsuhsc.edu/no/administration/cm/).
b. Date of the most recent bylaws revision:
October 2, 2008
The most recent revision of the Bylaws and Regulations of the LSU Board of Supervisors was made on
October 2, 2008. The LSUHSC-NO Faculty Senate Constitution and Bylaws were last revised in August,
2008, and the last revision of the LSUHSC-NO School of Medicine Faculty Assembly Bylaws was on April
10, 2003.
c. Briefly describe how the bylaws are made available to the faculty.
As stated above, the LSU System Board of Supervisors Bylaws and Regulations and Permanent
Memoranda, the Bylaws of the LSUHSC Faculty Senate and the School of Medicine Faculty Assembly, the
LSUHSC-NO Faculty Handbook, and the Chancellor’s Memoranda are all easily accessible on component
websites within the main LSU website. Faculty may also keep abreast of all updates made to the Bylaws
and Regulations, LSUHSC-NO Chancellor’s Memoranda and LSU System Permanent Memoranda by an
email subscription sign up service, details of which are given in the Faculty Handbook.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS- 5. The governing board responsible for oversight of the medical school must have and follow
formal policies and procedures to avoid the impact of conflicts of interest of members in the
operation of the school, its associated hospitals, or any related enterprises.
There must be formal policies and procedures to avoid the impact of conflicts of interest, such as
the requirement that a board member recuse him/herself from any discussion or vote relating to a
matter where there is a potential for a conflict of interest to exist. The school also must provide
evidence (for example, from board minutes, annual signed disclosure statements from board
members) that these policies and procedures actually are being followed. Some conflicts related
to personal or pecuniary interests in the operation of the school may be so pervasive as to
preclude service on the governing board.
The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College is
established by Article 8, Section 7 of the Louisiana Constitution. It is a constitutionally empowered board
granted the authority and responsibility to “supervise and manage the institutions, statewide
agricultural programs, and other programs administered through its system.”
The Board of Supervisors is the governing authority of the Louisiana State University Health Sciences
Center and the LSUHSC School of Medicine – New Orleans. Formal Conflict of Interest policies for the
LSU Board of Supervisors are in place and are referenced in IS 6e.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-6. Terms of governing board members should be overlapping and sufficiently long to permit
them to gain an understanding of the programs of the medical school.
_____________________________________________________________
a. Check any units for which the governing board is directly responsible:
X
X
X
X
Parent University
Health Science Center
Medical School
Other (describe below)*
* LSU Health Care Services Division (the state-wide system of public hospitals, most of which support
educational programs)
b. Year of board chair’s appointment and length of board chair term(s) of office
Appointed -August 29, 2008; Term – One year
Mr. James P. Roy (Chairman)
P.O. Box 3668
Lafayette, LA 70502
(337) 593-4100
jroy@lsu.edu
Mr. Roy represents the 7th Congressional District, and his term of service on the Board itself ends on
June 1, 2010; he is chair of the Board until August 29, 2009. He is an attorney.
d. Summarize the procedure for appointment and renewal of university or health science center board
members, including the chair. Describe the length of members’ terms, the number of times that a member
can be reappointed, and the staggering of appointments, if appropriate.
The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College is
established by Article 8, Section 7 of the Louisiana Constitution. It is a constitutionally empowered board
granted the authority and responsibility to “supervise and manage institutions, statewide agricultural
programs, and other programs administered through its system.” The constitution provides that the
membership of the board is composed of two members from each congressional district and one
member from the state at large, appointed by the governor with confirmation of the Louisiana Senate.
Those members serve six-year terms, which are staggered; Board members service is limited to two
consecutive six-year terms. In addition, a student member is selected to serve a one year term.
e. Provide copies of policies and procedures intended to prevent or address conflicts of interest among
board members (including recusal from discussions or decisions if a potential conflict occurs), and
strategies for dealing with actual or perceived conflicts of interest if they arise. Provide examples to
illustrate that these policies are being followed.
Formal policies and procedures have been established to avoid the impact of conflicts of interest. For
example, there is a requirement that a board member recuses him/herself from any discussion or vote
relating to a matter where there is a potential for a conflict of interest to exist. The Conflict of Interest
policy for the Board of Supervisors is attached.
LCME Medical Education Database 2009-10
I. Institutional Setting
(ADD TO APPENDIX)
f. If the medical school is governed by its own board of trustees, or is overseen directly by a
subcommittee of the university or health science center board, provide a separate description for
appointment and renewal of its members, conflict of interest policies, and strategies for addressing actual
or perceived conflicts of interest.
Not applicable.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS- 7. Administrative officers and members of a medical school faculty must be appointed by, or on
the authority of, the governing board of the medical school or its parent university.
___________________________________________________________________________________
Briefly describe the role of the governing board in the appointment of administrative officers and faculty
of the medical school.
The following web link (http://www.lsuhsc.edu/no/administration/pm/pm-69.aspx) and a section of the
LSU Bylaws (Section 2-5.1) deal with the LSU System policies for LSU Board of Supervisors authority and
its ability to delegate authority to the President or Chancellor.
As stated in recently revised Permanent Memorandum #69 (January 8, 2009), certain personnel actions
must be approved by the Board (Section A) with salary threshold compensation modifications for the
two LSUHSC campuses. As is relevant to the School of Medicine, the appointment of the dean and
amendments to, or extensions of, appointment agreements and increases or decreases in compensation
require Board approval. Other administrative appointments in the Dean’s Office generally require
approval by the LSU President’s Office.
Many of the School of Medicine faculty appointments, particularly to senior basic science and to highlypaid clinical science faculty members, require Board approval because of the compensation level that is
proposed. At lower proposed compensation levels the Board delegates some appointment authority to
the President and others to the Chancellor with compensation levels falling within a range subject to the
President’s review and approval. The LSU Board of Supervisors encourages the use of standard
templates for offers to faculty (see Permanent Memorandum #69), and deviations from the normal
terms also require review and approval by the LSU System Office or LSU General Counsel. The School of
Medicine has used standard letters of offer for many years, and the templates for faculty appointments
are posted on the School of Medicine Faculty Affairs web site.
All personnel actions for administrative officers and faculty are regularly reported to the President and
the Board in a format that is set by the President after consultation with the Board. In recent years, and
particularly with the issuance of Permanent Memorandum #69, the School of Medicine has received
more detailed directives by the Board of Supervisors and the President on matters relating to
appointment of administrative officers and faculty members.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-8. The chief official of the medical school, who usually holds the title “dean,” must have ready
access to the university president or other university official charged with final responsibility for
the school, and to other university officials as are necessary to fulfill the responsibilities of the
dean’s office.
The Office of the Dean is currently occupied by Steve Nelson, MD. The Dean is responsible for all aspects
of operations of the School of Medicine. The Dean reports to the Chancellor of LSU Health Sciences
Center – New Orleans, Larry H. Hollier, MD. The Chancellor is the Chief Executive Officer for the LSUHSC
campus, responsible for the operations of all six of the component professional schools. The Chancellor
reports to the President of the LSU System, John Lombardi, PhD.
Fred Cerise, MD, the Vice President for Health Affairs, also reports to the President of the LSU System
and serves as a liaison between the LSU Health Sciences Center campuses, the LSU Health Care Services
Division (the state system of seven public “Charity” hospitals operated by LSU), and the two LSU Schools
of Medicine. The lines of reporting for these officials, and their relationship with other administrative
bodies, is detailed in the organizational chart provided in the Appendix.
Suffice it to say, the Dean has direct and ready access to the Chancellor. He also is able to talk and meet
with Dr. Cerise (Vice President) and Dr. Lombardi (President) as needed.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-9. There must be clear understanding of the authority and responsibility for medical school
matters among the vice president for health affairs, the dean of the medical school, the faculty, and
the directors of the other components of the medical center and university.
___________________________________________________________________________________
a. Provide a position description for the dean and, if applicable, the vice president for health affairs or
equivalent.
INSERT PD for DEAN
The Dean of the School of Medicine is appointed by, and serves at the pleasure of, the Chancellor of the
LSU Health Sciences Center and the LSU Board of Supervisors. This appointment requires approval of the
Board of Supervisors. The Dean reports to the Chancellor, who, as mentioned earlier, is the Chief
Executive Officer for LSUHSC – New Orleans and its six component professional schools. Through
multiple avenues of communication, the faculty clearly understands the dean’s authority and
responsibility for the School of Medicine operations; these lines of communication include, but are not
limited to, Administrative Council, Faculty Asembly,and General Faculty and department faculty
meetings.
INSERT PD for CHANCELLOR
The Dean is accountable for all educational, research, and service programs of the School of Medicine,
as well as for its financial affairs. Largely, his activities are reviewed by the Chancellor, Dr. Hollier. While
the dean’s role is primarily, but not exclusively, internal to the school, the chancellor’s role is both
internal and external, being the principal spokesperson for the LSUHSC campus to civic and state officials
and to private partners. Both the Dean and Chancellor have, as mentioned earlier, access to the Vice
President for Health Affairs and Medical Education and to the President.
INSERT PD for VP
The Vice President serves as a liaison and a resource for the Dean and the Chancellor in coordinating the
complex and inter-related programs of the school and campus more broadly. The Vice President, Dr.
Cerise, is involved with strategic planning and development of performance targets, develops health
care delivery and education policies, and he provides leadership for the development of annual budgets
and long range financial planning for both LSUHSC campuses and the LSU Health Care Services Division.
The Vice President provides leadership and guidance to the President of the LSU System and the LSU
Board of Supervisors; he works collaboratively with all LSU programs related to health care delivery and
health sciences education; and, he serves as a liaison between the Chancellors and the President.
b. Supply a chart showing the relationships among the medical school and university administration,
other schools and colleges, institutes, centers, etc. Include, if appropriate, the reporting relationships for
the director of any teaching hospitals owned or operated by the medical school or university and for the
medical faculty practice plan.
(ADD TOO for SOM, LSU and LSUHSC)
As discussed earlier, the Chief Executive Officer (Michael Butler, MD, MHA, Interim CEO) for LSU Health
Care Services Division (the seven state “public” hospitals operated by LSU or HCSD) reports directly to
the President; several of the HCSD hospitals support undergraduate and graduate education or service
programs for the School of Medicine, including MCLNO (Interim LSU Public Hospital), Earl K. Long
Medical Center in Baton Rouge, University Medical Center in Lafayette, Bogalusa Medical Center, and
Lallie Kemp Medical Center in Independence. Dr. Butler, like the LSUHSC Chancellors, also works
collaboratively with the Vice President for Health Affairs and Medical Education as noted earlier.
LCME Medical Education Database 2009-10
I. Institutional Setting
The Chief Executive Officer, Frank Opelka, MD, of the LSU HealthCare Network, a not-for-profit support
organization for the LSUHSC – New Orleans and the medical faculty group practice, is the Vice
Chancellor for Clinical Affairs, reporting to Dr. Hollier, as Chancellor, and to Dr. Nelson, as Dean. The
Chief Executive Officer of the HealthCare Network is also accountable to the Board of Directors of the
organization. The Chief Medical Officer of the HealthCare Network is the Associate Dean for Clinical
Affairs, Thomas Nolan, MD, MBA, who reports to the Dean and to the Chief Executive Officer for the
organization.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-10. The dean must be qualified by education and experience to provide leadership in medical
education, scholarly activity, and care of patients.
___________________________________________________________________________________
Include here a brief resume of the dean’s academic and administrative experience. In the Appendix,
provide a full CV.
Steve Nelson, MD, Dean of the School of Medicine, is highly regarded bythe faculty and students for his
accomplishments as teacher, clinician, and researcher. He has spent the majority of his academic career
at the LSUHSC School of Medicine. He is the John H. Seabury Professor of Medicine, and Professor of
Pediatrics, Physiology, and Microbiology and Immunology. He is an active researcher with long-standing
grant support from the National Institutes of Health and other funding agencies. He was appointed Dean
in September 2007 after a national search conducted by a committee representative of the LSUHSC
campus.
Since 1984 Dr. Nelson has been an active staff member (Pulmonary/Critical Care) at MCLNO and at other
facilities in the New Orleans Area. His major clinical interests include pneumonia, adult cystic fibrosis,
and sepsis. Dr. Nelson has served on our faculty in multiple roles including that of Section Chief of
Pulmonary/Critical Care Medicine and Vice Chair in the Department of Medicine. Most notably, he is
the Director of the Alcohol Research Center, a large interdepartmental project funded by the National
Institute on Alcohol Abuse and Alcoholism with an annual budget of $2M. His research interests are
primarily directed at understanding normal pulmonary host defense mechanisms and determining the
potential of biological response modifiers for prevention and treatment of pulmonary infections. He has
obtained recognition for exemplary teaching of medical students, residents, and fellows. He serves on
the editorial board of several journals, is a member of the Bests Doctors in America, and is the author of
196 peer reviewed publications and 30 book chapters. The complete curriculm vitae for Dr. Nelson is
provided in the Appendix.
Degree
MD – McGill University, Montreal, Canada, 1978
Internship:
Medicine, Johns Hopkins Hospital, Baltimore, Maryland, 1978-1979
Residency:
Medicine, Johns Hopkins Hospital, Baltimore, Maryland, 1979-1981
Fellowships:
Clinical Fellowship in Pulmonary Medicine, Johns Hopkins Hospital, Baltimore, Maryland, 1981-1982
Research Fellowship in Pulmonary Medicine, Johns Hopkins Hospital, Baltimore, Maryland, 1982-1984
Fellowship in Environmental Health Sciences, School of Hygiene and Public Health, Johns Hopkins
Hospital, Baltimore, Maryland, 1982-1984
Board Certifications:
Licentiate, Medical Council of Canada -l978
Diplomate, National Board of Medical Examiners - 1979
Diplomate, American Board of Internal Medicine - 1981
FLEX - 1984
LCME Medical Education Database 2009-10
I. Institutional Setting
Diplomate, American Board of Internal Medicine, Pulmonary Disease - 1986
Diplomate, American Board of Internal Medicine, Critical Care Medicine - 1987
Medical Licensure:
Maryland, 1981, D26487
Louisiana, 1984, 06586R
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-11. The medical school administration should include such associate or assistant deans,
department chairs, leaders of other organizational units, and staff as are necessary to accomplish
the missions of the medical school.
There should not be excessive turnover or long-standing vacancies in medical school
leadership. Medical school leaders include the dean, vice/associate deans, department
chairs, and others where a vacancy could negatively impact institutional stability,
especially planning for or implementing the educational program. Areas that commonly
require administrative support include admissions, student affairs, academic affairs,
faculty affairs, graduate education, continuing education, hospital relationships,
research, business and planning, and fund raising.
___________________________________________________________________________________
a. Attach a chart showing the organizational structure of the dean’s office.
The Dean’s Office Organizational chart is attached and is available to the faculty and students on the
Dean’s Office website: http://www.medschool.lsuhsc.edu/administration/docs/deans_office_chart.pdf.
b. List the percent of effort which each associate and assistant dean contributes to the administrative
support of the medical school and for each, indicate his/her date of appointment to the administrative role.
Indicate if any associate/assistant dean position is being filled on an interim basis.
There are currently no associate/assistant dean positions that are filled on an interim basis.
Position
Dean
Assoc Dean for Fac & Inst Affairs
Dir of Faculty Development
Assoc Dean for Student Affairs
Assist Dean for Student Affairs
Assoc Dean for Research
Dir of Research Development
Assoc Dean of Admissions
Assoc Dean for Acad Affairs
Assist Dean for Acad Affairs
Dir of Basic Science Curriculum
Dir of Clinical Science Curriculum
Director of OMERAD
Assoc Dean for Fiscal Affairs
Assoc Dean for Clinical Affairs
Assoc Dean for Hlth Care Qual & Safety
Assoc Dean for Alumni Affairs
Assoc Dean for Comm & Minority Hlth Ed
Assoc Dean of Baton Rouge Affairs
Assist Dean of VA Affairs
Assistant Dean at Children’s Hospital
Assoc Dean of Lafayette Affairs
LCME Medical Education Database 2009-10
Name
Steve Nelson, MD
Janis Letourneau, MD
Paula Gregory, PhD
Joseph Delcarpio, PhD
Fred Lopez, MD
Wayne Backes, PhD
Jean Jacob, PhD
Samuel McClugage, PhD
Charles Hilton, MD
Richard DiCarlo, MD
Michael Levitzky, PhD
Robin English, MD
Sheila Chauvin, PhD
Keith Schroth, MBA
Tom Nolan, MD, MBA
Dwayne Thomas, MD
Cathi Fontenot, MD
Edward Helm, MD, MHA
W. Chapman Lee, MD
Paul Rosenfield, MD
Alan Robson, MD
James Falterman, MD
Appt
9/18/2007
6/1/1996
2/01/2009
1/1/2006
7/1/01
10/1/2001
11/1/2008
7/1/2000
7/1/2000
7/1/2002
2/10/1998
11/1/2008
10/1/2002
6/20/2003
11/1/2007
12/5/2008
1/1/2009
1/1/1996
10/1/2007
11/1/1996
???
10/1/2007
% Effort
100%
100%
30%
100%
80%
50%
30%
50%
100%
100%
33%
50%
100%
100%
50%
100%
70%
80%
100%
Gratis
Gratis
90%
I. Institutional Setting
c. Indicate the term of appointment for department chairs and the number of times that appointment can
be renewed.
Department chairs are appointed for an indefinite period.
d. Indicate the date of appointment for each currently sitting department chair.
Department
Cell Biology & Anatomy
Biochemistry & Molecular Biology
Genetics
Microbiology, Immunology & Parasitology
Pharmacology & Experimental Therapeutics
Physiology
Anesthesiology
Dermatology
Family Medicine
Internal Medicine
Neurology
Neurosugery
Obstetrics and Gynecology
Ophthalmology
Orthopedics
Otorhinolaryngology
Pathology
Pediatrics
Psychiatry
Radiology
Surgery
Urology
Stanley S. Scott Cancer Center
Gene Therapy Program
Neurosciences Center
Name
Samuel McClugage, PhD
Arthur Haas, PhD
Jay K. Kolls, MD
Ronald Luftig, PhD
Kurt Varner, PhD (interim)
Patricia Molina, MD, PhD
Alan Kaye, MD, PhD
Lee Nesbitt, MD
Kim LeBlanc, MD, PhD
Charles Sanders, MD
John England, MD
Frank Culicchia, MD
Thomas Nolan, MD, MBA
Donald Bergsma, MD
Andrew King, MBBCh
Daniel Nuss, MD
Jack Strong, MD
Ricardo Sorensen, MD
Howard Osofsky, MD, PhD
Leonard Bok, MD, JD, MBA
Christopher Baker, MD
J. Christian Winters, MD
Augusto Ochoa, MD
Alistair Ramsay, PhD
Nicolas Bazan, MD, PhD
Appt Date
9/1/2007
7/15/2004
1/1/2009
9/1/1983
12/1/2006
9/1/2008
1/31/2005
10/26/2004
9/1/2002
7/1/1989
11/19/2007
6/19/2006
8/1/2002
7/1/2003
7/1/2008
12/2/2000
4/1/1966
7/1/2000
7/1/1986
10/1/2006
12/1/2007
11/1/2006
11/1/2007
7/1/2005
7/1/1989
e. List the departments without a permanent chair and the date when the last permanent chair left office
Describe the status and timelines of recruitments to fill vacant chair positions.
Currently, there is only one Department (Pharmacology and Experimental Therapeutics) without a
permanent Department Head. The Department of Pharmacology has had an interim head since the
resignation of the permanent head in December 2006. Dr. Nelson, in concert with the department,
decided to suspend the pharmacology search for a short period of time due to the stability of the
department.
However, the Dean is conducting searches to replace the permanent Department Heads in the
Departments of Ophthalmology and Pathology; it is hoped that these positions will be filled by July 2009
or soon thereafter. With these latter searches no interim heads have been named because of the
anticipated speed of the search and because both department heads are comfortable remaining in their
seats while the searches are underway.
LCME Medical Education Database 2009-10
I. Institutional Setting
Since beginning as Dean, Dr. Nelson has named two permanent Department Heads in basic sciences, in
Genetics and in Physiology, both vacated due to retirements; he also has filled the Department Head
position in Orthopaedics, vacated by a disability-retirement.
Each department head search is conducted on a national basis with the committee comprised of campus
leaders and senior faculty members, and often with one outside consultant (if an endowed chair is being
considered as part of the recruitment package), with oversight from the Dean’s Office.
The search committee for Pathology includes an outside consultant from New Mexico, Mary Lipscomb,
MD, who satisfies the Louisiana Board of Regents requirement for an outside expert on the search
committee for endowed chairs. The advertisements for this position were posted in late 2008 and early
2009. To date, there have been approximately 10 applications, and three excellent candidates have
already been interviewed; a fourth candidate will be interviewed in March, 2009. Second visits for the
top candidates are anticipated to be in April, 2009, with an incumbent starting by July, 2009. The
Ophthalmology Department Head position was advertised beginning in October, 2008 and more than a
dozen applicants responded. Of those, two have been invited for visits in March and April, with a new
head hoped to be in place by Summer, 2009. This search committee will use an outside expert to
evaluate short-listed candidates, again fulfilling the Regents requirement for selection of an incumbent
for an endowed chair.
f. Briefly describe how, how often, and by whom the performance of chairs is reviewed.
The Dean formally evaluates the department heads and center directors at least oncea year; however,
the Dean schedules regular detailed reviews of departmental operations at least twice a year. During
the formal annual review, the Administrative Annual Review form (available on the School of Medicine
Faculty Affairs website ) is submitted in conjunction with the chair’s curriculum vitae.
g. Briefly describe the budgetary authority of department chairs, and the sources of funding for
departmental budgets.
The School of Medicine uses a budget allocation methodology that follows general Mission Based
Budgeting principles. The departments receive a budget allocation using a few fundamental formulaic
calculations. The department heads (and center and program directors) have delegated budgetary
authority within the limits or allocations established by the Dean’s Office. The Dean has ultimate
authority and accountability for the School of Medicine budget; the Dean receives recommendations
and advice from the Associate Dean for Fiscal Affairs, who exercises oversight over all the departmental
expenditures.
In the basic science departments, Mission Based Budgeting (MBB) guides the funding allocation for
teaching based directly upon the amount of teaching required for the educational programs of the
department. MBB also formulaically allocates funding for part of the salaries of research faculty; it is
anticipated that research grants support approximately 50% of the salaries for individual research
faculty members. Should a faculty member cover more than 50% of his/her compensation through
salary on grants, the department benefits financially from the additional salary “offset”. MBB also
allows for formula-driven funding allocations for administrative support for the department head and
faculty and for basic academic expenses (travel, dues) and for 50% of the department head salary and
benefits. Basic Science departments can build reserves through the generation of indirect costs on
grants, a portion of which accrues to each department, and offset of salary for research faculty funded
through extramural programs. Department Heads have broad discretionary use of reserve funds in
LCME Medical Education Database 2009-10
I. Institutional Setting
accordance with school, campus and university policies. Basic science departments can also request
funding from the dean to recruit new investigators (salary and start up) with the hope that extramural
funding will be successfully sought to cover costs of future research.
Like the basic science departments, the clinical science departments receive a formula-driven budget
allocation based on the number of full-time equivalent faculty members required for their educational
programs, the number of research faculty involved in funded investigational work, the total number of
faculty full-time equivalents and the attendant administrative and academic expenses, the Department
Head compensation, and the number of training programs in the department. Additionally, clinical
science departments generate revenue from the faculty physician practice (the LSU HealthCare
Network) and through contracts, established to formalize arrangements for professional services,
medical direction, and resident supervision to private and governmental entities. As is the case with
basic science departments, clinical science Department Heads can request funding to support the
recruitment of investigators and the recruitment of clinicians. Dean’s commitments to clinical science
departments for faculty recruitment are made with the expectation that individual faculty will generate
sufficient revenue (through extramural research programs or through clinical collections or contracts) to
support their activities. Clinical departments can build reserves through their portion of indirect costs
generated from grant revenues, from salary on grants offsets, and cost savings or departmental “taxes”
added into clinical contracts during negotiations. Clinical science Department Heads have broad
discretionary use of reserve funds in accordance with school, campus and university policies.
See also Part A, item (a.) in this section of the database.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-12. A medical school should be a component of a university offering other graduate and
professional degree programs that contribute to the academic environment of the medical school.
There should be regular and formal review of all graduate and professional programs in
which medical school faculty participate, to foster adherence to high standards of quality
in education, research, and scholarship, and to facilitate the progress and achievement of
the trainees.
___________________________________________________________________________________
a. Numbers of students enrolled in master’s and doctoral programs taught by medical school faculty.
Department or Program
Master’s Students
Biostatistics*
4
Biochemistry and Molecular
0
Biology
Cell Biology and Anatomy
0
Human Genetics
0
Microbiology, Immunology and
4
Parasitology
Neuroscience
1
Oral Biology
5
Pathology
0
Pharmacology and Experimental
1
Therapeutics
Physiology
0
*Largely a program of the School of Public Health
Doctoral Students
5
13
4
9
18
22
NA
1
20
10
b. Are there university or medical school policies that require regular review of graduate education
programs (master’s, doctoral)? If so, include a copy of the policy or related documents in the appendix.
All graduate programs in the state of Louisiana are reviewed periodically by the Louisiana Board of
Regents – the regulatory unit for higher education in the state.
http://www.regents.state.la.us/Academic/PP/Policies/2-6.html
“Academic Affairs Policy 2.06
Board of Regents Reviews of Existing Academic Programs/Units
The Board of Regents will periodically review and evaluate program quality and productivity at all levels
of higher education. Affected institutions will be required to participate in these reviews and
evaluations. Interested persons will be given an opportunity to appear before the Board of Regents prior
to decisions in each particular case.”
Programs with low completion rates are reviewed and if not successful, are terminated.
Within the LSU System, the LSU Health Sciences Center – New Orleans is accredited as an
independent entity by the Southern Association of Colleges and Schools. During the accreditation
process, the School of Graduate Studies is reviewed intensely because it is the only school that has no
other accreditation process.
LCME Medical Education Database 2009-10
I. Institutional Setting
c. Describe the process used for review of doctoral programs in the biomedical sciences.
The doctoral programs are under the aegis of the seven basic science departments (Biochemistry and
Molecular Biology; Cell Biology and Anatomy; Genetics; Microbiology, Immunology and Parasitology;
Pathology; Pharmacology and Experimental Therapeutics; Physiology) and the Neuroscience Center. A
new doctoral program in Biostatistics has recently been approved by the Board of Supervisors of the LSU
System and the Board of Regents of the state. This doctoral program is administered through the School
of Public Health but under the auspices of the School of Graduate Studies. The Dean of the School of
Graduate Studies, who also serves as the Vice Chancellor for Academic Affairs, is ultimately responsible
for review of doctoral programs. He is advised by the Graduate Advisory Council (GAC) which is made up
of the graduate coordinators from each of the degree-granting programs and another faculty member
who is appointed by the Department Head of each of the graduate programs. Thus, each doctoral
degree-granting program has two representatives to the GAC. The Curriculum Committee of the GAC
reviews requests for new courses and for changes in courses. Upon recommendation of the Curriculum
Committee, the GAC approves both the courses offered in the curriculum and changes to the
curriculum. The recommendation of the GAC is brought to the Dean of the School of Graduate Studies
for final approval. The GAC also approves nominations of faculty to be members of the Graduate
Faculty. Membership in the Graduate Faculty is required for faculty to be graduate student advisors for
masters and doctoral degrees. Applications to the Graduate Faculty are reviewed by the Membership
Committee of the GAC. Their recommendation is brought to the GAC whose approval is required prior to
the approval by the Dean. The doctoral program for each individual student is overseen by the student’s
Dissertation Committee which consists generally of four faculty members from the department and one
member from another Department or another University. All must be members of the Graduate Faculty.
The Committee members and the Department Head must sign their approval of both the Preliminary
Exam and the Defense prior to approval by the Dean of the School of Graduate Studies. The office of the
Dean of the School of Graduate Studies tracks students for timely completion of their doctoral training
program.
See also Part A, item (b.) in this section of the database.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-12-A. Medical students should learn in clinical environments where graduate and continuing
medical education programs are present.
In order to link medical student education to the later stages of the medical education
continuum, medical students should spend time in settings where graduate and
continuing medical education programs are present. It is expected that medical students
will participate, where appropriate, in the activities associated with these programs. The
graduate and continuing medical education programs at training sites where medical
students are located should be accredited by the appropriate accrediting bodies.
___________________________________________________________________________________
a. For each clinical facility where one or more students take a required core clerkship (except
ambulatory, community-based sites), mark a (+) if residents in ACGME-accredited programs are
involved in medical student education in that clerkship at that site; place a (–) for any clerkships offered at
that site where there is no resident participation.
Clinical Facility
Name
Ochsner-Kenner
MCLNO-LSU Interim
Hospital(University)
Earl K. Long
UMC-Lafayette
Joe Taylor-Lafayette
Our Lady of the
Lake-Baton Rouge
West Jefferson
East Jefferson
Baton Rouge
General
New Orleans
Adolescent Hosp
DePaul Campus
(MCLNO)
Ochsner-Jeff Hwy
Childrens
Bogalusa Medical
Center
Lake Charles
Touro
Fam. Med.
+
+
Int. Med.
Ob/Gyn
Pediatrics
Psychiatry
+
Surgery
+
+
+
+
+
+
+
+
+
+
+
-
+
+
-
-
+
+
+
+
+
+
+
+
+
+
b. If the medical school does not include a separate required clerkship in any of the above disciplines (for
example, in the case of a longitudinal clinical track for some students), describe these students’
interactions with residents, including the residents’ specialties and the settings in which these interactions
occur.
Not applicable
LCME Medical Education Database 2009-10
I. Institutional Setting
c. Provide the number of residents who are the responsibility of your faculty, by training program (Note:
If the school operates geographically separate clinical campuses, provide a separate table for each
campus):
Specialty of Training
Program
Dermatology
Medicine / Dermatology
Emergency Medicine
Medicine/Emergency Med
Family Medicine-Kenner
Medicine-Categorical
Medicine-Preliminary
Medicine/Pediatrics
Neurology
Child Neurology
Neurosurgery
OB/GYN
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pediatrics
PM&R
Psychiatry
Child Psychiatry
Surgery-Categorical
Surgery-Preliminary
Plastic Surgery
Medicine-A/I
Medicine-Cardiology
Medicine-G/I
Medicine-ID
Medicine-Nephrology
Medicine-Pulmonary
Medicine-Rheumatology
Neurology-Clinical
Neurophysiology
Ophthalmology-Retina
Orthopaedics-Pediatrics
Otolaryngology-Fellow
Pathology-Surgical
Pediatrics-A/I
Pediatrics –Endocrinology
Pediatrics – GI
Pediatrics-
PGY-1
residents
2
10
2
7
10
9
7
3
7
4
3
2
17
6
10
7
5
LCME Medical Education Database 2009-10
Total
Residents
Clinical Fellows
(ACGME-approved
programs)
Clinical Fellows
(Non-ACGME
approved programs)
16
2
43
9
21
35
23
14
2
7
28
25
20
14
7
56
21
29
6
38
5
4
1
13
6
5
6
8
2
1
3
1
1
1
4
3
2
4
I. Institutional Setting
Hematology/Oncology
Pediatrics - Neonatology
Pediatrics - Nephrology
PM&R – Pain Medicine
Surgery – Critical Care
Surgery – Vascular
3
1
3
2
2
The residencies for Anesthesiology and Radiology were accredited for July 1, 2009.
Specialty of Training
Program
*Sponsored by LSU School of
Medicine – New Orleans
Family Medicine-Bogalusa
Specialty of Training
Program
*Sponsored by LSU School of
Medicine – New Orleans
Family Medicine-Lake Charles
Specialty of Training
Program
*Sponsored as Earl K. Long
Hospital - a separate
sponsoring institution for
ACGME
EKL-Emergency Medicine
EKL-Int Medicine-Categorical
EKL-Int Medicine-Preliminary
EKL-OB/GYN
Specialty of Training
Program
*Sponsored as University
Medicine Center-Lafayette - a
separate sponsoring
institution for ACGME
UMC-Family Medicine
UMC-Family Medicine
Geriatrics
UMC-Internal Medicine
residents
Total
Residents
4
8
PGY-1
residents
Total
Residents
7
23
PGY-1
PGY-1
residents
15
10
7
4
Total
Residents
Clinical Fellows
(Non-ACGME
approved programs)
Clinical Fellows
(ACGME-approved
programs)
Clinical Fellows
(Non-ACGME
approved programs)
Clinical Fellows
(ACGME-approved
programs)
Clinical Fellows
(Non-ACGME
approved programs)
Clinical Fellows
(ACGME-approved
programs)
Clinical Fellows
(Non-ACGME
approved programs)
41
33
residents
Total
Residents
8
24
PGY-1
Clinical Fellows
(ACGME-approved
programs)
1
9
LCME Medical Education Database 2009-10
27
I. Institutional Setting
d. Describe the mechanism used for oversight and coordination of graduate medical education, including
evaluation and allocation of training positions. Note any programs currently on probation, as well as
programs being substantially expanded or reduced in size.
The School of Medicine oversight of the graduate medical education training is done through the LSU
Office of Graduate Medical Education with the Associate Dean for Academic Affairs as the leader. The
oversight committee (Graduate Medical Education Committee) holds monthly meetings and follows a
timeline of issues to be discussed at each meeting throughout the year to ensure that training programs
are up to date on compliance and administrative issues regarding the education of residents. The
Graduate Medical Education Committee is comprised of residency and fellowship program directors,
chief residents and other residents, senior educators, and administrative staff. Some of its
responsibilities are as follows.
Internal Program Reviews give the LSU Office of Graduate Medical Education an opportunity to evaluate
the training programs at mid accreditation cycles to rectify any weakness or citations that may be seen
in a program. The committee also reviews the materials developed in support of new residencies and
fellowships before they are submitted to the respective Resident Review Committees. The committee
develops policies and procedures and proposes acquisition and allocation of the many resources needed
for compliance with ACGME Residency Review Committee requirements. The establishment,
implementation, and refining of institutional policies for graduate medical education, including those
involving discipline, due process, selection and promotion, are handled by the committee. The allocation
of training positions is overseen by the Office of Graduate Medical Education and also approved by the
ACGME. Programs participate in the NRMP – National Residency Matching Program.
e. For each accredited institution, provide the following information regarding ACGME Institutional
Review of graduate medical education programs sponsored by the school or its major teaching hospital(s):
Date of Last ACGME
Institutional Review
5/22/2008 (LSU SOM- N.O.)
5/28/2008 (UMC-Lafayette)
5/17/2005 (Earl K Long-B.R.)
Date of Next
Review
Status
Continued
Accreditation
Continued
Accreditation
Continued
Accreditation
11/2013
10/2011
Anticipated date
10/2009
f. If the medical school or its clinical affiliates are accredited by the ACCME to sponsor continuing
medical education for physicians, indicate each program’s current accreditation status, length of
accreditation granted, and year of the next accreditation review.
Program Sponsor
Accred. Status
LSU School of Medicine,
New Orleans
ACCME Accreditation
Length of Accred. Term
6 years
Year of Next Review
11/2011
g. Describe how medical students have the opportunity to participate in continuing medical education
programs. Is participation in any continuing medical education programs expected/required?
LCME Medical Education Database 2009-10
I. Institutional Setting
Students and residents are allowed to participate in competency based CME programs in our Learning
Centers where applicable, and all students participate in various departmental Grand Rounds which
have CME sponsorship by the school through the IPE. Participation requirements are handled on
individual departmental levels.
See also Part A, item (c.) in this section of the database.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-13. The program of medical education leading to the MD degree must be conducted in an
environment that fosters the intellectual challenge and spirit of inquiry appropriate to a community
of scholars.
___________________________________________________________________________________
a. If not already described in the response to standard IS-1, briefly summarize institutional goals and
priorities relating to research and scholarship.
These goals are taken directly from the recent Strategic Plan (2008).
 Goal #1
Promote excellence and innovation in all School of Medicine educational programs
o Enhance undergraduate education in context of LCME accreditation standards
 Assure comparability in educational opportunities across training sites
 Conduct independent evaluations of clerkship experiences in New
Orleans, Baton Rouge and Lafayette
 Strengthen administrative relationships and support for clerkships in
New Orleans, Baton Rouge and Lafayette
 Develop comparable didactic (core curricular) experiences in New
Orleans, Baton Rouge and Lafayette
 Assess technical and space support for teaching activities in Baton
Rouge and Lafayette and address deficiencies if identified
o Emphasize competency-based educational programs in curriculum objectives
 Incorporate ACGME core areas of competence into undergraduate and graduate
curricula
o Introduce students and house officers to basic principles of clinical and translational
research integrating principles into preclinical courses, developing on-line basic science
modules for required clerkships, and developing a Biomedical Sciences Course
o Establish data base of educational experiences and an Electronic Learner Portfolio
project
 Develop a consistent tracking method for required clinical experiences
 Centralize student and faculty evaluations and outcomes data
 Begin development of Electronic Learner Portfolio
o Enhance simulation programs in Student Learning Center and Center for Advanced
Practice
 Conduct comprehensive planning effort focused on Student Learning Center and
Center for Advanced Practice
 Strengthen operational model to ensure greater responsiveness to specialtyspecific needs
 Solidify designation as American College of Surgeons Comprehensive
Education Institute
 Consider creation of a Simulation Subcommittee to the Computer-Assisted
Learning Curriculum Committee
 Encourage scholarship in educational programs using simulation and
competency-based curricular goals
 Evaluate staffing mix and role definitions to assure optimal blend of
technical/training support and those involved in content development
 Assess feasibility of partnering with hospital training sites (especially HCSD
facilities) to coordinate simulation-based educational efforts focused on patient
care and outcomes (i.e. CMS designated “never events”)
LCME Medical Education Database 2009-10
I. Institutional Setting

o
Initiate faculty development in basic curriculum using simulation and case-based
teaching
Expand and strengthen Rural Scholars Track
 Assess full range of clinical (i.e. office-based primary care, nursing home, and
hospice or end-of-life care settings), didactic, and scholarly experiences, as well
as associated settings, that would lead to a strong and distinctive Rural Scholars
Track
 Develop written curriculum and learning objectives to distinguish Rural Scholars
Track from the remainder of the undergraduate curriculum
 Formalize administrative support for program and expand training site
opportunities
 Review admissions recruitment strategies
 Increase exposure to primary care in curriculum
 Goal #2
Foster a culture of academic and investigative excellence
o Enhance research capabilities of clinical departments and prioritize the recruitment of
faculty and faculty leadership with translational research expertise
o Continue support for intramural research funding
 Continue Clinical Translational Research Initiative (LSUHSC Research Council)
 Expand scope of SOM Research Enhancement Programs
o Implement curricular changes emphasizing basic and translational research
 Expand research content in pre-clinical courses
 Develop semester course for clinical trainees (Biomedical Sciences Course)
o Support faculty through mentoring and research development programs
 Fill position of Director of Research Development
 Assist departments and centers in developing faculty support in
research efforts
 Build mentoring programs for individual (junior) faculty through senior
faculty, department heads, and program and center directors
 Work with departments and centers to develop regular research
programs (research or work in progress or grant-seeker sessions)
 Coordinate multiple seminar series opportunities
o Create a Research Advisory Committee which includes senior research faculty members
 Provide specific recommendations to departments and centers for potential
research development and faculty development
 Assist in development of semester Biomedical Sciences Course (see above)
 Provide recommendations to Associate Dean for Research on web development
 Assist in selection of Dean’s Distinguished Lectureship nominees
o Develop mechanism through SOM or LSUHSC to better address research infrastructure
needs, particularly core laboratories
 Consider feasibility of creating SOM Research Infrastructure Committee under
Associate Dean for Research
 Undertake needs assessment for new cores
 Make recommendations for best utilization of resources
 Standardize core facilities operations and charges
o Improve SOM Office of Research web-based tools
 Improve research website
LCME Medical Education Database 2009-10
I. Institutional Setting



o
Develop relevant links to active research units
Hyperlink to large funded programs
Develop thematically based link to individual investigator research
strengths and interests
 Post recent news and funding opportunities
 Data Base for Researchers
 Catalog expertise, major research equipment, and scientific
accomplishments
 Identify available research opportunities or collaborations for students,
house officers, and junior faculty
Enhance SOM “Scientific Programs”
 Consider Grand Rounds Panel Series with clinical and basic science faculty
involvement
 Encourage research seminars within all departments/centers
 Assess feasibility of SOM seminar series featuring junior faculty
 Consider seminar series in technology transfer
 Encourage regular interactions between Office of Technology Transfer and
research faculty members
 Create Dean’s Distinguished Lectureship Series for a noteworthy visiting
professor
b. Summarize institutional efforts or programs that address research ethics, scientific misconduct,
conflicts of interest, and human subjects protection. List the administrative units that oversee such
programs, and describe their target audiences.
The LSUHSC-NO “Human Subjects Protection Program” is managed by Kenneth Kratz, PhD, Director,
LSUHSCOffice of Research Services (ORS: http://www.lsuhsc.edu/no/administration/rs/). In addition to
Dr. Kratz, this program has three full time coordinators. Dr. Kratz acts as chair of the Institutional
Review Board (IRB) portion of this program that provides review, approval, and oversight of all human
subjects research at LSUHSC-NO. The program currently manages over 600 studies, half of which are
greater than minimal risk clinical trials. Policies and procedures of the IRB and all forms related to
human subject protection are available at the IRB website at the following URL:
http://www.lsuhsc.edu/no/administration/rs/irb/default.htm .The program uses the Collaborative
Institutional Training Initiative (CITI) for its mandatory training in human subject protection. All
members of all human subject research teams must complete this training. This includes faculty, staff
and students who are involved in these projects. The learning modules within CITI required by LSUHSCNO include not only training in human subject protection but also Good Clinical Practice and research
misconduct. Access to the CITI website and LSUHSC-NO instructions for use of the program are available
through the IRB website listed previously.
Research misconduct is monitored by the Vice-Chancellor for Academic Affairs, Joseph M.
Moerschbaecher, PhD. He acts as the Research Integrity Officer who conducts investigations of research
misconduct under the LSUHSC-NO research misconduct policy and through its assurance with the Office
Research Integrity (ORI). This policy (sect. 10.7) is available in the Faculty Handbook at the following
URL:
http://www.lsuhsc.edu/no/administration/academic/FacultyHandbook.pdf . As required under the
assurance, a report on cases of research misconduct (plagiarism, fabrication of data, and falsification of
data by faculty, staff and students) is provided yearly to ORI. As listed at the following URL:
LCME Medical Education Database 2009-10
I. Institutional Setting
http://www.lsuhsc.edu/no/administration/academic/StandingCommittees2008-09%20.pdf , a standing
Committee on Scientific Misconduct is appointed by the ORI. This committee helps in the investigation
of cases of research misconduct and makes recommendations to the Institution through the ORI as to
the outcome of its investigations.
Policies and procedures with regard to conflicts of interest in research projects are outlined in
Chancellor’s Memorandum 35 (CM 35) available at the following URL:
http://www.lsuhsc.edu/no/administration/cm/cm-35.aspx . This process requires investigators to
provide an attestation form from all members of a study team (faculty, staff and students) as to whether
they have any potential conflicts of interest with the potential sponsor. If potential conflicts exist, then
the specific study team member having that conflict must follow the CM 35 process by providing a full
financial disclosure. With this disclosure a standing Conflict of Interest Review Committee (see
http://www.lsuhsc.edu/no/administration/academic/StandingCommittees2008-09%20.pdf ) develops a
management plan for the conflict of interest. If human subjects are involved in the project, then the IRB
must review the plan to determine if subject welfare is adequately protected by the plan. Investigators
and study team members must agree to comply with the management plan.
All of these programs are established by the LSU Health Sciences Center to fulfill federal regulatory
requirements. Just as importantly, however, they help create an environment in which all members of
the university sense the weight and need for responsible conduct in research and the ethics which
underlie this conduct. The institution attempts to convey such ethics to our medical students through
specific courses within the medical school curriculum.
During the second year, case studies that deal with research ethics are presented in the “Legal and
Ethical Issues in Clinical Medicine” section of course “Science and Practice of Medicine” (SPM 200). The
cases are discussed in groups of 40 students in the Fall and Spring semesters. These cases deal with the
following research ethics issues:
The Fall case relates to informed consent in clinical research, and purpose and function of the IRB,
including approval, annual review, random monitoring, how human subject research is highly regulated
by the federal government, minimizing risks and maximizing benefits, and the equitable selection of
subjects. The core dilemma presented in this discussion is how to advance scientific knowledge while
protecting human subjects through current regulations and ethical principles based on the Nuremberg
Code, the Declaration of Helsinki, and the Belmont Report.
The Spring case relates to scientific misconduct, financial conflicts of interest, Bayh-Dole, etc. legalizing
use of research for development and partnering with industry, the violation of the trust - cures such as
thresholds and ceilings, bans and separating decisions from funds, disclosures, increased federal
government oversight - proposals for disclosure & uniform accreditation, audits and inspections -with
some anecdotes of Academic Centers who violated the trust. Finally the larger issue of physician
contracts with industry - phase IV post drug approval, etc. - are discussed.
In development, for presentation during the third year, is an amplification of research ethics using the
CITI program (CITI learner group: L3 course director Joanne Marier, JD) discussed earlier. This will be a
required activity in the “Applied Ethical and Legal Issues in Clinical Medicine” during the student
clerkships, beginning in the 2009-2010 academic year. This online training will again examine issues on
human subjects protection and scientific misconduct.
LCME Medical Education Database 2009-10
I. Institutional Setting
And last, in the fourth year, a special topics course “Legal Issues for Providers” is presented during a
two-hour lecture to the entire class. Issues related to conflicts of interest and clinician contracts with
industry are presented. This discussion centers on clinical research with devices and drugs and hired
marketing bureau activities.
While course work helps convey the weight and need for research ethics and related programs, it is the
actual behavior of the faculty that set the example of appropriate conduct of research. Other areas of
ethics education occur in classroom discussion, via activities performed during clerkships, and while
students gain practical experience doing research projects, thus insuring that students are immersed in
an environment of ethical behavior related to research.
Other programs contribute to this environment including HIPAA research compliance activities
monitored by the ORS (http://www.lsuhsc.edu/no/administration/rs/HIPAA/default.htm), Institutional
Bio-safety Committee and Radiation Safety Committee activities assisted by the ORS and Office of
Environmental Health and Safety (http://www.is.lsuhsc.edu/safety/default.aspx), and the Animal
Welfare Program and Institutional Animal Care and Use Committee
(http://www.lsuhsc.edu/no/administration/rs/IACUC_Forms.htm), which is managed by the ORS. Ethical
and regulatory issues related to these programs are provided to students through their involvement in
research programs.
See also information for standards FA-5 and FA-8 in Section IV of the database, and Part A, item (e .) in
Section V of the database.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-14. Medical schools should make available sufficient opportunities for medical students to
participate in research and other scholarly activities of the faculty, and encourage and support
student participation.
It is expected that medical schools will provide an appropriate number and variety of
research opportunities to accommodate those students desiring to participate. To
encourage participation, medical schools could do such things as provide information
about available opportunities, offer elective credit for research, hold research days, or
include research as a required part of the curriculum. Support for student participation
could include offering or providing information about financial support for student
research (such as stipends).
___________________________________________________________________________________
a. Briefly describe the opportunities available for medical student participation in research, including the
time periods when students may do so, the number of students involved in each type of program
(e.g., MD/PhD, MD/MS, summer research, year out research), and the funding sources that are available
to support student participation.
There are currently four programs in the LSU Health Sciences Center that offer opportunities for medical
students to participate in research: the MD/PhD program, summer research, the Honors program, and
the MD/MPH program. In addition, there are annual Research Day activities in the Schools of Graduate
Studies and Allied Health Professions, the Neuroscience Center and the Departments of Medicine and
Pediatrics, as well as in several other departments or units within the school, through which medical
students can participate in presenting their own research and in learning more about the research
being performed at LSUHSC. Additional Seminar Series are sponsored by the Clinical and Basic Science
Departments as well as the Centers of Excellence and seminars are widely advertised to the LSUHSC
community on the Electronic Bulletin Boards.
Programs through which research is made available to medical students:
MD/PhD Program
The traditional time course for the program is the first two years of medical school followed by
3-5 years in graduate school to complete the PhD. Students then return to the 3rd and 4th years of
medical school to complete the MD degree. There are currently 26 students in the MD/PhD program – 6
in the 1st year of medical school, 5 in the 2nd year and 15 in graduate school. Of the 15 in graduate
school, 5 will be completing the PhD in 2009 and returning for the 3rd year of medical school. Students
are provided a tuition waiver for the first 2 years of medical school. During the graduate school portion
of the program, students receive both a tuition waiver and a stipend through the department in which
they complete their dissertation research. Currently some students are supported by an NIAAA training
grant which has recently been renewed (3rd funding period) by Gregory Bagby, PhD of the Department
of Physiology. Some students are funded through National Service Research Awards through NIH. Some
students are funded through supplements to NIH grants and individual NIH grants, and, finally, some
students are supported by funds from the School of Graduate Studies. The websitesfor the MD/PhD
Program are: http://graduatestudies.lsuhsc.edu/MD_PhD.htm and
http://www.medschool.lsuhsc.edu/admissions/programs.aspx#MD.
Summer Research
LSUHSC offers several summer research programs that provide research opportunities for
medical students. All of them focus on research during the 8 week summer break between the first and
second years of medical school. One program is the Medical Student Summer Research Fellowship
LCME Medical Education Database 2009-10
I. Institutional Setting
which sponsors approximately 15-20 students per year. All students give oral presentations at a the
Medical Student Summer Research Forum and then the three top presenters are given travel support to
attend the National Student Research Forum sponsored by the University of Texas Medical Branch in
Galveston, TX.
There are two other summer research programs. One program under the supervision of Paula
Gregory, PhD is a combined program between Tulane University and LSU Health Sciences Center funded
by the Louisiana Gene Therapy Consortium, Louisiana Vaccine Consortium, and the Louisiana Cancer
Research Consortium. It offers support for medical students at both institutions as well as
undergraduate and high school students. Medical students generally participate in this program during
the summer between the first and second years of medical school. Approximately 10 medical students
are supported through this mechanism per year. The website for this program is:
http://www.medschool.lsuhsc.edu/genetics/summer_student_program.aspx.
The other summer research program is under the supervision of Alfredo Lopez, MD, PhD and
John Estrada, MD. It had been funded by the National Cancer Institute (“Short Research Experiences in
Cancer”) for 20 years, but funding has expired; renewal of funding is ongoing. Approximately 6-8
medical students participate in this program per year which generally supports students between the
first and second years of medical school. In addition, matriculating medical students and undergraduate
college students participate, such that there are 20 total students who participate each year in this
program. Two of these slots are supported by funding from the Stanley S. Scott Cancer Center, indicating
institutional commitment to student research in cancer. The goal of this program is to foster an interest
in cancer research in students, with the hope that they will pursue this as an ultimate career goal.
Significantly, there is an active effort to recruit and place underrepresented minority students into this
program, and a number of students each year are from Xavier University, a traditionally AfricanAmerican institution in New Orleans.
Honors Program
Students who have performed well academically during firstyear of medical school and are
interested in continuing their summer research, are invited to join the Honors Program. Their research is
performed during available time in the second and third years of medical school, during which they give
presentations on their research at least once per year. In their fourth year the students are required to
write a thesis and present their research in a seminar setting. The research is supported by the mentor,
but the students do not traditionally receive a stipend during the second and third years of medical
school. The website describing this program is:
http://www.medschool.lsuhsc.edu/admissions/programs.aspx#honors.
MD/MPH Program
Students enrolled in medical school are allowed to take courses and complete the requirements
for the MPH degree. Students are not required to pay additional tuition. The accrediting program
requires that students receive the same training, i.e. number of hours of coursework, whether they are
enrolled in the MPH program by itself or simultaneously with their medical school education. Generally,
3-5 students complete the MD and MPH programs simultaneously. The website with information about
the MPH program is: http://publichealth.lsuhsc.edu/Degrees.html.
b. Describe how students are informed about opportunities to participate in research.
Students are informed about research opportunities through the School of Medicine Office of
Admissions and Office of Student Affairs, the School of Medicine website, brochures given to medical
students at orientation and by personal communication of instructors teaching in their courses primarily
during the first year of medical school.
LCME Medical Education Database 2009-10
I. Institutional Setting
See also Part A, item (d.) in this section of the database.
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-14-A. Medical schools should make available sufficient opportunities for medical students to
participate in service-learning activities, and should encourage support and student participation.
“Service-learning” is defined as a structured learning experience that combines
community service with preparation and reflection. Students engaged in service-learning
provide community service in response to community-identified concerns and learn about
the context in which the service is provided, the connection between their service and
their academic coursework, and their roles as citizens and professionals [Definition from
Seifer SD. “Service learning: Community-campus partnerships for health professions
Education.” Academic Medicine 1998;73(3):273-277].
“Sufficient opportunities” means that students who wish to participate in a servicelearning activity should have the opportunity to do so. To encourage student
participation, medical schools could do such things as developing opportunities in
conjunction with relevant communities or partnerships, providing information about
available opportunities, offering elective credit for participation, or holding public
presentations or public forums. Support for student participation could include offering
or providing information about financial and social support for student service-learning
(such as stipends, faculty preceptors, community partnerships).
___________________________________________________________________________________
a. Is some type of service learning experience required, either as part of a regular course or as a selective?
If yes, describe.
The Service Learning Elective (SLE) offered at the LSU School of Medicine provides multiple
opportunities for students to participate in community service activities. Students with over 75 hours
service learning by the beginning of their fourth year of medical school will have their SLE hours
mentioned in their MSPE (i.e., Dean’s Letter) when applying to residency programs. The SLE is composed
of Professional Development and Community Service hours. If a student chooses not to complete 75
hours towards SLE credit, no mention of the elective is made. Consequently, students are encouraged
to complete the elective, but are not penalized if they do not.
b. Briefly describe the opportunities for medical student participation in voluntary service-learning
activities. Include the types of service learning opportunities that are available, the general level of
student involvement, and the sources and level of funding available for such activities.
Students can receive SLE credit hours through projects run by various student organizations (see
Appendix). Projects are pre-approved for credit hours by submitting a proposal to the Student
Government Association (SGA). Some organizations require participation in at least one of their
community service projects to be considered an active member.
Funding for student organizations and their community service projects is available through student
government or through individual fund raisers conducted by each organization. For example, every
year, the medical school sponsors a 5K race at Audubon Park in New Orleans called Tiger Run.
Registration is open to the public and the entry fee is between $15 and $20. Money raised by Tiger Run
is divided between the student-run homeless clinic and the SGA activity fund. Throughout the year,
student organizations can submit a proposal to SGA and request funding for approved projects from the
activity fund. Many student-run interest groups hold fund raisers at the beginning of the year and
collect dues from their members. Additionally, grant requests to national agencies may be made for
LCME Medical Education Database 2009-10
I. Institutional Setting
financial support. In addition to student leadership of these organizations, at least one faculty advisor
provides oversight. Of note, 45.7% of Class of 2009 received SLE credit.
Below are some historical examples of student organizations and their respective community service
projects:
 Admissions tours – college day tour guide (3 hours/tour)
 American Medical Association
o Stroke/diabetes screenings (2-4 hours/session)
o Glaucoma screening (3 hours/training session)
 American Medical Student Association
o Blood pressure & glaucoma screenings (1-5 hours/session)
 Asian Pacific-American Medical Student Association
o Blood pressure & glaucoma screenings (2-6 hours/session)
 Camp Tiger: a weeklong camp put on by first year medical students for disabled children
o Counselor (40 hours/week)
 Christian Medical and Dental Society
o Medical mission trip (60 hours/week)
 Day with the Docs: high school students interested in medicine get an interactive tour from a
medical student’s perspective
o Tour guides (3 hours/session)
o Teaching sessions (3 hours/session)
o Emergency care (3 hours/session)
o Student panel (1 hour/session)
 Edgar Hull Society (Internal Medicine Interest Group)
o Ozanam Inn (homeless shelter) volunteer (3 hours/clinic)
 Emergency Medicine Interest Group
o Teaching CPR to high schoolers (3 hours/teaching session)
o Choking awareness (1.5 hours/session)
o Healthcare provider renewal class (4 hours/class)
o Pediatric Basic Life Support (4 hours/class)
o Community healthcare provider class (8 hours/class)
 Family Medicine Interest Group
o Tar Wars: anti-smoking campaign in local schools (3 hours/class)
o Eighth grade career day presenter (3 hours)
 Geriatric Medicine Interest Group
o Blood pressure screenings (1-2 hours/session)
o Senior Olympics (up to 6 hours)
 Hispanic Clinic
o Clinic volunteer (1-4 hours/session)
 Student-run Homeless Clinics
o Adult clinic volunteer (4 hours/session)
o Ob/Gyn clinic volunteer (3 hours/session)
o Pediatric clinic volunteer (3 hours/session)
o HIV counselor training (14 hours)
 Integrative Medicine Interest Group
o Whole Foods blood pressure screenings (4 hours/session)
 Habitat for Humanity (hours vary by project)
 Obstetrics Interest Group
o Labor and delivery beautification volunteer
LCME Medical Education Database 2009-10
I. Institutional Setting








o Prenatal education classes (2 hours)
o Ob/Gyn clinic volunteer (up to 5 hours/day)
Pediatric Interest Group
o Young Docs presentation leaders and volunteers (2-4 hours/session)
o Children’s Hospital bingo nights and movie nights (3 hours/session)
Psychiatry Student Interest Group
o National Alliance of Mental Illness patient education volunteer (2 hours)
Public Outreach Depression Screening Program
o Training (1 hour/session)
o Screenings (4 hours/session)
Relay for Life participants (up to 12 hours)
Student International Health Organization
o Clinic volunteer for 7 day mission trip (8 hours/day)
o Conversational Spanish clinic (3.5 hours/clinic day)
Student National Medical Association
o Health professions high school recruitment (2 hours/visit)
o Health professions tour guide (4 hours/tour)
o Summer science interviews (up to 10 hours)
o Trick-or-Treat at Children’s Hospital (2 hours)
o Nursing home visits (up to 3 hours/visit)
Students Making It a Little Easier (SMILE)
o Children’s Hospital clinic parties (3 hours/party)
o Christmas toy distribution at Children’s Hospital (up to 4 hours)
o Audubon Zoo trip (4 hours)
Women in Medicine
o Race for the Cure volunteer (hours variable)
c. Describe how students are informed about opportunities to participate in service-learning activities..
There are many ways that medical students are informed about service-learning activities, beginning
with their acceptance to the Louisiana State University School of Medicine in New Orleans. Each student
is provided material prior to medical school that contains relevant information about service-learning
opportunities such as Camp Tiger, the freshman class service project. These packets also contain
information about the many student-run organizations on campus. These organizations and their
meetings are major mechanisms by which information regarding service learning opportunities is
communicated. At the beginning of the school year, an organization fair is held to introduce the new
students to the opportunities that are available to them through each organization. At this time,
students are encouraged to attend each organization’s initial meeting.
Through the school’s service learning elective (SLE), students can learn about the service-learning
projects associated with each organization, and also the amount of elective credit that is awarded for
each project. As each organization prepares for an upcoming project, students are sent emails informing
them of how they can get involved. Usually, each organization has several meetings each semester,
providing additional opportunities for informing interested students about service learning
opportunities. Needless to say, student organizations encourage all of their members to become
involved in these projects. In addition to the individual organization-specific emails, the SGA’s elected
secretary sends out weekly announcements to the entire student body, informing them of upcoming
events as well as who to contact if interested in participating in service-learning opportunities. Some
LCME Medical Education Database 2009-10
I. Institutional Setting
recent student volunteer work has received national media attention by helping to rebuild Hurricane
Katrina-destroyed houses through the St. Bernard Project. Media coverage is another method for
informing students and the local community about the efforts occurring at the medical school.
Specifically, here is a recent e-mail sent to the students regarding SLE:
From: Mai, Sophia V.
Sent: Thursday, January 22, 2009 9:18 AM
To: MEDICINE 2012
Subject: SLE information
As promised, below is a summary of top points discussed in McKenzie Mayo’s SLE presentation on
Wednesday. Because the Service Learning Elective (SLE) is an ongoing project, I recommend that you
bookmark these points for future reference (I also attached it in a word document).
 SLE is not required, only encouraged. Upon completion, it will be included on your transcript.
 There are 2 separate components to SLE: Professional Development (PDE) and Community
Service (CSE). You can earn only CSE credit or only PDE credit, both, or none.
 To earn CSE credit you must complete 75 hours in at least 3 different activities. These are
activities that benefit the community outside of LSU. Examples include the usual volunteering
activities like blood drives, homeless clinics, or mission trips.
 To earn PDE credit you must complete 75 hours in at least 3 different activities. These are
activities that are needed to implement a community service activity or develop peer education
programs. Examples include mock practicals, interview tours, planning for Camp Tiger.
 Projects from CSE and PDE can overlap. You do not have to have a total of 6 different activities
to earn both CSE and PDE. You just need 3 different activities for each SLE component.
 Activities must be completed from the start of 1st year to October of your 4th year. The only
exception to this is Camp Tiger (the summer before your first year).
 Only activities listed on the approved list provided by the SLE committee may be included on the
SLE form (the list is attached). If it is not listed on the list you must submit a proposal to the
SLE committee to be voted on during the next committee meeting. You may get proposal
information and examples from the class secretary.
 The form is to be filled out every semester for the previous semester (for example, you will
complete the Fall 2008 SLE form in Spring of 2008) and submitted to the class secretary before
the deadline.
 Each activity listed on the form must be confirmed by signature or email.
 At the end of each semester, the class secretary will compile a spreadsheet with the each
person’s hours. She will be able to tell you how many hours you have accumulated as well as if
you qualify to earn the credits.
The deadline for submitting Fall 2008 SLE forms is March 20, 2009 (This is 2 weeks after the 2nd test so
there is adequate time for everyone!). Directions for completing and submitting forms are below:
LCME Medical Education Database 2009-10
I. Institutional Setting

Print out an attached SLE form and fill out activity information including the date,
name/organization, and number of hours. There is a column for approval by the coordinator
that must be signed. If you cannot get a physical signature, an email confirmation is acceptable.
Please print the email and staple to the form.

There will be a box underneath the NTS folders in the atrium of the MEB. Please deposit all
forms in the box by March 20, 2009. At the end of each week, I will try to send an email to
individuals confirming recipient of the form.
Christian Hernandez (VP of community affairs) and I will be meeting with the SLE committee sometime
this month or in February. There is still some confusion on whether committee members for Camp
Tiger (aside from the committee chairs) are eligible to earn PDE credit. As soon as a clear and concise
decision is made on the issue, I will inform the class. As for now, please fill out your SLE forms (it doesn’t
take long at all) and if you have any questions about any aspect of SLE, please do not hesitate to email
me. Also, I added a calendar on our bulletin board outside of the lecture hall with our weekly schedules
(including lectures, DXR, SPM schedules, holidays, and social events). I’ll update this every month. If
you have any other suggestions that would make our academic lives easier and flow more smoothly,
please email me.
Thanks,
Sophia Mai
LSU-SOM, Class of 2012
Phone: (504) 975-9177
e-mail: smai@lsuhsc.edu
LCME Medical Education Database 2009-10
I. Institutional Setting
IS-15. All medical school faculty members should work closely together in teaching, research, and
health care delivery.
Because the education of both medical students and graduate physicians requires an
academic environment that provides close interaction among faculty members, those
skilled in teaching and research in the basic sciences must maintain awareness of the
relevance of their disciplines to clinical problems. Conversely, clinicians must maintain
awareness of the contributions that basic sciences bring to the understanding of clinical
problems. These reciprocal obligations emphasize the importance of collegiality among
medical school faculty across disciplinary boundaries and throughout the continuum of
medical education.
___________________________________________________________________________________
Describe any organized activities or events that promote faculty collaboration in the achievement of the
school’s missions and goals, such as integrated teaching efforts, collaborative research projects or
programs, or faculty development activities. Note any obstacles (such as geographic separation) that may
impede collaboration and describe how they are mitigated.
The committee canvassed Department Heads in the Clinical and Basic Sciences Departments. The
following tables give examples of collaboration in the three areas outlined above.
Basic Science Departments
DEPARTMENT
Anatomy
TEACHING
The Department offers
first year Medical
Students courses such as,
Human Prenatal
Development, Medical
Gross Anatomy and
Medical Neuroscience in
conjunction with
Pediatrics, Surgery,
Genetics, and Neurology.
Fourth year Medical
Students collaborate
with Surgery, Radiology,
Pathology, ENT and
OB/GYN in the Senior
Surgical Anatomy
Elective.
Biochemistry
The Biochemistry faculty
collaborates with other
Basic Science
Departments in team
teaching the first year
LCME Medical Education Database 2009-10
RESEARCH
A Bioinformatics
Specialist collaborates
with investigators from
Biochemistry and other
Departments in the
SERVICE
The Department is joined
with Physiology,
Pathology, Genetics,
OB/GYN, Anatomy,
Psychiatry, Neuroscience
I. Institutional Setting
graduate course,
Integrated Graduate
Curriculum (Cell Biology
& Development) for the
Graduate School of
Biomedical Sciences.
School of Medicine on
bioinformatic projects
involving protein and
gene sequence analysis,
in addition to software
development.
Teaming with
Pharmacology, first year
Medical Students are
offered Medical
Pharmacology and
Medical Biochemistry.
Other collaborations with
Pharmacology have
resulted in two
submitted grants with
the topic of determining
the structure of specific
proteins. Collaborations
with The Cancer Center
and Ochsner Foundation
Clinic are on the role of
ISG15 in cancer
progression and
Parkinson’s disease.
Center, LSU Alumni and
the LSU Foundation to
participate in Strategic
Planning and
Communications
workgroups.
Collaborations with
Pathology, Biostatistics,
Pharmacology and
Genetics are on the
etiology of breast cancer.
Genetics
The Department offers a
multitude of courses in
association with other
Departments. First year
Medical Students are
offered Medical Genetics
through the Medical
School and Pediatrics.
Genetics Through
Lifespan is offered at the
Nursing School. Genetics
in Physical Therapy is
offered to Physical
Therapy Students
through Allied Health.
First year graduate
students take Molecular
Biology and Control of
Gene Expression, working
with the Biochemistry
Department. Other
classes are offered
LCME Medical Education Database 2009-10
The Department
collaborates on many
grants with other
organizations such as,
Tulane Medical School,
Washington University,
Mayo Clinic, University of
Cincinnati, University of
Colorado, Karmanos
Cancer Institute,
University of Toledo
College of Medicine,
Saccomanno Research
Institute, National
Human Genome
Research Institute, MD
Anderson Cancer Center,
National Cancer Institute,
National Human Genome
Research Institute, Ponce
School of Medicine and
Nicholls State University.
The Department is joined
with Physiology,
Pathology, OB/GYN,
Anatomy, Psychiatry,
Neuroscience Center, LSU
Alumni and the LSU
Foundation to participate
in Strategic Planning and
Communications
workgroups.
Members of the faculty
are associated with the
LSUHSC Committee on
Women’s Affairs, Faculty
Assembly, the Graduate
Advisory Council, the
Curriculum Committee,
the Council on
Professional Conduct, the
Institutional Biosafety
Committee, and the Area
I. Institutional Setting
Microbiology
Pharmacology
Physiology
through Allied Health
Professions, the Doctor
of Audiology program,
and Tulane Medical
School.
The Graduate Students,
Medical Students and
Dental Hygiene Students
are offered courses in
collaboration with
Children’s Hospital,
Pennington Center,
Hansen’s Center, the
School of Dentistry, the
Department of Medicine,
and Pediatrics.
Students in the
Department take
Medical Physiology and
Pharmacology courses,
offered in conjunction
with Medicine, MIP,
Opthalmology, Genetics,
Neurology,
Anesthesiology, Geriatric
Medicine, Family
Medicine and the School
of Allied Health.
The department teaches
1st year medical
students, nurse
anesthetists, and
graduate students.
Collaborative teaching
arrangements exist with
Jimmy Cairo, PhD and
Ben DeBoisblanc, MD at
the School of Allied
Health Department of
Medicine.
LCME Medical Education Database 2009-10
Health Education Center.
Research collaborations
occur with many
Departments, such as
Infectious Diseases, Gene
Therapy, Pharmacology,
Pathology, OB/GYN,
Molecular Sciences,
Pediatrics,
Ophthalmology, and
Physiology.
The Department
collaborates with Strategic
Planning Research and
Core Facilities, Radiation
Safety Committee,
Institutional Biosafety
Committee, Teaching
Academy Committee,
Faculty Senate, N.O. and
School Outreach Program.
The Department
participates in a Seminar
series and Journal Club
with Physiology.
We have an R01, NIDA
funded grant with
Physiology, Microbiology,
Animal Care and
Pathology regarding THC
impact on SIV
progression.
Our COBRE grant is with
Physiology, Biochemistry,
Pathology and Surgery,
“Mentoring in
Cardiovascular Biology”.
The THC impact on SIV
progression R01, NIDA
funded, project involves
the following
Departments or Schools:
Physiology (Molina, PI),
Pharmacology
(Winsauer, Varner),
Microbiology (Amedee),
Animal Care (Birke) and
Pathology (Zeiske,
Troxclair).
The Department is joined
with Pathology, Genetics,
OB/GYN, Anatomy,
Psychiatry, Neuroscience
Center, LSU Alumni and
the LSU Foundation to
participate in Strategic
Planning and
Communications
workgroups.
I. Institutional Setting
Clinical Science Departments
DEPARTMENT
Anesthesiology
TEACHING
RESEARCH
The Department
provides lectures to the
medical students within
the Pharmacology,
Surgery & Neuroscience
Departments.
Lectures and simulation
teaching on airway
management are
offered to the
Emergency Medicine
residents. Teaching is
provided by attending
staff to ER, Surgery, and
Anesthesia residents, as
well as medical students
and critical care fellows
in the Trauma ICU. The
Department collaborates
in the multidisciplinary
Pain Fellowship that
includes Neurology,
PM&R, Psychiatry and
Anesthesiology fellows.
A clinical Gross Anatomy
course is offered to
medical students,
interns and residents.
Dermatology
Family Medicine
LCME Medical Education Database 2009-10
HEALTH CARE DELIVERY
Anesthesiology faculty
collaborate on a daily
basis with Surgery and
Surgery subspecialties
in the care of patients
in the operating room
at University Hospital
and Kenner Oschner.
Collaborations with
Eugene Woltering in
Surgery – angiogenesis
studies in psoriasis
patients using antiangiogenesis agents.
A collaboration with Dr.
Ouhtit in PathologyGenetics on melanoma
and non-melanoma
skin cancer patients.
An interdepartmental
project between Family
Medicine and Pediatric
Genetics: to establish
etiological diagnoses
for adult patients with
developmental
disorders.
The revamping of the
community ICU at YYY
Medical Center was
done to facilitate
dialogue between
academic intensivists
and community
physicians who are
accustomed to an
I. Institutional Setting
In collaboration with
Family Medicine,
patient recruitment for
studies are conducted
by the Department of
Nephrology.
open-model ICU.
Internal Medicine:
The LSU Tumor Board
has collaborations with
the LSU Department of
Surgery and the
Department of
Medicine.
Gastroenterology
The Carcinoid Clinic, a
subspecialty clinic
based at OchsnerKenner Medical Center,
is composed of LSU
surgical and medical
specialists.
Assistant Professor,
Shier Sission
collaborates with
medical students,
internal and family
medicine residents.
Geriatrics
In the School of Allied
Health, LSU PT and OT
students rotate at the
John Hainkel Nursing
Home, for which we
have responsibility for
the delivery of medical
services.
Hematology and
Oncology
The Cancer Center
supports a seminar
series that provides a
forum for faculty across
the School of Medicine
to hear speakers on a
variety of research
topics.
LCME Medical Education Database 2009-10
Public Health –
currently working with
an MPH candidate from
the School of Public
Health regarding
research in the area of
vaccine use in nursing
home populations.
LSU Dental School has
developed a contract
affiliated with the LSU
John Hainkel Nursing
Home, for which the
section provides
delivery of care,
providing ongoing
dental/oral and hygiene
care.
The Department works
with Cancer Center
researchers in
developing
collaborative projects.
The Cancer
Centerprovides support
for surgical specialists
for clinical trials
(NSABP, etc.)
The Tumor Board
organizes the ongoing
multi-disciplinary
conference, enhancing
resident, fellow, and
I. Institutional Setting
student teaching, as
well as multi-modal
patient care for cancer
patients.
Several faculty
participate in the second
year MIP course as
lecturers and Julio
Figueroa is the CoDirector of this course.
Infectious Diseases
The Infectious Diseases
(ID) research programs
intersect with many
Departments at the
Medical Center,
especially Microbiology.
The ID STD core lab
supports Microbiology
faculty research
programs, providing
clinical specimens for
projects. Members of
the ID section and MIP
faculty are coinvestigators on several
grants.
Surgery, Urology,
Gynecology,
Orthopedics and
Medical Oncology and
Hematology are jointly
developing a central
access number for
patients with cancer.
Major collaborative
clinical endeavors are
located in the HIV
Outpatient Clinic on
South Roman Street,
collaborating with the
following Departments:
Ophthalmology, OB
GYN, Dermatology, Oral
Surgery and General
Dentistry (Dental
School) and Psychiatry.
Other Departments
having collaborations in
research are:
Pediatrics, through the
Research Institute for
Children at Children’s
Hospital; Physiology;
Pathology; OB GYN;
School of Public Health;
the Gene Therapy
Program; the Stanley
Scott Cancer Center;
and, the Dental School.
Active research
collaborations exist in
the Section of
Pulmonary Medicine.
LCME Medical Education Database 2009-10
I. Institutional Setting
Nephrology and
Hypertension
The Department has a
bi-monthly joint case
presentation with the
Section of
Rheumatology. Lectures
are held in conjunction
with Family Medicine,
Physiology, Radiology,
Physiology and
Pharmacology.
The Department also
participates in lecture
series with Tulane
School of Medicine,
Physiology, Tulane
School of Public Health,
Geriatric Board Review
Course, and Family
Medicine Review
Course.
Residents and fellows of
Trauma, Orthopaedics
and Neurosurgery are
taught about exams,
prognosis and early
management of SCI and
TBI, along with
management of
agitation in TBI and
clinical issues, i.e., vent
weaning in high SCI.
Physical Medicine and
Rehabilitation
PM &R hold lectures
several times each year
for the School of Allied
Health (PT/OT) and
participates in the
interdisciplinary
Musicians’ clinic.
The Department has
Pharmaceutical
Industry Grants: five
clinical research trials
(ongoing), Geriatrics
has three ongoing and
one that terminated in
2008, and Family
Medicine has one
ongoing and three
performed/completed
between 2006-2008.
The Department
participates in activities
and public service with
the Louisiana Public
Hospitals, leader of
disease management
(hypertension).
The Department, along
with the Department of
Comparative Medical
Sciences,LSU School of
Veterinary Medicine,
and the Department of
Pathology, Tulane
Medical School has a
Pharmaceutical
Industry Grant, PI
initiated, bench
research in 2005 –
2009.
PM &R participates
heavily in the Trauma
program, including
preparation for the site
visit that led to
certification as a Level I
Trauma center.
The Department helped
develop the policy that
all SCI, TBI and major
amputation cases are
evaluated by a protocol
that involves consult of
PM & R within 2-3 days
post trauma.
Having one of the few
LCME Medical Education Database 2009-10
I. Institutional Setting
PM & R ACGME
accredited Pain
fellowships in the
country, this program
merged with Neurology
to allow a broadened
training opportunity for
the fellows.
PM & R participates in
weekly interdisciplinary
pain programs with LSU,
VA and Tulane trainees
and faculty.
The Department has a
joint appointment with
the School of Public
Health in the
Environmental and
Occupational Health
Sciences, a grant with
the Alcohol Research
Center and an Alcohol
Training Grant with the
Department of
Physiology.
Pulmonary/Critical Care
Medicine
Freshmen are offered a
Physiology Course
through joint
appointments with the
LSU Department of
Physiology. Other
lectures include the
Departments of
Pharmacology, Surgery
and the Dental School.
Research collaborations
include the Department
of Genetics, the Gene
Therapy Program, the
Cancer Center and
Tulane Gene Therapy
Program.
The Department has an
Alcohol Research
Center T32 Training
Grant from the Alcohol
Research Center, as
well as a grant from the
Gene Therapy Center
on Tuberculosis, and
one from the
Environmental
Protection Agency on
Oxidase and Iron
Metabolism.
Research with Tulane
University involves
immunosuppressive
neuropeptides in
animal models of
collagen-induced
arthritis and psoriasis
and psoriatic arthritis.
This is in collaboration
LCME Medical Education Database 2009-10
Monthly RenalRheumatology
Conference, Monthly
Citywide Rheumatology
Conference (in
collaboration with
Ochsner Medical
Center Rheumatology
Department).
I. Institutional Setting
with the Tulane
University Peptide
Center, funded by the
LA State Board of
Regents.
Rheumatology
Neurology
Role of Chlamydia
trachomatis in Reactive
arthritis: In
collaboration with the
University of South
Florida College of
Medicine. Funded by
the National Institutes
of Health.
Psoriatic arthritis
outcome measures:
In collaboration with
GRAPPA (an
international research
group for the study of
psoriatic arthritis).
Neurosurgery – medical
students (MS IV) do a
combined 4-week
rotation for
Neurology/Neurosurgery
with shared faculty
teaching responsibilities
and lectures.
Residents from
Neurosurgery do
Neurology electives in
University Hospital (UH)
and faculty clinics;
residents from
Neurology do electives
on Neurosurgery at UH
and West Jefferson
Hospital; monthly
combined Neurology
and Neurosurgery grand
rounds.
Pediatrics – residents
rotate through pediatric
neurology, which is
LCME Medical Education Database 2009-10
Radiology – several
collaborative research
projects in multiple
sclerosis and
cognitive/behavioral
neurology supported by
the NIH.
Psychiatry- PGY1
rotations (required) in
Neurology .
Pediatrics- upper level
pediatric resident
rotations (in pediatric
neurology).
Neurosurgery – several
collaborative projects in
deep brain stimulation
to assess benefit and
cognitive changesthese are both animal
and human studies;
several collaborative
projects in epilepsy via
the Epilepsy Monitoring
Unit (EMU) at West
Jefferson Hospital.
Neurosurgery –
collaborative efforts at
UH , CH, and West
Jefferson Hospital; the
Epilepsy Monitoring
Unit (EMU) at West
Jefferson Hospital is a
joint venture of
Neurology and
Neurosurgery.
Psychiatry – several
collaborative research
projects in epilepsy
surgery and epilepsy
pharmacological
Stroke team at UH is a
collaborative effort
between neurology,
neurosurgery,
medicine, critical care,
radiology, emergency
medicine, and
I. Institutional Setting
within the Department
of Neurology.
Pathology – weekly
lectures and pathology
conferences at Childrens
Hospital (CH).
Cell Biology and
Anatomy – neurology
faculty teach in the
Neuroscience course for
MSI .
Medicine – PGY1
Neurology residents do
one year of internal
medicine at LSUHSC.
therapy.
rehabilitation services.
Psychology – several
collaborative research
projects in autism
spectrum disorder and
developmental
stuttering at CH in
cognitive/behavioral
neurology and pediatric
neurology and with
Psychology at Tulane.
Sleep lab at UH is a
joint effort between
neurology and
Pulmonary Medicine.
Pharmacology –
collaborative projects in
neuropathic pain and
sodium channel
pathophysiology. These
studies are also done in
collaboration with the
Department of
Physiology at the Univ
of Colorado.
Memory Disorders
Clinic at Ochsner
Medical Center is a
joint effort between
Cognitive/Behavioral
Neurologists from
LSUHSC and
neurologists,
psychiatrists, and social
services from Ochsner.
Neuroscience Center –
NIH funded projects on
brain ischemia and
epileptogenesis in
conjunction with Dr.
Nicolas Bazan.
Neurosurgery
Monthly interdepartmental epilepsy
conference is held with
Neurology Department.
The faculty presents 10
lectures in the first year
Medical School
Neuroscience course, as
well as a lecture on
anatomical dissection
for the fourth year
Medical School of
Surgical Anatomy.
Monthly lectures are
presented to the senior
Medical School Clinical
Neuroscience rotation.
LCME Medical Education Database 2009-10
The Department is
collaborating with the
Neuroscience Center of
Excellence on funded
projects investigating
the treatment of
chronic pain, reversal of
re-perfusion stroke
injury, and mechanisms
of growth in malignant
primary brain tumors.
The OMFS service has a
four month rotation of
one of their first year
residents on the
Neurosurgery service.
That resident is fully
incorporated into the
service and functions as
a first year
Neurosurgery resident.
I. Institutional Setting
Obstetrics &
Gynecology
Collaborative efforts
with other departments:
Anatomy – annual
lectures on pelvic
anatomy, cadaver
dissections and cadaver
surgical procedures.
Pathology – weekly
pathology conferences.
Pediatrics – teach PGY1
newborn resuscitation
and life support
certification and
pediatric & adolescent
gynecology lectures.
Family Medicine (FM) –
lecture residents in FM
for their didactic
curriculum and FM
residents rotate in
OB/GYN clinics.
Surgery – laparoscopic
simulation skills training,
joint surgical skills
curriculum and
SAGES/FLS.
ID – HIV research
project collaboration
between faculty and
resident and Chlamydia
resident research
project.
OMERAD – research
study design and
analyses, education
effectiveness,
interdepartmental
collaboration and
facilitate inter-school
collaboration.
PGY1 rotations for
Emergency Medicine
and Family Medicine
residents. Family
Medicine OB coverage
at UMC to support
program.
Ophthalmology
MS II surgical rotation
elective- 2 wk
ophthalmic
clinic/surgery rotation.
Microbiology,
Immunology &
Parasitology (MIP) –
several collaborative
research projects in
HSV gene therapy and
Epstein bar virus.
Numerous consults
with all clinical
departments on
individual patient care
at the MCLNO, UH,
Lafayette, Bogalusa,
EKL, and private clinics.
MSIII Clerkship (10 days)
Lectures and workshops
on Ophthalmology.
Residents- Collaborative
teaching of LSUHSC
Family Practice residents
in Bogalusa, Lafayette,
UH, MCLNO, EKL and
private clinics.
Internal MedicineLecture series 2/yr.
Neuroscience- several
collaborative projects
investigating the
relationship between
Alzheimer’s and HSV
and the effects of
oxidative stress on
retinal epithelial cell
function.
Cancer Centercollaborative projects
on immunological
suppression.
LCME Medical Education Database 2009-10
I. Institutional Setting
Dental Schoolcollaborative project on
polymer material
analysis.
MSIV Research rotation
(1 month) with
departmental research
faculty.
Orthopaedics
The Orthopaedic
Department has a
teaching relationship
with the Anatomy
Department.
Collaborations occur
with Microbiology and
ID on biofilm formation
on various materials.
The LSU Hand Surgery
Program has
collaborations with
Plastic Surgery.
Research collaborations
with the Department of
Pathology to investigate
articular cartilage.
Orthopaedics is
participating in the
spinal deformity study
group, with a data base
of over 5,000 cases.
Orthopaedics
collaborates closely
with Surgery in the
level one Trauma
Center at the LSU
interim hospital.
An internationally
recognized bioengineer
who is a clinical faculty
member, is supported
by the Brown
Foundation.
Otorhinolaryngology
The Department has a
teaching relationship
with the Department of
Anatomy, presenting an
Emergency
Airway/Cricothyrotomy
Workshop to over 100
first-year students and
three hours of neck
dissection and
parotidectomy anatomy
and surgical techniques
lectures as part of an
elective course received
by fourth year students.
Students and residents
participate in
conferences, such as the
multi-disciplinary Tumor
Board, which enhances
LCME Medical Education Database 2009-10
Faculty members with
an interest in research
are encouraged to
submit proposals. To
further development of
faculty research
through collaborative
efforts, the Chairman
will serve as a liaison to
research directors and
principal investigators
throughout the school.
The Department
collaborates with the
Departments of
Pediatrics and Family
Medicine at Children’s
Hospital of New
Orleans in the care of
pediatric patients, as
well as student and
resident education.
The Department
participates in the
Surgery clerkship of
third year students, and
provides a fourth year
elective to seniors.
During the junior
rotation, students
rotate through Our
I. Institutional Setting
Pathology
teaching and patient
care for head and neck
oncology patients.
Mentoring from faculty
is provided to those
interested in entering an
Otolaryngology-Head
and Neck Surgery
residency program.
Faculty sharpens their
teaching and mentoring
skills by attending a
series of seminars
(Teaching the Teachers
to Teach), and receiving
manuals. These
measures promote
uniformity and
continuity of the
different services and
the assurance that each
faculty member
understands their role in
resident and student
education.
The Department is
involved in teaching
sophomore medical
students two major
courses in the second
year. Elective teaching
experiences are
provided in the senior
year and for medical
technology students in
the School of Allied
Health.
Lady of the Lake
Regional Medical
Center, Earl K. Long
Medical Center,
University Medical
Center and Children’s
Hospital of New
Orleans.
Research collaborations
with the Department of
Pharmacology, the
COBRE Research Group,
and the Cancer Center
have been established.
The Department
provides service to the
Interim LSU Public
Hospital, the Bogulusa
Medical Center and
Children’s Hospital.
The Department also
serves seven HCSD
Hospitals supporting all
the laboratories in this
system.
Faculty teaches graduate
students and MD/PhD
students, providing
education for
gastroenterology
fellows, ob-gyn residents
and pathology residents.
Pediatrics
The Department has a
combined Internal
LCME Medical Education Database 2009-10
The Department of
Pediatrics collaborates
I. Institutional Setting
Medicine/Pediatric
training program.
with the Surgery,
Urology, ENT, and
Radiology Departments
in the care of pediatric
patients at Children’s
Hospital.
The Family Medicine
residents rotate at
Children’s Hospital for
their pediatric
requirements.
Psychiatry
The Department teaches
Science and Practice in
Medicine 100 with
Family Medicine and
Pediatrics Faculty.
It assists School of
Nursing faculty with
instructing students
during their psychiatry
clinical rotation.
The Department assists
The School of Allied
Health’s Occupational
Therapy Department by
providing lectures about
psychiatric conditions.
Neurology residents
rotate through the
emergency psychiatry
service.
The Department has a
PGY2 course,
“Neuropsychiatry”, with
faculty from the
departments of
Neuroanatomy,
Neurology, and
Neurosurgery who
lecture to the residents.
The faculty provides
lectures for meds/peds
residents about
psychiatric diagnosis and
treatment.
Pediatric Neurology
fellows rotate through
the outpatient child
psychiatry specialty
clinics.
Tulane Social Work
LCME Medical Education Database 2009-10
Collaboration with
Neurology and
Neurosurgery in
investigator initiated
trials for treatment of
depression in patients
with temporal lobe
epilepsy and the study
of patients with
psychogenic nonepileptic seizures.
Collaboration with
Pediatrics on research
concerning post
traumatic stress
symptoms and
symptoms of
depression in children
and adolescents
following Hurricane
Katrina.
Collaboration with
Anesthesiology on
components of ECT
delivery.
Collaboration with
Surgery to determine
the degree of
psychopathology in a
surgical follow up clinic
at a level one trauma
center. Collaboration
with the Office of
Mental Health, Tulane
School of Social Work
and UCLA on impact
and efficacy of State
Crisis Counseling and
specialized services
Consultation with all
departments at
University Hospital
related to combined
medical/surgical and
psychiatric needs.
Planned collaborations
to evaluate patients
prior to Bariatric
surgery.
Collaboration with
Neurology and
Neurosurgery in the
Epilepsy Center of
Excellence with
referrals for preoperative evaluations
for DBS implantation
and implantation of
spinal cord stimulators.
Collaborative
consultations with the
Department of
Pediatrics on
outpatient specialty
needs at the
Department’s
outpatient clinics.
Provision of psychiatric
inpatient care in
collaboration with
Pediatrics at the
Children’s
Hospital/Evergreen
Health Management
Adolescent Unit (just
recently
accomplished).
I. Institutional Setting
Radiology
interns receive training
and outpatient and
community based
psychiatry programs.
programs.
Research and
collaboration with
Medicine, Emergency
Medicine and Nursing
related to secondary
traumatic stress.
Radiology teaches an
annual 2 week course
for LSU School of
Medicine.
Radiology has
collaborated with
Orthopedic Surgery and
Neurology on Research
projects.
The Department
participates in Grand
Rounds and gives
lectures for various
subspecialties, e.g.:
Breast Imaging for
Surgery Department,
Interventional Radiology
for OB/GYN and CTAngiography in Trauma
for the Trauma
Interdisciplinary
Conference.
The Department Chair
has worked extensively
on restarting a residency
program, which will
commence in July 2009.
Surgery
The Surgery Department
has a third year clerkship
in surgery coordinating
with Vascular,
Cardiothoracic, Urology,
Pediatric Surgery,
Plastics Surgery, ENT and
Orthopaedic services.
LCME Medical Education Database 2009-10
The Department
participates actively
with several
departments in
University Hospital-LSU
Tumor Board (weekly),
which involves Clinical,
Radiology -Pathology
Correlation.
Radiology has a
representative at the
weekly Pulmonary Case
Conference, as well as
the Internal Medicine
Morning Report
meeting.
The Department
participates in the
Trauma Peer Review
weekly conference, and
the weekly Breast Case
Management
Conference, which
meets in the Medical
School, Department of
Pathology. All cases are
reviewed for Clinical,
Radiology and
Pathology correlation.
Working with the
Center for Advanced
Practice, the
Department of Surgery
faculty participates in
the education of
students and residents,
and team training of
nurses and
anesthesiologists.
I. Institutional Setting
Collaborations with
Eugene Woltering’s
research with GI med,
Dermatology, Oncology,
and multiple patients
and grants.
Carcinoid
The Trauma Group
conducts prevention
research with the SPH
and multiple research
studies on trauma and
critical care.
Trauma/Critical Care
The Carcinoid Group
has a large national
referral practice at
Kenner Regional
Hospital, with
collaborations with GI
Medicine and Medical
Oncology.
Collaborations with
Tulane Surgery and LSU
Anesthesiologists on
care of trauma and
critically ill patients.
Vascular works with
Interventional
Radiology on stents.
Vascular
Urology
Dr. Bazan acts as
Clerkship Director for
the Surgery Clerkship.
The Department offers
3rd and 4th year clinical
clerkships: 2-4 Junior
medical students per
rotation and 5-7 Senior
“sub-internships”.
Senior rotations include
General Urology,
Urologic Oncology and
Urologic Research.
In collaborating with
Anatomy, residents
assist in teaching Junior
medical students
genitourinary anatomy
(assist in dissection).
Collaborations with
Surgery include faculty
lectures at GS trauma
conference and grand
rounds. The
Department participates
in Surgery’s Cohn’s
Conference and junior
surgical small groups.
Urology teams with
LCME Medical Education Database 2009-10
Dr. Bazan is doing
collaborative research
on a COBRE grant with
Pharmacology.
Urology collaborates
with the School of
Public Health on several
projects, including the
Metabolic Syndrome in
Prostate Cancer (Grant
awarded) and NC/LA
Prostate Cancer Project
(SPORE with Stanley the
Scott Cancer Center).
Collaborations with the
Stanley Scott Cancer
Center involve joint
efforts in developing
GU malignancy
research programs and
LCRC Tumor banking
with Cancer Center.
Pulmonary Medicine
collaborations have
resulted in 2 IRB
approved clinical trials
initiating through
pulmonary clinical trials
division.
The Department has a
Prostate Cancer
Screening Directorship
and an ESWL
Directorship at LSU
Interim Hospital. The
Proposed Directorship
in Urodynamics at LSU
Interim Hospital is in
direct collaboration
with Gynecology,
Neurology and
Neurosurgery. In
collaboration with
Urogynecology at EJGH
Touro and LSU Interim
Hospital, a joint
fellowship program has
emerged in female
pelvic medicine and
reconstructive surgery.
Collaboration with
Ochsner Clinic involves
Pediatric Urology,
Female Urology and
Voiding Dysfunction.
Advanced
I. Institutional Setting
Gynecology in academic
instruction of fellows in
urogynecology. Urology
is joined with Medicine
in giving lectures at IM
grand rounds.
The Program Director
coordinates Urology
residents at LSU and
Ochsner.
Coordinated faculty
research with Dr. Nick
Bazan.
percutaneous stone
management is a result
of collaboration with
Interventional
Radiology at LSU
Interim Hospital and
EJGH. The Department
collaborates with LSU
Neurology in the
Multiple Sclerosis Clinic
and patient outreach
programs.
Obstacles:
 Lack of horizontal and vertical integration of knowledge and resources into the educational
process.
 Lack of education director at departmental level to direct and re-design entire curriculum.
 Lack of coordination (cooperation) between departments.
 Under-development of web based curriculum.
 Geographic separation (de-centralization) of faculty and students/residents.
 Lack of time commitment (financial) of faculty.
 Lack of development of clinical faculty as educators.
 Poor faculty knowledge of available resource.
 Lack of commitment for inpatient rehab at UH and delays in start of PM & R and EMB clinics.
 Barriers to collaboration for Family Medicine remain to be geographic separation, with few
Faculty located downtown and Residencies spread across Kenner, Lafayette, Lake Charles, and
Bogalusa.
 Competing clinical/administrative demands for clinical faculty participating in research.
 Departments with which we collaborate are at scattered sites.
 There are funding challenges for non-clinical positions in light of fiscal uncertainties.
 Although the Department of Psychiatry is trying very hard to respond to requests, it is difficult to
respond to urgent needs of LSU facilities in other regions of the state.
LCME Medical Education Database 2009-10
I. Institutional Setting

IS-16. Each medical school must have policies and practices to achieve appropriate
diversity among its students, faculty, staff, and other members of the academic community
and must engage in ongoing, systematic, and focused efforts to attract and retain students,
faculty, staff, and others from demographically diverse backgrounds.
Aspiring future physicians will be best prepared for medical practice in a diverse society if they
learn in an environment characterized by, and supportive of, diversity and inclusion. Such an
environment will facilitate physician training in:




Basic principles of culturally competent health care
Recognition of health care disparities and the development of solutions to such burdens
Importance of meeting the health care needs of medically underserved populations
Development of core professional attributes, such as altruism and social accountability,
needed to provide effective care in a multidimensionally diverse society
Each school should articulate its expectations regarding diversity across its academic community
in the context of local and national responsibilities, and regularly assess how well such
expectations are being achieved. Schools should consider in their planning elements of diversity
including, but not limited to, gender, racial, cultural and economic diversity. Schools should
establish focused, significant, and sustained programs to recruit and retain suitably diverse
students, faculty members, staff, and others.
_____________________________________________________________________________________
a. Provide a copy of all current mission statement(s) and policies at your institution that are related
to assuring a diverse student body, faculty, and staff.
The LSUHSC-NO Diversity Initiative envelopes all of the school and campus policies that can be found at
the following locations. Slight variations in emphasis occur, due the the particular needs and nature of
the segment of the population to which each is addressed.






Faculty Handbook Section 4.4
http://www.medschool.lsuhsc.edu/admissions/Criteria.aspx
http://www.lsuhsc.edu/no/administration/cm/cm-10.aspx
http://www.lsuhsc.edu/no/administration/hrm/forms/administrative%20Procedures.doc
http://www.lsuhsc.edu/no/administration/cm/cm-56.aspx
http://www.medschool.lsuhsc.edu/faculty_affairs/pdf/som_strategic_plan.pdf.

Describe the process by which these statements and policies were developed, approved, and
implemented at your institution.
The processes involved in the development of these statements and policies are varied. In the case of
the Diversity Initiative, a focused plan was developed at the request of the Chancellor. In other instances
deficience and/or omissions are adrdressed by the development of new policies or revisions of old ones.
If deficiencies were observed, or if situations and needs dictated, these statements and policies were
developed and approved via the mechanisms that are established and appropriate for each type of
document (e.g., for the Faculty Handbook, Chancellor Memoranda, etc.).
LCME Medical Education Database 2009-10
I. Institutional Setting
The overarching LSUHSC – NO Diversity Initiative was developed by the former Associate Vice Chancellor
for Academic and Multicultural Affairs, Loren Blanchard, PhD. It will become part of the Strategic Plan
for the LSUHSC-NO along with relevant benchmarks. This initiative was developed primarily by the
Associate Vice Chancellor using input from the deans of the component schools of LSUHSC-NO, the
faculty and its leadership bodies, and representatives of the student body. It was approved by the
Chancellor and is in the process of being implemented.
The Faculty Handbook is the responsibility of the Vice Chancellor for Academic Affairs. The content of
the LSUHSC Faculty Handbook is regularly reviewed and revised by a committee representative of the
component schools of the campus to maintain consistency with Federal and State Regulations, LSU
System Bylaws and Policies, and other over-riding regulations or policies; specific input from the Faculty
Senate is sought on Faculty Handbook changes. The handbook specifically references diversity on
campus and our equal opportunity policies for hiring. The Chancellor has the authority to approve the
content of the Faculty Handbook.
The School of Medicine Admissions Committee reviews its mission statement and introductory page on
the web site annually; changes that are made are the consensus product of the committee members
and approved by the Dean. Each year the committee members are reminded of the diversity goals of the
admissions process. Additionally, orientation for new committee members stresses the importance of a
diverse and representative student body. Implementation of these policies is evidenced by the strong
record of diversity in matriculated students in the student body. These data are reviewed annually by
the Admissions Office and by the Office of Community and Minority Education and reported to the
General Faculty, the Administrative Council, and to the Dean.
The website for Human Resource Management outlines the advertisement, recruitment, selection, and
hiring process for faculty and staff. The check list on the website outlines how our process and
procedures conform to Federal and State Regulations. All EEOC guidelines are adhered to and
implemented. The Assistant Manager of Human Resources has the responsibility of drafting the policies,
with final approval lying with the Chancellor. Implementation of these policies is evidenced by the
consistency with which Human Resource Management requires the submission of appropriate
documentation before an individual can be formally hired as faculty or staff. An annual report for the
campus on diversity is prepared for the Vice Chancellor for Academic Affairs; this report reviews our
collective campus data and relevant sections are appended for reference.
Chancellor’s Memoranda are typically developed by the relevant Vice Chancellor, with or without input
from the campus leadership or faculty as needed, and approved by the Chancellor. As mentioned below
the Chancellor’s Memorandum #10 affirms our commitment to adhere to all federal and other relevant
regulations in regard to hiring practices for faculty and staff. Implementation is addressed in the
previous paragraph. Moreover, there are several steps in the recruitment and hiring process (as laid out
in the procedural document attached) (ATTACH PROCEDURAL DOCUMENT TO APPENDIX) that demand
a process that encourages a broad slate of candidates. The preamble to Chancellor’s Memorandum #56
outlines the rights of students from all backgrounds and implicitly defines our commitment to diversity;
the appeal process for students is defined in this document.
The School of Medicine Strategic Plan, recently completed and under implementation, cites diversity
and community outreach as overarching goals. The Strategic Plan was developed through a consensus
process focusing on specific charges from the Dean by a large number of participating faculty members,
faculty leadership, and strategic partners. The participating faculty members were selected to be widely
representative of the school, across departments, appointment track and rank, race, and gender; formal
LCME Medical Education Database 2009-10
I. Institutional Setting
representation by the School Faculty Assembly and the LSUHSC Faculty Senate was also included. The
Strategic Plan was presented to the Administrative Council and was approved by the Dean. We are
currently in the early stages of implemented many of the initiatives that were developed and included in
the Strategic Plan.

Describe how these statements and policies are made known to current and prospective
applicants, students, employees, faculty, and staff
Applicants are made aware of the relevant commitments and policies largely through our web and
printed materials prepared for the admissions process. Students have access to diversity policies
through the LSUHSC and School of Medicine websites and by email distributions on important changes
or additions to our policies; the Associate Dean for Student Affairs is principally responsible for
communications with students. Policies are discussed at General Faculty Meetings and Administrative
Council Meetings. Department Heads and Center Directors are responsible for communicating policy
changes and adoption of new policies to their faculty members. There is an electronic subscription
service that faculty and staff can use that announces and directly links to all new LSU System and
LSUHSC policies. The Chancellor also holds campus Town Hall Meetings that are venues for the entire
campus community to learn about new policies and procedures.
b Describe how your institution defines or characterizes diversity for its students, faculty, and staff. What
dimensions of diversity are considered? If different definitions apply to any of these institutional
constituencies, provide each relevant definition.
In its broadest sense, diversity is the richness of differences - genetic, environmental, and cultural - that
results in variety in human beings. A diversity of members in the LSUHSC community is desirable, as it
allows all members of the school to experience these differences, become enriched by this exposure,
and to respond in an appropriate and beneficial way to those who are different from oneself. This is
particualry important in the education of medical students. Physicans diagnose and treat all patients
with equivalent professionalism and care, and it is important for our students to be aware of issues that
stem from the diversity of the patient population. For example, an understanding of a higher incidence
of a disease in a certain racial population or the dietary restrictions of those from different cultures can
affect the ability of a physician to efficaciously manage a patient. As far as is possible, LSUHSC-NO
strives to promote diversity at all levels on campus.
Formally, we report diversity in accordance with the federally defined categories of American Native,
Asian, African American, and Hispanic, as well as gender. However, other subtle dimensions of diversity
are also considered, particularly in the admissions process for the entering class, including
disadvantaged backgrounds not necessarily driven by ethnicity or race.
In the context of your definition of diversity, describe how your policies related to diversity are put into
practice in each of the following areas:
 Student recruitment, selection, and retention
 Financial aid
 Educational program
 Faculty /staff recruitment, employment, and retention
 Faculty development
 Liaison activities with community organizations
LCME Medical Education Database 2009-10
I. Institutional Setting
The mission of the Louisiana State University Health Sciences Center in New Orleans (LSUHSC – NO) is to
provide education, research, and public service through direct patient care and community outreach.
Clearly, our community is diverse by any standard. LSUHSC – NO provides vital public service through
direct patient care, including care of uninsured and indigent patients. LSUHSC – NO works cooperatively
with two Area Health Education Centers (AHEC’s), whose programs focus on improving the number and
distribution of health care providers in underserved rural and urban areas of Louisiana and on
supporting existing rural health care providers through continuing education programs.
The Medical School Admissions Committee strives to, as far as possible, recruit and admit Louisiana
residents from every geographic, economic, social and cultural dimension of the State of Louisiana.
While it is not possible to exactly recapitulate the demographics of the State, every effort is made to
recruit as represeantative a student body as is feasible. As stated in the Office of Admissions website,
“The primary goal of the School of Medicine in New Orleans is to produce competent, humanistic
physicians. In order to meet this goal, the School of Medicine finds that having a diverse student body is
essential. Diversity in all its forms benefits students by creating a dynamic, productive, and positive
learning environment that promotes better cross-cultural and cross-racial understanding. Ultimately,
the benefit of classroom diversity will help the School of Medicine produce individuals who are able to
be effective clinicians within a multi-cultural environment.” The Admissions Committee evaluates all
applicants in three major areas: humanitarian qualities, overall excellence, and diversity of experience.
As part of this process, any and all of the following holistic criteria are evaluated: academic factors,
strength of the letters of recommendation, personal interviews with the members of the Admissions
Committee, employment history and whether or not the applicant had to work to go to college,
community service, quantitative and qualitative assessment of the extracurricular activities, awarded
honors, unique personal attributes, hobbies and interests, socioeconomic background, where in the
State of Louisiana the applicant was raised, strong motivation to practice in a medically underserved
areas of the state, and whether there were any factors in the applicant’s background that may have
hindered them from achieving a higher level of academic achievement. The Admissions Committee
believes that the proper consideration of these factors will result in our institution matriculating and
graduating a cross-section of our state’s population so that these graduates can deliver quality health
care to the citizens of the State of Louisiana.
To promote diversity and encourage minority and disadvantaged accepted students to matriculate into
our School of Medicine, we offer via financial aid, the Disadvantaged Scholarship. Each year
scholarships are provided to qualified students on a yearly basis, provided the student remains in good
academic standing. Students are selected on the basis of financial need and scholarship.
Louisiana is largely a rural state, and rural areas do not have enough physicians, resulting in inadequate
access to medical care for its residents. The LSU School of Medicine in New Orleans implemented a
Rural Scholars’ Track, with a goal to identify and train physicians who will most likely practice medicine
in rural settings in the State of Louisiana. We believe the Rural Scholars’ Track will improve the delivery
and quality of the rural health care system through a combination of education, service, collaboration,
and research specific to these underserved areas of the state. Forty-four students (MS I = 15; MS II = 10;
MS III = 10; MS IV = 9) are currently enrolled in the Rural track in the SOM.
More specifically, LSU School of Medicine has developed programs aimed at broadening diversity among
their applicants for medical school admission and has major programs in place intended to enhance
diversity in the applicant pool. In 1981, LSU School of Medicine established the Office of Minority
Affairs, now identifed as the Office of Community and Minority Health Education (CMHE). The mission
of the Office is to increase access and improve the quality of health care for all Louisiana residents,
LCME Medical Education Database 2009-10
I. Institutional Setting
especially the poor, the minority, and the underserved populations, with a vision to increase the number
of competent underrepresented minority physicians practicing quality health care and eliminating
health care disparities within the State of Louisiana. The Office of CMHE is an administrative unit within
the Office of the Dean, and it maintains close working relationships with the Offices of Admissions and
Student Affairs. The Office is directed by Edward Helm, MD, MHA, Associate Dean, an administrator
nationally recognized for his innovative programs.
Recruitment of underrepresented minority and disadvantaged student representatives of the
population for the state of Louisiana is a major goal for the CMHE Office. CMHE has designed activities
and programs that will increase minority and disadvantaged students’ awareness of and exposure to
opportunities at LSUHSC. Specific programs intended to enhance diversity in the medical school
admissions applicant pool are:
Recruitment (LSUHSC funded since 1981) unstructured activities: K-12 Science Clubs, K-12 Health
Profession Awareness Days, premedical advisor counseling, recruitment visits and tours, medical school
counseling, and mock interviews.
Preliminary Education (funded by federal grant from 1985-August 31, 2007 and September 1, 2008 to
present) structured activity: 8-week High School Summer Science Program for 60 high school junior and
senior students each year.
Facilitating Entry (funded by federal grant from 1985-August 31, 2007 and September 1, 2008 to
present) structured activities: MCAT preparatory review twice/year for 40 college students per review
and an 8-week summer Prematriculation Program for newly accepted disadvantaged medical students.
In order to develop a more competitive applicant pool for minority and disadvantaged students within
Louisiana, CMHE developed formal educational partnerships (greater than 10 years) with health
professions schools (Medicine, Dentistry, Nursing, Allied Health) within the LSU Health Sciences Center,
New Orleans Public Schools, Historically Black Colleges and Universities in New Orleans and Baton
Rouge, and community physician organizations. Formal linkages between CMHE and their partners exist
so that collaborative relationships can provide necessary structured and unstructured programs to assist
minority and disadvantaged students. Aside from year-round recruitment visits to academic
institutions, planning and coordination sessions are conducted specific to each activity. It must be noted
that the LSU School of Medicine provides a supportive environment for all students but wants
particularly to ensure the retention and graduation of their disadvantaged students. The Offices of
Student Affairs and CMHE, offer academic monitoring and counseling, a mentoring program, and
USMLE, Step I and II prep courses, all of which contribute to the success of our students in medical
school. The Office of the Dean of the School of Medicine funds individual tutoring for all medical
students, if needed, and this is, thus, available to disadvantaged and underrepresented minority
students.
The academic community of the School of Medicine is committed to maintaining an environment of
open and honest intellectual inquiry. To promote respect for all, the students, residents, and faculty of
the School of Medicine adopted a Code of Professional Conduct that governs questions of all
professional conduct. As stated in the Preamble for the Council on Professional Conduct, “… faculty,
residents, and students have the right to enjoy an educational environment characterized by the highest
standards of ethical professional conduct. The individuals who comprise the LSUHSC campus come from
different cultural backgrounds. The students, residents, and faculty share the responsibility, to
themselves and to their colleagues, to protect their individual rights and those of the academic
community as a whole.”
LCME Medical Education Database 2009-10
I. Institutional Setting
Through an Honor Code, the students of the LSU School of Medicine affirm their adherence to promote
a mutual trust and honor among faculty, students, and staff. The Mission Statement for the student
Honor Code states, “As future physicians, we must maintain our educational pursuit at a level consistent
with the integrity of our chosen profession. We believe that ethics, social responsibility, and academic
integrity are an essential part of our experience as medical students in a diverse community that
encompasses a wealth of people and their experiences. Violation of these basic principles will be
considered an Honor Offense.” Specific situations that are considered concerning for any of our student
body are referred to the Council on Professional Conduct with the understanding that our students are
entitled to study and pursue their professional and personal aspirations in an environment that is free
from any type of disrespect.
In 2008, the School of Medicine formally adopted a revised set of curriculum objectives. Our curriculum
focuses on the acquisition of basic skills in the core areas of physician competence. Student
competencies are taught and evaluated in the classroom, in simulation labs, and in training hospitals
and clinics. Some of the student competencies include respect for the patient’s autonomy and cultural
beliefs and for communication competencies that include the need to understand and overcome the
patient’s literacy, linguistic, or cultural barriers. New curriculum initiatives are developed and
monitored by the Curriculum Oversight Committee, which aim to ensure that the overall goals and
objectives are achieved. First-year medical students are provided with Clinical Forums in their Science
and Practice of Medicine 100 course, where medical ethics, professionalism, patient-physician
communication, human development, social issues, cultural competency, and healthcare policy lend
themselves to discussion in small group formats. In turn, the Curriculum Evaluation Committee is
responsible for evaluation of the content and success of individual courses and clerkships. Our
residency programs also endorse and teach “6 Core Competencies”, with an emphasis on sensitivity to a
diverse patient population as the fifth competency.
The Dean has also recently appointed Paula Gregory, PhD to serve as Director of Faculty Development.
Dr. Gregory will be charged with organizing and distributing information on the many faculty
development initiatives already in plance and with supporting faculty orientation, career planning, and
special support for minority and women faculty. Dr. Nelson, as dean, has also encouraged and been
supportive of faculty participating in AAMC programs targeted at minorities and women and in ELAM,
which is targeted at women seeking leadership roles within academic medicine.
Also, Dr. Nelson has recently appointed Dwayne Thomas, MD, MHA as Associate Dean for Health Care
Quality and Safety. Currently, on special assignment with David Satcher, MD, as a fellow in his health
disparities program at Morehouse School of Medicine, Dr. Thomas will play a critical role in the
implementation of modules dealing with health care disparities into the undergraduate and graduate
medical education programs and in educational and interventional programs for our faculty.
Finally, the varied community service activities involving our student body, house officers, and faculty
serve to promote an appreciation for diversity in our own community and more broadly. The Service
Learning Elective (SLE) formally recognizes students deeply committed to their community, large and
small. Moreover, the recently adopted School of Medicine Strategic Plan outlines several new avenues
of outreach and service that will strengthen our ties with the community and hoefully enhance diversity
within the school.
c. Based on your institution’s definition of diversity and the LCME standard that “schools should
consider in their planning elements of diversity including, but not limited to, gender, racial, cultural and
economic diversity,” report in the table below information regarding the percentage of enrolled students
LCME Medical Education Database 2009-10
I. Institutional Setting
and employed faculty and staff in each of the categories included in your institution’s definition of
diversity.
Category
Am. Indian/AK
Native
First Year
Students
All Students
Faculty
Staff
(define)*
Male/Female
(T = 186)
Male/Female
(T = 713)
Male/Female
Male/Female
0/0
4.30/5.38
Asian
1.08/4.84
Black
2.69/2.15
Hispanic
Other Race or
Unknown Race
0.14/0.00
0.18/0.00
0.00/0.19
5.05/5.89
9.52/5.11
6.38/6.00
2.66/3.65
3.00/3.00
4.84/20.12
2.10/1.40
5.47/2.12
0.39/3.48
N/A
N/A
47.97/23.63
15.28/43.33
2.15/2.15
3.23/1.40
45.70/29.57
White
Total NonDisadvantaged
Total
Disadvantaged
44.04/30.43
87.63
86.4
12.37
13.6
Also see standards ED-21 and MS-8.
LCME Medical Education Database 2009-10
I. Institutional Setting
APPENDIX FOR IS-1
STRATEGIC PLAN CONTRIBUTORS
Organizing Committee
Steve Nelson, MD
Dean
Janis G. Letourneau, MD
Associate Dean for Faculty and Institutional Affairs
Wayne Backes, PhD
Associate Dean for Research
Keith Schroth
Associate Dean for Fiscal Affairs
Alan Burgener, MHA
Consultant
Educational Enhancement Workgroup
Richard DiCarlo MD (Group Leader)
Juzar Ali, MD
James Campbell, MD
Joe Delcarpio, PhD
Robin English, MD
Jimmy Falterman, MD
Charles Hilton, MD
Richard Howes, MD
George Karam, MD
Kim LeBlanc, MD
W. Chapman Lee, MD
Fred Lopez, MD
Robin McGoey, MD
John Paige, MD
Russell Russo, L-4
Ryan Vega, L-2
Richard Whitworth, PhD
Research Infrastructure and Core facilities Work Group
Alistair Ramsay, PhD (Group Leader)
Ashok Aiyar, PhD
Diego Aviles, MD
Wayne Backes, PhD
Eduardo Davila, PhD
Timothy Foster, PhD
Arthur Haas, PhD
Daniel Kapusta, PhD
Ben Kelly, PhD
Jay Kolls, MD
Ken Kratz, PhD
Ronald Luftig, PhD
David Martin, MD
Carol Mason, MD
Augusto Ochoa, MD
LCME Medical Education Database 2009-10
I. Institutional Setting
Seth Pincus, MD
Johnny Porter, PhD
Judd Shellito, MD
Kurt Varner, PhD
Community Outreach and Engagement
Robert Maupin, MD (Group Leader)
Ceryl Lynn Besch, MD
Sean Collins, MD
Charles Cefalu, MD
Erich Conrad, MD
John England, MD
Daniel Frey, MD
Cacky Hebert, MD
Edward Helm, MD
Scott Nelson, L-4
Frank Opelka, MD
Alison Quayle, PhD
Heidi Sinclair, MD
Faculty Development and Mentoring
Peter Winsauer, PhD (Group Leader)
Nicolas Bazan, MD, PhD
Andrew Catling, PhD
Sheila Chauvin, PhD
Stephania Cormier, PhD
Vin Dasa, MD
Paula Gregory, PhD
Amy Gutierrez, MD
Tonya Jagneaux, MD
Janis Letourneau, MD
Michael Levitzky, PhD
Betty Lo, MD
Erich Richter, MD
Bo Sanders, MD
Kelly Sorrells, MD
Ann Tilton, MD
Wayne Vedeckis, PhD
David Welsh, MD
Clinical Centers of Excellence
Christopher Baker, MD (Group Leader)
Jack Andonie, MD
Donald Bergsma, MD
Leonard Bok, MD
Stephen Brierre, MD
Michael Butler, MD
Frank Culicchia, MD
Alan Kaye, MD
Andrew King, MD
Lee Nesbitt, MD
Thomas Nolan, MD
Jane Olds
Alan Robson, MD
Paul Rosenfeld, MD
Joel Sellers
Ricardo Sorensen, MD
LCME Medical Education Database 2009-10
I. Institutional Setting
Warren Summer, MD
J. Christopher Winters, MD
Communication Strategies
Patricia Molina, MD, PhD (Group Leader)
Brian Barkemeyer, MD
Daniel Barnhill, MD
Martha Brewer, MD
Bennett DeBoisblanc, MD
Cathi Fontenot, MD
Andrew Hollenbach, PhD
Stacey Holman, MD
Russell Klein, MD
Chad Leingang
James Leonard, MD
Sam McClugage, PhD
Daniel Nuss, MD
Howard Osofsky, MD
Jack Strong, MD
Judith Venuti, PhD
LCME Medical Education Database 2009-10
I. Institutional Setting
APPENDIX FOR IS-8
Approved: April 3, 2002
School of Medicine – Administrative Council Charter
LSU Health Sciences Center in New Orleans
Preamble
The leadership of the School of Medicine of the Louisiana State University Health Sciences
Center in New Orleans (LSUHSC-NO), within rules, regulations, and policies of the School and Health
Sciences Center, the LSU System, and the Board of Supervisors of the Louisiana State University and A
& M College, do hereby effect through this Charter the Administrative Council of the School of Medicine
(SOM).
Article I. Name.
Section 1. This organization shall be known as the Administrative Council of the School of Medicine in
New Orleans, LSUHSC, hereinafter referred to as the Administrative Council.
Article II. Purpose.
Section 1. To serve as a representative voice of the SOM leadership.
Section 2. To provide a means of communication between the faculty, SOM leadership, and the Dean of
the SOM.
A. To provide a means whereby the SOM leadership, through the Dean of the SOM, may refer
matters of common interest to a body representing the faculty or matters of interest or
concern to the LSUHSC-NO administration.
B. To provide a means whereby the leadership can formally offer suggestions or
recommendations to the Dean pertaining to matters of common interest. These matters
include, but are not limited to, advanced faculty appointments, promotions and tenure,
sabbatical requests, SOM policies and curriculum, ratification of medical graduates, and
relationships with the LSUHSC Foundation and LSU HealthCare Network.
Section 3. To accept and share responsibility with the Dean of efforts to fulfill the mission of the SOM.
Article III. Membership and Term of Office.
Section 1. Administrative Council shall be composed of a fixed core of voting members, comprised of the
Dean, the Associate and Assistant Deans, the Department Heads, the four elected representatives
of the Faculty Assembly of the SOM, and the Directors of the Centers of Excellence upon the
Dean’s designation.
Section 2. The Chancellor will also be appointed, as an ex officio member.
Section 3. The Dean has the discretion to appoint other non-voting (ex officio) members to the
Administrative Council, including, but not limited to, the Vice-Chancellors, Dean Emeritus,
Medical Director of Medical Center of Louisiana, Director of Libraries, President of the
LSUHSC Foundation, Director of Information Services, and Chief Executive Officer of the LSU
HealthCare Network.
Section 4. A Department Head can appoint a permanently designated, alternate representative to the
Administrative Council; however, such alternate representatives are subject to the approval of the
Dean. Alternate representatives must be senior faculty members of the department, must attend
meetings on a regular basis and can vote in the absence of the Department Head on any matters
before the Administrative Council.
LCME Medical Education Database 2009-10
I. Institutional Setting
Section 5. A simple quorum must be present for voting, either by secret, written ballot, show of hands, or
voice vote.
Section 6. A favorable recommendation by the Administrative Council to the Dean requires a two-thirds
majority vote.
Section 7. The term of office of a member of the Administrative Council will concur with the
appointment status defining membership, except for elected representatives from the Faculty
Assembly, whose terms are determined by the rules and bylaws of that organization.
Article IV. Meetings.
Section 1. The Administrative Council shall meet in regular monthly sessions, with a minimum of 10
meetings held each year. The schedule will be set at the beginning of each calendar year and
distributed to all members. The Dean may alter the dates of meetings as he may deem it necessary
or advisable.
Section 2. Special meetings of the Administrative Council may be called.
Section 3. Meetings will be governed by the Sturgis Standard Code of Parliamentary Procedures, latest
edition.
Section 4. Meetings of the Administrative Council shall be open.
Section 5. Some agenda items may require that the Administrative Council discuss and deliberate in
Executive Session. The Chairperson of the Administrative Council or presiding officer may call
an Executive Session; any voting member of the Administrative Council may request an
Executive Session that is approved by a simple majority vote of the members present.
Article V. Officers.
Section 1. The Dean of the SOM shall be the Chairperson of the Administrative Council and shall
normally be the presiding officer.
Section 2. The Associate Dean of Faculty and Institutional Affairs in the SOM shall be the Secretary of
the Administrative Council and shall be responsible for the agenda, minutes, and meeting
calendar.
Section 3. The Chairperson of the Administrative Council, in his absence, may delegate the responsibility
of presiding officer to any other voting member of the Administrative Council.
Article VI. Interpretation.
Provisions of this Charter, whenever unclear, ambiguous, or indefinite, shall be subject to
interpretation by a two-thirds majority vote.
LCME Medical Education Database 2009-10
I. Institutional Setting
APPENDIX FOR IS-10
Full CV for Dean of the School of Medicine
CURRICULUM VITAE
STEVE NELSON, M.D. C.M., F.C.C.P.
BIRTH DATE AND PLACE
November 26, l952
New York City, New York
HOME ADDRESS
812 Bonfouca Lane
Mandeville, Louisiana 70471
EDUCATION PreMedical Training
Undergraduate
1970-1974
Medical School
1974-1978
SUNY at Stony Brook, Stony Brook, New York, BS Biology (Departmental
Honors)
Faculty of Medicine, McGill University, Montreal, Canada (University Scholar)
Postgraduate Training
l978-l979
Internship (Medicine), Johns Hopkins Hospital, Baltimore, MD
1979-1981
Residency (second year, Medicine), Johns Hopkins Hospital, Baltimore, MD
Residency (third year, Medicine), Johns Hopkins Hospital, Baltimore, MD
l981-l982
Clinical Fellowship in Pulmonary Medicine, Johns Hopkins Hospital, Baltimore,
MD
1982-1984
Research Fellowship in Pulmonary Medicine, Johns Hopkins Hospital,
Baltimore, MD
1982-1984
Fellowship in Environmental Health Sciences, School of Hygiene and Public
Health, Johns Hopkins University, Baltimore, MD
LCME Medical Education Database 2009-10
I. Institutional Setting
APPOINTMENTS OR POSITIONS:
2007 – pres.
Dean, Louisiana State University Health Sciences Center, New Orleans, LA
2006 - 2007.
Program Director, GCRC, Tulane-LSU-Charity Hospital, New Orleans, LA
2005 – 2007
Section Chief, Pulmonary/Critical Care Medicine, Department of Medicine,
Louisiana State University Health Sciences Center, New Orleans, LA
2005 – 2007
Vice Chair Research, Department of Medicine, Louisiana State University Health
Sciences Center, New Orleans, LA
2003-2006
Associate Director, GCRC, Tulane-LSU-Charity Hospital, New Orleans, LA
2002- 2008
Director, Alcohol and Drug Abuse Center of Excellence, Louisiana State
University Health Sciences Center, New Orleans, LA
2002-pres.
Professor of Microbiology, Immunology, and Parasitology, Louisiana State
University Health Sciences Center, New Orleans, LA
2000-pres.
Director, Alcohol Research Center, Louisiana State University Health Sciences
Center, New Orleans, LA
1995-pres.
John H. Seabury Professor of Medicine, Department of Medicine, Louisiana
State University Health Sciences Center, New Orleans, Louisiana
1994-pres.
Professor of Medicine, Department of Medicine, Louisiana State University
Health Sciences Center, New Orleans, Louisiana
1994-pres.
Professor of Physiology, Department of Physiology, Louisiana State University
Health Sciences Center, New Orleans, Louisiana
1994-pres.
Professor, School of Graduate Studies, Louisiana State University Health
Sciences Center, New Orleans, Louisiana
1994-pres.
Clinical Professor of Medicine and Pediatrics, Tulane University School of
Medicine, New Orleans, Louisiana
1994-pres.
Staff Physician, Section of Pulmonary/Critical Care Medicine, Ochsner Clinic
and Hospital, New Orleans, Louisiana.
1990-1995
Director of Critical Care Units, University Hospital, New Orleans, Louisiana
1989-1994
Associate Professor, School of Graduate Studies, Louisiana State University
Health Sciences Center, New Orleans, Louisiana
1989-1994
Associate Professor of Medicine, Department of Medicine, Louisiana State
University Health Sciences Center, New Orleans, Louisiana
Associate Professor of Physiology, Department of Physiology, Louisiana State
University Health Sciences Center, New Orleans, Louisiana
1989-1994
1989-1994
Clinical Associate Professor of Medicine and Pediatrics, Tulane University
School of Medicine, New Orleans, Louisiana
LCME Medical Education Database 2009-10
I. Institutional Setting
1988-2005
Director of Research Laboratories, Division of Pulmonary/Critical Care,
Louisiana State University Health Sciences Center, New Orleans, Louisiana
1985-1989
Clinical Assistant Professor of Medicine and Pediatrics, Tulane University
School of Medicine, New Orleans, Louisiana
1988-1989
Assistant Professor of Physiology, Department of Physiology, Louisiana State
University Health Sciences Center, New Orleans, Louisiana
1985-pres.
Associate Medical Staff, Tulane Medical Center, New Orleans, Louisiana
1985-1994
Consultant, Handicapped Children's Services Program (Cystic Fibrosis), Office
of Preventive and Public Health Services, Department of Health and Human
Resources, State of Louisiana
l984-1989
Assistant Professor of Medicine, Louisiana State University Health Sciences
Center, New Orleans, Louisiana
1984-pres.
Staff Physician, Division of Pulmonary/Critical Care, Charity Hospital of New
Orleans, Louisiana
l984-pres.
Staff Physician, Division of Pulmonary/Critical Care, University Hospital, New
Orleans, Louisiana
1983-1984
Attending Physician, Medical Intensive Care Unit, Johns Hopkins Hospital,
Baltimore, Maryland
CERTIFICATION:
Licentiate, Medical Council of Canada - l978
Diplomate, National Board of Medical Examiners - 1979
Diplomate, American Board of Internal Medicine - 1981
FLEX - 1984
Diplomate, American Board of Internal Medicine,
Pulmonary Disease - 1986
Diplomate, American Board of Internal Medicine,
Critical Care Medicine - 1987
LICENSURE:
Maryland, 1981, D26487
Louisiana, 1984, 06586R
AWARDS:
1972
1976-l978
1976-1978
Phi Beta Kappa, SUNY at Stony Brook
Friends of McGill Scholarship, McGill University
University Scholar, Faculty of Medicine, McGill University
LCME Medical Education Database 2009-10
I. Institutional Setting
1982-1984
1984
1990
1995
1996
1996
1998
2002
2002
2003
2003
2003
2004
2004-2006
2006
2006
2007-2008
School Scholarship, Johns Hopkins University, School of Hygiene and Public
Health
Physician's Recognition Award, American Medical Association
Alpha Omega Alpha Honor Medical Society, LSU Medical School
John H. Seabury Professorship
Best Doctors in America: Southeast Region
Southern Society for Clinical Investigation
Best Doctors in America
Best Doctors in America
Who’s Who in Medicine and Healthcare
Guide to America’s Top Physicians
Top Internists, New Orleans Magazine
Pfizer Award for Excellence in Research
Who’s Who in America
Best Doctors in America
Who’s Who in Medicine and Healthcare
Edward C. Rosenow, III, Honor Lecture Award, American College of Chest
Physicians (for outstanding contributions to mentorship and training of chest
physicians)
Best Doctors in America
GRANTS:
1981-1982
1982-1984
1984-1985
1984-1987
1986-1987
1988-1993
1989-1991
1990-1993
1991-2000
1992-1993
1992-pres.
1993-2000
1997-2002
2000-2003
2000-2005
2001-2008
2001-2007
2003-2007
Fellowship in Adult Lung Diseases, American Lung Association
National Research Service Award, NIH
American Lung Association Research Award
Parker B. Francis Fellowship in Pulmonary Research, Puritan-Bennett
Foundation
Research Award, Laerdal Foundation for Acute Medicine
R29 NIAAA, “Effect of Alcoholism on TNF and Host Defense”, Principal
Investigator
Research Award, National Cystic Fibrosis Foundation, “Cytokine-Induced
Inflammatory Lung Disease in CF”, Principal Investigator
Research Award, Board of Regents, Louisiana Education Quality Support Fund,
“Sepsis-Induced Immune Dysfunction,” Co-Investigator
AA08845, NIAAA, “Alcohol, Immunosuppression, and Pneumocystis carinii,”
Co-Investigator
Research Award, AMGEN, Principal Investigator
Consultant, AMGEN
AA09803, NIAAA, Alcohol Research Center, “Alcohol, Infection, and
Host Response”, Associate Director and Principal Investigator
AA11760, NIAAA, “Alcohol, TB, Host Defense,” Co-Investigator
AA09803, NIAAA, Alcohol Research Center, “Alcohol, HIV Infection,
and Host Defense,” Director and Principal Investigator
Board of Regents, Health Excellence Fund, “Center for Lung Biology and
Immunotherapy”, Co-Investigator
AA13563, NIAAA, “The Effect of Alcohol on SIV Pathogenesis,” CoInvestigator
RR05096, NCRR, GCRC, Program Director
AA14293, NIAAA, “Alcohol Research Planning and Development Program”,
Co-Investigator
LCME Medical Education Database 2009-10
I. Institutional Setting
2003-2009
2004-2009
2005-2010
2007-2009
2007-2010
2007-2010
2009-2010
AA09803, NIAAA, Comprehensive Alcohol Research Center, “Alcohol, HIV
Infection, and Host Defense”, Director and Principal Investigator
AA11760, NIAAA, “Alcohol and Reactivation Tb”, Co-Investigator
RR021970, NCRR, COBRE, Co-Investigator
AA016118, NIAAA, “Alcohol Effects on Gene and Cytokine Expression of
Human Airway Epithelia”, Co-Investigator
014RCEEP-07, Board of Regents, “Clinical and Translational Research
Education and Commercialization Program (CTRECP) at Tulane University and
Louisiana State University Health Sciences Center”, Co-Principal Investigator
RCEEP-05 (2007-10), Board of Regents, “Development of a Nationally
Recognized Model in Research Commercialization, Education and Workforce
Development in Chemical Engineering and the Chemical Sciences through
University and Community College Collaborations”, Project Director
AA017494, NIAAA, “Alcohol and Impairment of the Granulopoietic Response
to Pneumonia”, Collaborator
SOCIETIES:
1974-pres.
1981-pres.
1984-pres.
1984-pres.
1984-pres.
1985-pres.
1986-pres.
1989-pres.
1995-pres.
2005-pres.
2008-pres.
New York Academy of Sciences
American College of Physicians
American Medical Association
American Society for Microbiology
American Thoracic Society
American Federation for Medical Research
American College of Chest Physicians (Fellow)
Research Society on Alcoholism
Orleans Parish Medical Society
Association of Professors of Medicine
American Clinical and Climatological Association
COMMITTEES:
1985-1988
1986-1999
1988-1990
1989-1995
1989-1997
1990-1996
1990-1992
1990-1995
1991-1996
1992-1995
1993-1995
1993-1996
Charity Hospital AIDS Medical Advisory Committee
LSU Medical Center Institutional Review Board
Charity Hospital AIDS Research Committee
Clinical Sciences Delegate, LSU Medical Center Faculty Assembly
Animal Management Committee, LSU Medical Center
Program Committee for the Scientific Assembly on Microbiology,
Tuberculosis, and Pulmonary Infections, American Thoracic Society
Administrative Council of the Faculty Assembly, LSU Medical Center
Steering Committee, Section on Cardiopulmonary Infections, American
College of Chest Physicians
Steering Committee, Council on Critical Care, American College of Chest
Physicians
American Medical Association CPT Advisory Committee
Program Committee for the Scientific Assembly on Critical Care,
American Thoracic Society
Annual International Scientific Program Committee, American College of Chest
Physicians
LCME Medical Education Database 2009-10
I. Institutional Setting
1994-1996
1994-pres.
1997-2001
1997-1999
1998-2001
1999-2001
2000-2004
2002-pres.
2003-pres.
2006-pres.
2006-pres.
Program Committee Chairman, Scientific Assembly on Microbiology,
Tuberculosis, and Pulmonary Infections, American Thoracic Society
Ad hoc Reviewer, NIAAA
International Subcommittee, American College of Chest Physicians
Long Range Planning Committee, Assembly on Microbiology, Tuberculosis, and
Pulmonary Infections, American Thoracic Society
Research Advocacy Committee, American Thoracic Society
Chairman, Nominating Committee (MTPI Assembly), American Thoracic
Society
LSU Health Sciences Center MD/PhD Committee
Executive Committee, Research Council, LSUHSC
Tulane National Primate Research Center Resource Allocation Committee
Board of Directors, LSU Healthcare Network
Extramural Advisory Board (HIV-Related Biomedical Research), NIAAA
EDITORIAL BOARDS:
Clinical Pulmonary Medicine
1995-present
Mediguide to Pulmonary Medicine
1996-2001
Respiratory Medicine
1996-1998
Nosocomial Infections
1997-2000
Seminars in Respiratory and Critical Care Medicine 1998-present
Alcohol Research and Health (Journal of the
2006-present
National Institute on Alcohol Abuse and Alcoholism)
International Journal of Clinical and Experimental
2007-present
Medicine
MANUSCRIPT REVIEW:
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory Cell and Molecular Biology
Chest
Clinical Infectious Diseases
Journal of Infectious Disease
Critical Care Medicine
Journal of Immunology
PUBLICATIONS
JOURNALS:
1.
Nelson S, Carlson AD, and Copeland J: Mating-induced behavioral switch in female fireflies.
Nature 255:628-629, 1975.
2.
Nelson S, Prince D, and Terry P: Primary Hodgkin's disease of the lung. Thorax 38:3l0-311,
1983.
3.
Wang K and Nelson S: Transbronchial needle aspiration of a mediastinal mass: therapeutic
implications. Thorax 38:556- 557, 1983.
LCME Medical Education Database 2009-10
I. Institutional Setting
4.
Nelson S, Summer W, and Jakab G: Aminophylline-induced suppression of pulmonary
antibacterial defenses. Am Rev Respir Dis 131:923-927, 1985.
5.
White J, Nelson S, Jakab G, and Lanser M: Methylprednisolone impairs the bactericidal activity
of alveolar macrophages. J Surg Res 39:46-52, 1985.
6.
White J, Nelson S, Winkelstein J, Booth F, and Jakab G: Impairment of antibacterial defense
mechanisms of the lung by extrapulmonary infection. J Infect Dis 153:202-208, 1986.
7.
Nelson S, Laughon B, Bartlett J, Summer W, and Jakab G: Characterization of the pulmonary
inflammatory response to an anaerobic bacterial challenge. Am Rev Respir Dis 133:212-217,
1986.
8.
Astry C, Nelson S, Karam G, and Summer W: Interactions of clindamycin with the antibacterial
defenses of the lung. Am Rev Respir Dis 135:1015-1019, 1987.
9.
Nelson S, Summer W, Terry P, Warr G, and Jakab G: Erythromycin suppresses pulmonary
antibacterial defenses - A potential mechanism of superinfection in the lung. Am Rev Respir Dis
136:1207-1212, 1987.
10.
Cosmo L, Risi G, Nelson S, Subramanian P, Martin D, and Haponik EF: Fatal hemoptysis in
acute bacterial endocarditis. Am Rev Respir Dis 137:1223-1226, 1988.
11.
Nelson S, Waring WW, and Summer WR: Cystic fibrosis in the young adult. Pulmonary and
Critical Care Update 3 (19), 1988.
12.
Nelson S, Chidiac C, and Summer WR: The pathogenesis and prevention of nosocomial
pneumonia. J Crit Ill 3:12-24, 1988.
13.
Summer WR and Nelson S: Severe community-acquired pneumonia. Pulmonary Perspectives 5
(2) Summer, 1988.
14.
Herndandez OG, Nelson S, Haponik EF, Lopez A, and Summer WR: Obligate nasal breathing in
an elderly woman: increased risk of nasogastric tube feeding. J Parent Enter Nutr 12:531-532,
1988.
15.
Harris SE, Nelson S, Astry CL, Bainton BG, and Summer WR: Endotoxin-induced suppression
of pulmonary antibacterial defenses against Staphylococcus aureus. Am Rev Respir Dis
138:1439-1443, 1988.
16.
Cosmo L, Nelson S, Haponik E, Teaford T, and Summer WR: Nontraumatic hepatic
diaphragmatic herniation: demonstration by computed chest tomography. J La State Medical
Society 140:41-44, 1988.
17.
Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, and Summer WR:
Compartmentalization of intraalveolar and systemic lipopolysaccharide- induced tumor necrosis
factor and the pulmonary inflammatory response. J Infect Dis 159:189-194, 1989.
18.
Summer WR, Curry P, Haponik EF, Nelson S, and Elston R: Continuous mechanical turning of
ICU patients shortens length of stay in some diagnostic related groups. J Crit Care 4:45-53, 1989.
LCME Medical Education Database 2009-10
I. Institutional Setting
19.
Summer WR, Elston R, Thorpe L, Nelson S, and Haponik EF: Aerosol bronchodilator delivery
methods: relative impact on pulmonary function and cost of respiratory care. Arch Int Med
149:618-623, 1989.
20.
Nelson S, Bagby G, and Summer WR: Alcohol suppresses lipopolysaccharide- induced tumor
necrosis factor activity in serum and lung. Life Sci 44:673-676, 1989.
21.
Summer WR and Nelson S: Nosocomial pneumonia: Characteristics of the host-pathogen
interaction. Respir Care 34:116-124, 1989.
22.
D'Souza NB, Bagby GJ, Nelson S, Lang CH, and Spitzer JJ: Acute alcohol infusion suppresses
endotoxin-induced tumor necrosis factor production. Alcohol Clin Exp Res 13:295-298, 1989.
23.
Mahatma M, Haponik EF, Nelson S, Lopez A, and Summer WR: Phenytoin-induced acute
respiratory failure with pulmonary eosinophilia. Am J Med 87:93-94, 1989.
24.
Chidiac C, Nelson S, Summer WR, and Mouton Y: Experimental models of pneumonia. Pathol
Biol 37:754-758, 1989.
25.
Nelson S, Bagby GJ, Bainton BG, and Summer WR: The effects of acute and chronic alcoholism
on tumor necrosis factor and the inflammatory response. J Infect Dis 160:422-429, 1989.
26.
Bainton BG, Nelson S, Chidiac C, Bagby GJ, and Summer WR: Anti-inflammatory agents in
sepsis and acute lung injury. Effects of methylprednisolone and ibuprofen on TNF and
pulmonary host defenses. Critical Care Report 1:201-207, 1990.
Mason C, Nelson S, and Summer WR: Prevention of nosocomial pneumonia. J Emer Med
22:31-37, 1990.
27.
28.
Nelson S, Chidiac C, Bagby G, and Summer WR: Endotoxin-induced suppression of lung host
defenses. J Med 21:85-103, 1990.
29.
Mason C, Nelson S, and Summer W: Community-acquired pneumonia. Pulmonary Perspectives
7 (2) Summer, 1990.
30.
Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G, and Summer W: Pentoxifylline
inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci
47:1023-1029, 1990.
31.
Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, and Nelson S: Divergent efficacy of
anti-TNFa antibody in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88,
1991.
32.
Burlew BP, Noel P, and Nelson S: Local antibiotic therapy in bronchopulmonary infections.
Critical Care Report 2:136-144, 1991.
33.
Nelson S: The effects of thermal injury on systemic and pulmonary host defenses. Critical Care
Report 2:241-253, 1991.
34.
Bagby GJ and Nelson S: The role of tumor necrosis factor in the host's response to infection.
Critical Care Report 2:176-187, 1991.
LCME Medical Education Database 2009-10
I. Institutional Setting
35.
Schuler A, Spolarics Z, Lang C, Bagby G, Nelson S, and Spitzer JJ: Upregulation of glucose
metabolism by granulocyte-monocyte colony-stimulating factor. Life Sci 49:899-906, 1991.
36.
Mahatma M, Agrawal N, Dajani EZ, Nelson S, Nakamura C, and Sitton J: Misoprostol but not
antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha.
Dig Dis Sci 36:1562-1568, 1991.
37.
Nelson S, Bagby G, Nakamura C, Stewart L, Lipscomb G, Summer W, and Andresen J:
Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol
treated rats. J Infect Dis 164:901-906, 1991.
38.
Spolarics Z, Schuler A, Bagby G, Lang C, Nelson S, and Spitzer J: In vivo metabolic response of
hepatic nonparenchymal cells and leukocytes to granulocyte-macrophage colony-stimulating
factor. J Leukoc Biol 51:360-365, 1992.
39.
deBoisblanc BP, Meszaros K, Burns A, Bagby G, Nelson S, and Summer WR: Effect of
dichloroacetate on mechanical performance and metabolism of compromised diaphragm muscle.
J Appl Physiol 72:1149-1155, 1992.
40.
Mason CM, Summer WR, and Nelson S: Pathophysiology of pulmonary defense mechanisms. J
Crit Care 7:42-56, 1992.
41.
Nakamura C, Nelson S, Lippton H, Bagby G, and Summer W: Contrasting effects of misoprostol
on systemic and intrapulmonary lipopolysaccharide-induced tumor necrosis factor-alpha. Life
Sci 50:1869-1876, 1992.
42.
Lang CH, Bagby GJ, Dobrescu C, Nelson S, and Spitzer JJ: Effect of G-CSF on sepsis-induced
changes on neutrophil accumulation and organ glucose uptake. J Infect Dis 166:336-343, 1992.
43.
Shellito J, Nelson S, and Sorensen R: Effect of pyocyanine, a pigment of Pseudomonas
aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages.
Infect Immun 60:3913-3915, 1992.
44.
Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, and Diehl AM: Antibodies to
tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol
263:G579-585, 1992.
45.
Lang CH, Bagby GJ, Dobrescu C, Nelson S, and Spitzer JJ: Modulation of the glucose metabolic
response to endotoxin by granulocyte colony-stimulating factor. J Appl Physiol 263:R11221129, 1992.
46.
Mason C, Dunn C, Kabir S, Nelson S, Summer W, and Dal Nogare AR: Gastrointestinal gramnegative colonization accompanies oropharyngeal colonization but is not adversely affected by
elevation of gastric pH. J Crit Care 7:244-250, 1992.
47.
Nelson S, Shellito J, Mason C, and Summer W: Alcohol and bacterial pneumonia. Alcohol
Health and Research World 16:73-81, 1992.
48.
Mason C and Nelson S: Normal host defenses and impairments associated with the delayed
resolution of pneumonia. Semin Resp Infect 7:243-255, 1992.
LCME Medical Education Database 2009-10
I. Institutional Setting
49.
Mason C, Nelson S, and Summer W: Bacterial colonization-pathogenesis and clinical
significance. Immunol Allergy Clin North Am 13:93-108, 1993.
50.
Greenberg SS, Xie J, Wang Y, Kolls J, Shellito J, Nelson S, and Summer W: Ethanol relaxes
pulmonary artery by release of prostaglandin and nitric oxide. Alcohol 10:21-29, 1993.
51.
Kolls J, Beck JM, Nelson S, Summer WR, and Shellito J: Alveolar macrophage release of tumor
necrosis factor during murine Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol
8:370-376, 1993.
52.
Kolls JK and Nelson S: The young adult with cystic fibrosis. Mediguide to Infectious Diseases
13:1-8, 1993.
53.
Akerman PA, Cote PM, Yang SQ, McClain C, Nelson S, Bagby G, and Diehl AM: Long-term
ethanol consumption alters the hepatic response to the regenerative effects of TNF-alpha.
Hepatology 17:1066-1078, 1993.
54.
Kolls JK, Nelson S, and Summer WR: Recombinant cytokines and pulmonary host defense: a
review. Am J Med Sci 306:330-335, 1993.
55.
Xie J, Wang Y, Lippton H, Cai BC, Nelson S, Kolls J, Summer WR, and Greenberg S: Tumor
necrosis factor inhibits stimulated but not basal release of nitric oxide. Am Rev Respir Dis
148:627-636, 1993.
56.
Greenberg S, Xie J, Wang Y, Cai B, Kolls J, Nelson S, Hyman A, Summer WR, and Lippton H:
Tumor necrosis factor-alpha inhibits endothelial-dependent relaxation. J Appl Physiol 74:23942403, 1993.
57.
Xie J, Wang Y, Kolls J, Malinski T, Nelson S, Summer W, and Greenberg S: Tumor necrosis
factor-α inhibits contractions to sympathetic nerve stimulation by a nitric oxide-dependent
mechanism. Proc Soc Exp Biol Med 203:446-453, 1993.
58.
Kolls JK, Xie J, LeBlanc R, Malinski T, Nelson S, Summer WR, and Greenberg SS: Rapid
induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin
and its suppression by prednisolone. Proc Soc Exp Biol Med 205:220-229, 1994.
59.
Nelson S: Overview of granulocyte colony-stimulating factor in bacterial infections in the nonneutropenic host. Clin Infect Dis 18:197-204, 1994.
60.
Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, and Nelson S: Loss of
compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care
Med 149:1107-1111, 1994.
61.
Mason C, Nelson S, and Summer W: Bacterial translocation in the pathogenesis of pneumonia.
Clin Pulm Med 1:215-222, 1994.
62.
Greenberg S, Xie J, Wang Y, Kolls J, Malinski T, Summer W, and Nelson S: Ethanol suppresses
LPS-induced mRNA for nitric oxide synthase II in alveolar macrophages in vivo and in vitro.
Alcohol 11:539-547, 1994.
63.
Daon E, Summer WR, Nelson S, and Mason CM: Cimetidine does not impair the pulmonary
clearance of Pseudomonas aeruginosa in normal rats. Dig Dis Sci 39:1469-1472, 1994.
LCME Medical Education Database 2009-10
I. Institutional Setting
64.
D'Souza NB, Nelson S, Summer WR, and Deaciuc IV: Expression of tumor necrosis factor-α
and interleukin-6 cell-surface receptors of the alveolar macrophage in alcohol-treated rats.
Alcohol Clin Exp Res 18:1430-1435, 1994.
65.
Diehl AM, Yin M, Fleckenstein J, Yang SQ, Lin HZ, Brenner DA, Westwick J, Bagby G, and
Nelson S: Tumor necrosis factor α induces c-jun during the regenerative response to liver injury.
Am J Physiol 267:G552-G561, 1994.
66.
D'Souza NB, Mandujano FJ, Nelson S, Summer WR, and Shellito JE: CD4+ T lymphocyte
depletion attenuates LPS-induced TNF secretion by alveolar macrophages in the mouse.
Lymphokine Cytokine Res 13:359-366, 1994.
67.
King J, deBoisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Summer WR, and
Nelson S: Effect of G-CSF on acute lung injury in the rat. Am J Respir Crit Care Med 151:302309, 1995.
68.
Nelson S, Mason C, Bagby G, and Summer W: Alcohol, tumor necrosis factor, and tuberculosis.
Alcohol Clin Exp Res 19:17-24, 1995.
69.
Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, and Nelson S: Exacerbation of
acute and chronic murine tuberculosis by administration of a TNF receptor-expressing
adenovirus. J Infect Dis 171:400-405, 1995.
70.
Greenberg S, Xie J, Kolls JK, Nelson S, Didier P, and Mason C: Ethanol supresses Mycobacteria
tuberculosis-induced mRNA for nitric oxide synthase in alveolar macrophages, in vivo. Alcohol
Clin Exp Res 19:394-401, 1995.
71.
Mason CM, Kolls JK, and Nelson S: Pathogenesis and host defense in pulmonary infections.
Current Opinion in Pulmonary Medicine 1:163-170, 1995.
72.
Kolls JK, Lei D, Nelson S, Summer WR, Greenberg S, and Beutler B: Adenovirus-mediated
blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary
host defense. J Infect Dis 171:570-575, 1995.
73.
Kolls JK, Xie J, Lei D, Greenberg S, and Nelson S: Differential effects of in vivo ethanol on
LPS-induced TNF and nitric oxide production in the lung. Am J Physiol 268: 991-998, 1995.
74.
Mandujano JF, D'Souza NB, Nelson S, Summer WR, Beckerman RC, and Shellito JE:
Granulocyte-macrophage colony-stimulating factor administration and Pneumocystis carinii
pneumonia in mice. Am J Respir Crit Care Med 151:1233-1238, 1995.
75.
Kolls JK, Nelson S, and Weinacker A: Gene therapy for lung diseases. Clin Pulm Med 2:238243, 1995.
76.
Dale DC, Liles WC, Summer WR, and Nelson S: Review: Granulocyte colony-stimulating factor
(G-CSF): role and relationships in infectious diseases. J Infect Dis 172:1061-1075, 1995.
77.
D'Souza NB, Mandujano F, Nelson S, Summer W and Shellito J: Alcohol ingestion impairs host
defenses predisposing otherwise healthy mice to Pneumocystis carinii infection. Alcohol Clin
Exp Res 19:1219-1225, 1995.
LCME Medical Education Database 2009-10
I. Institutional Setting
78.
Diehl AM, Yang SQ, Yin M, Lin HZ, Nelson S, and Bagby G: Tumor necrosis factor-alpha
modulates CCAAT/enhancer binding proteins-DNA binding activities and promotes hepatocytespecific gene expression during liver regeneration. Hepatology 22:252-261, 1995.
79.
D'Souza NB, Nelson S, Summer WR, and Deaciuc IV: Alcohol administration modulates
alveolar macrophage tumor necrosis factor-α, superoxide anion and nitric oxide secretion in the
rat. Alcohol Clin Exp Res 20:156-163, 1996.
80.
deBoisblanc BP, Dobrescu C, Skrepnik N, Nelson S, Spitzer JJ, and Bagby GJ:
Compartmentalization of glucose utilization after intravenous vs intratracheal challenge with
lipopolysaccharide. Am J Physiol 270:L452-458, 1996.
81.
Dunne JR, Dunkin BJ, Nelson S, and White JC: Effects of granulocyte colony-stimulating factor
in a non-neutropenic rodent model of Escherichia coli peritonitis. J Surg Res 61:348-354, 1996.
82.
Kolls JK, Lei D, Odom G, Nelson S, Summer WR, Gerber M, and Shellito J: Transient CD4lymphocyte depletion prolongs transgene expression of E1-deleted adenoviral vectors. Human
Gene Therapy 7:489-497, 1996.
83.
Williams LM, Fussell S, Veith RW, Nelson S, and Mason C: Pulmonary veno-occlusive disease
in an adult following bone marrow transplantation: case report and review of literature. Chest
109:1388-1391, 1996.
84.
Summer RS, Summer WR, Kolls J, and Nelson S: Cytokines and pulmonary host defense. Clin
Pulm Med 3:129-136, 1996.
85.
Mason CM, and Nelson S: Pathophysiology of community-acquired pneumonia and treatment
strategies based on host-pathogen interactions: the inflammatory interface. Sem Resp Crit Care
Med 17:213-220, 1996.
86.
Mason CM, Guery BPH, Summer WR, and Nelson S: Keratinocyte growth factor attenuates lung
leak induced by alpha-naphthylthiourea in rats. Crit Care Med 24:925-931, 1996.
87.
Daifuku R, Movahhed H, Fotheringham N, Bear M, and Nelson S: Time to resolution of
morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia. Resp
Med 90:587-592, 1996.
88.
Lei D, Lehmann M, Shellito JE, Nelson S, Siegling A, Volk HD, and Kolls JK: Non-depleting
anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene
expression in rats. Human Gene Therapy 7:2273-2279, 1996.
89.
Kolls JK, Lei D, Vasquez C, Odom G, Summer WR, Nelson S, and Shellito J: Exacerbation of
murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor.
Am J Respir Cell Mol Biol 16:112-118, 1997.
90.
Guery BPH, Mason CM, Dobard EP, Beaucaire G, Summer WR, and Nelson S: Keratinocyte
growth factor attenuates alphanaphthylthiourea-induced lung injury by increasing transalveolar
sodium reabsorption. Am J Respir Crit Care Med 155:1777-1784, 1997.
91.
Lei D, Lancaster JR, Joshi MS, Nelson S, Stoltz D, Bagby GJ, Odom G, Shellito JE, and Kolls
JK: Activation of alveolar macrophages and lung host defenses using transfer of the interferongamma gene. Am J Physiol 272:L852-L859, 1997.
LCME Medical Education Database 2009-10
I. Institutional Setting
92.
Nelson S: (panel member). From the bench to the bedside: the future of sepsis research.
Executive Summary of an American College of Chest Physicians, National Institute of Allergy
and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop. Chest 111:744753, 1997.
93.
Kolls JK, Lei D, Nelson S, Summer WR, and Shellito JE: Pulmonary cytokine gene therapy.
Adenoviral-mediated murine interferon gene transfer compartmentally activates alveolar
macrophages and enhances bacterial clearance. Chest 111:104S, 1997.
94.
Zhang P, Bagby GJ, Stoltz DA, Spitzer JA, Summer WR, and Nelson S: Modulation of the lung
host response by granulocyte colony-stimulating factor in rats challenged with intrapulmonary
endotoxin. Shock 7:193-199, 1997.
95.
deBoisblanc BP, Mason CM, Andresen J, Logan E, Bear MB, Johnson S, Shellito J, Summer
WR, and Nelson S: Phase 1 Safety Trial of Filgrastim (r-metHuG-CSF) in non-neutropenic
patients with severe community-acquired pneumonia. Resp Med 91:387-394, 1997.
96.
Stoltz DA, Bagby GJ, and Nelson S: Use of G-CSF in the treatment of acute infectious diseases.
Current Opinion Hematol 4:207-212, 1997
97.
Zhang P, Nelson S, Summer W, and Spitzer JA: Acute ethanol intoxication suppresses the
pulmonary inflammatory response in rats challenged with intrapulmonary endotoxin. Alcohol
Clin Exp Res 21:773-778, 1997.
98.
Skerrett SJ, Bagby G, Schmidt R, and Nelson S: Antibody-mediated depletion of tumor necrosis
factor-α impairs pulmonary host defenses to Legionella pneumophila. J Infect Dis 176:10191028, 1997.
99.
Mason CM, Nelson S, Dobard E, and Summer WR: Intraportal lipopolysaccharide suppresses
pulmonary antibacterial defense mechanisms. J Infect Dis 176:1293-1302, 1997.
100.
Zhang P, Bagby GJ, Stoltz DA, Summer WR, and Nelson S: Enhancement of peritoneal
leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit
Care Med 26:315-321, 1998.
101.
Zhang P, Bagby GJ, Xie M, Stoltz DA, Summer WR, and Nelson S: Acute ethanol intoxication
inhibits neutrophil β2-integrin expression in rats during endotoxemia. Alcohol Clin Exp Res
22:135-141, 1998.
102.
Kolls JK, Lei D, Stoltz D, Zhang P, Schwarzenberger PO, Ye P, Bagby G, Summer WR, Shellito
JE, and Nelson S: Adenoviral-mediated interferon-gamma gene therapy augments pulmonary
host defense of ethanol treated rats. Alcohol Clin Exp Res 22:157-162, 1998.
103.
Guery B, deBoisblanc B, Fialdes P, Sarphy TG, Nelson S, Chidiac C, Beaucaire G, Summer WR
and Mason CM: Pulmonary stress injury within physiological ranges of airway and vascular
pressures. J Crit Care 13:58-66, 1998.
104.
Omidvari K, Casey R, Nelson S, Olariu R, and Shellito J: Alveolar macrophage release
of
tumor necrosis factor-α in chronic alcoholics without liver disease. Alcohol Clin Exp Res 22:567572, 1998.
LCME Medical Education Database 2009-10
I. Institutional Setting
105.
Bagby GJ, Stoltz, DA, Zhang P, Bohm RP, and Nelson S: SIV infection, alcohol and host
defense. Alcohol Clin Exp Res 22:193S-195S, 1998.
106.
Prakash O, Joshi BH, Zhang P, Aw TY, Teng S, Ali M, Shellito JE and Nelson S: Transgenic
mouse model of ethanol as a cofactor in HIV disease. Alcohol Clin Exp Res 22:266S-268S,
1998.
107.
Nelson S, Belknap SM, Carlson RW, Dale D, deBoisblanc B, Farkas S, Fotheringham N, Ho H,
Marrie T, Movahhed H, Root R, and Wilson J: A randomized controlled trial of filgrastim as an
adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia
(CAP). J Infect Dis 178:1075-1080, 1998.
108.
Nelson S and Summer WR: Innate immunity, cytokines, and pulmonary host defense. Infect Dis
Clin of North Am 12:555-567, 1998.
109.
Guery B, Nelson S, Viget N, Fialdes P, Summer WR, Dobard E, Beaucaire G, and
Mason
CM: Fluorescein-labeled dextran concentration is increased in BAL fluid after ANTU-induced
edema in rats. J Appl Physiol 85:842-848, 1998.
110.
Mason CM, Dobard E, Kolls J, and Nelson S: The effect of alcohol on bacterial translocation in
rats. Alcohol Clin Exp Res 22:1640-1645, 1998.
111.
Prakash O, Zhang P, Xie M, Ali M, Zhou P, Coleman R, Stoltz DA, Bagby GJ, Shellito JE, and
Nelson S: The human immunodeficiency virus type 1 tat protein potentiates ethanol-induced
neutrophil functional impairment in transgenic mice. Alcohol Clin Exp Res 22:2043-2049, 1998.
112.
Bagby GJ, Zhang P, Stoltz DA, and Nelson S: Suppression of the G-CSF response to E. coli
challenge by alcohol intoxication. Alcohol Clin Exp Res 22:1740-1745, 1998.
113.
Omidvari K, deBoisblanc BP, Karam G, Nelson S, Haponik E, and Summer W: Early transition
to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical
outcomes, and cost analysis. Resp Med 92:1032-1039, 1998.
114.
Morrow SL, Larson JE, Nelson S, Ren T, and Cohen JC: Modification of development by the
CFTR gene in utero: evidence for a secretory cell missing (scm) activity. Mol Med Metabolism
65:203-212, 1998.
115.
Schwarzenberger P, LaRussa V, Miller A, Ye P, Huang W, Zieske A, Nelson S, Bagby G, Stoltz
D, Mynatt R, Spriggs M, and Kolls JK: Interleukin 17 stimulates granulopoiesis in mice: use of
an alternate, novel, gene therapy derived method for in vivo evaluation of cytokines. J Immunol
161:6383-6389, 1998.
116.
Zhang P, Bagby GJ, Stoltz DA, Summer WR, and Nelson S: G-CSF modulates the pulmonary
host response to endotoxin in the absence and presence of ethanol intoxication. J Infect Dis
179:1441-1448, 1999.
117.
Greenberg S, Zhao X, Hua L, Wang JF, Nelson S, and Ouyang J: Ethanol inhibits lung clearance
of Pseudomomas aeruginosa by a neutrophil and nitric oxide dependent mechanism, in vivo.
Alcohol Clin Exp Res 23:735-744, 1999.
118.
Stoltz DA, Zhang P, Nelson S, Bohm RP Jr, Murphey-Corb M, and Bagby GB: Ethanol
suppression of the functional state of polymorphonnuclear leukocytes obtained from uninfected
LCME Medical Education Database 2009-10
I. Institutional Setting
and simian immunodeficiency virus infected rhesus macaques. Alcohol Clin Exp Res 23:878-884,
1999.
119.
Kolls JK, Habetz S, Shean MK, Vazquez C, Brown JA, Lei D, Schwarzenberger P, Ye P, Nelson
S, Summer WR, and Shellito, JE: Interferon-gamma and CD8+ T-cells restore host defenses
against P. carinii in mice lacking CD4+ T-cells. J Immunol 162:2890-2894, 1999.
120.
Nelson S. A question of balance (Editorial). Am J Respir Crit Care Med 159:13651367, 1999.
121.
Mason CM and Nelson S: Pulmonary host defenses: Implications for therapy. Clin
Chest Med 20:475-488, 1999.
122.
Greenberg SS, Ouyang J, Zhao X, Parrish C, Nelson S, and Giles TD: Effects of
ethanol on neutrophil recruitment and lung host defense in nitric oxide synthase I and nitric oxide
synthase II knockout mice. Alcohol Clin Exp Res 23:1435-1445, 1999.
123.
Zhang P, Nelson S, Summer W, and Spitzer JA: Serine/threonine phosphorylation mediates the
phagocytic response of alveolar macrophages in rats challenged with intratracheal endotoxin.
Shock 13:34-40, 2000.
124.
Stoltz DA, Nelson S, Kolls JK, Zhang P, Bohm RP, Jr., Murphey-Corb M, and Bagby GJ: In
vitro ethanol suppresses alveolar macrophage TNF-α during simian immunodeficiency virus
infection. Am J Respir Crit Care Med 161:135-140, 2000.
125.
Hunt JD, Robert EG, Zieske AW, Bautista AP, Bukara M, Lei D, Shellito JE, Nelson S, Kolls JK,
and Skrepnik N: Orthotopic human lung cancer xenografts in BALB/c mice immunosuppressed
with anti-CD4 monoclonal antibodies and chronic alcohol comsumption. Cancer 88:468-479,
2000.
126.
Nelson S, Summer WR, and Mason CM: The role of the inflammatory response in chronic
bronchitis: therapeutic implications. Sem Respir Infect 15:24-31, 2000.
127.
Zhang Z, Cork J, Ye P, Lei D, Schwarzenberger PO, Summer WR, Shellito JE, Nelson S, and
Kolls JK: Inhibition of TNF-α processing and TACE-mediated ectodomain shedding by ethanol.
J Leukoc Biol 67:856-862, 2000.
128.
Rodriguez FH, Nelson S, and Kolls JK: Cytokine therapeutics for infectious diseases. Curr
Pharm Des 6:665-680, 2000.
129.
Mason CM, Dobard E, Kolls JK, and Nelson S: Ethanol and murine interleukin (IL)-12
production. Alcohol Clin Exp Res 24:553-559, 2000.
130.
Zhang P, Summer WR, Bagby GJ, and Nelson S: Innate immunity and pulmonary host defense.
Immunol Rev 173:39-51, 2000.
131.
Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z, Bagby G, Nelson S, and
Kolls JK: Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor
for IL-17-mediated granulopoiesis. J Immunol 164:4783-4789, 2000.
LCME Medical Education Database 2009-10
I. Institutional Setting
132.
Welsh DA, Summer WR, Dobard EP, Nelson S, and Mason CM: Keratinocyte growth factor
prevents ventilator-induced lung injury in an ex vivo rat model. Am J Respir Crit Care Med
162:1081-1086, 2000.
133.
Nelson S and Mason CM: The inflammatory response in chronic bronchitis. Sem Respir Crit
Care Med 21:79-86, 2000.
134.
Nelson S, Heyder AM, Stone J, Bergeron MG, Daugherty S, Peterson G, Fotheringham N, Welch
W, Milwee S, and Root R: A randomized controlled trial of filgrastim for the treatment of
hospitalized patients with multilobar pneumonia. J Infect Dis 182:970-973, 2000.
135.
Kolls JK and Nelson S: Immune modulation in the treatment of respiratory infection. Respir Res
1:9-11, 2000.
136.
Zhang P, Bagby GJ, Kolls JK, Summer WR, Andresen J, and Nelson S: The effects of
granulocyte colony-stimulating factor and neutrophil recruitment on the pulmonary chemokine
response to intratracheal endotoxin. J Immunol 165:458-465, 2001.
137.
Nelson S, Bagby GJ, and Dale D: Cytokine treatment of bacterial pneumonia. Sem
Respir Infect 16:38-46, 2001.
138.
Welsh DA, Guery BPH, DeBoisblanc BP, Dobard E, Creusy C, Mercante D, Nelson S, Summer
WR, and Mason CM: Keratinocyte growth factor attenuates hydrostatic pulmonary edema in an
isolated, perfused rat lung model. Am J Physiol 280:H1311-H1317, 2001.
139.
Wunderink RG, Leeper K, Schein R, Nelson S, DeBoisblanc BP, Fotheringham N, and Logan E:
Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 119:523-529,
2001.
140.
Prakash O, Rodriguez VE, Tang ZY, Zhou P, Coleman R, Dhillon G, Shellito JE, and Nelson S:
Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency
virus type 1 Tat-expressing transgenic mice. Alcohol Clin Exp Res 25:450-456, 2001.
141.
Boé DM, Nelson S, Zhang P, and Bagby GJ: Acute ethanol intoxication suppresses lung
chemokine production following infection with Streptococcus pneumoniae. J Infect Dis
184:1134-1142, 2001.
142.
Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE,
and Kolls JK: Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am
J Respir Cell Mol Biol 25:335-340, 2001.
143.
Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W,
Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Perscho JJ, and Kolls JK:
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte
colony-stimulating factor expression, neutrophil recruitment and host defense. J Exp Med
194:519-528, 2001.
144.
Nelson S: Novel nonantibiotic therapies for pneumonia: cytokines and host defense.
Chest 119:419S-425S, 2001.
LCME Medical Education Database 2009-10
I. Institutional Setting
145.
Mason CM, Dobard E, Shellito J, and Nelson S: CD4+ lymphocyte responses to pulmonary
infection with Mycobacterium tuberculosis in naïve and vaccinated BALB/c mice. Tuberculosis
81:327-334, 2001.
146.
Zhang P, Bagby GJ, Boe DM, Zhong Q, Schwarzenberger P, Kolls JK, Summer WR, and Nelson
S: Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia.
Alcohol Clin Exp Res 26:65-73, 2002.
147.
Zhang P, Nelson S, Holmes MC, Summer WR, and Bagby GJ: Compartmentalization of
macrophage inflammatory protein-2, but not cytokine-induced neutrophil chemoattractant, in rats
challenged with intratracheal endotoxin. Shock 17:104-108, 2002.
148.
Stoltz DA, Nelson S, Kolls JK, Zhang P, Bohm RP Jr, Murphey-Corb M, and Bagby GJ: Effects
of in vitro ethanol on tumor necrosis factor-alpha production by blood obtained from SIV infected
rhesus macaques. Alcohol Clin Exp Res 26:527-534, 2002.
149.
Quinton LJ, Nelson S, Boe DM, Zhang P, Zhong Q, Kolls JK, and Bagby GJ: The granulocyte
colony-stimulating factor response following intrapulmonary and systemic bacterial challenges. J
Infect Dis 185:1476-1482, 2002.
150.
Prakash O, Tang ZY, Zhou P, Peng X, Kolls J, Shellito J, and Nelson S: Ethanol decreases the
efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line. Alcohol
Clin Exp Res 26:295-302, 2002.
151.
Nelson S and Kolls JK: Alcohol, host defense and society. Nature Rev Immunol 2:205-209,
2002.
152.
Zhang P, Bagby GJ, Happel KI, Summer WR, and Nelson S: Pulmonary host defenses and
alcohol. Front Biosci 7:d1314-1330, 2002.
153.
Nelson S: Alcohol and bacterial pneumonia. J Resp Dis 23:326-328, 2002.
154.
Holmes MC, Zhang P, Nelson S, Summer WR, and Bagby GJ: Neutrophil modulation of the
pulmonary chemokine response to lipopolysaccharide. Shock 18:555-560, 2002.
155.
Winsauer PJ, Moerschbaecher JM, Brauner I, Lancaster JR, Bagby GJ, and Nelson S: Alcohol
unmasks SIV-induced cognitive impairments in rhesus monkeys. Alcohol Clin Exp Res 26:18461857, 2002.
156.
Spitzer JA, Zhang P, Bagby GJ, Stowe CV, and Nelson S: Sex differences in the modulation by
ethanol of lung chemotaxis. Alcohol 28:95-102, 2002.
157.
Prakash O and Nelson S: Alcohol and liver disease. The Ochsner J 4:241-244, 2002.
158.
Root RK, Lodato RF, Ward P, Cade JF, Fotheringham N, Milwee S, Vincent JL, Torres A, Rello
J, and Nelson S: Multicenter, double-blind, placebo-controlled study of the use of filgrastim in
patients hospitalized with pneumonia and severe sepsis. Crit Care Med 31:367-373, 2003.
LCME Medical Education Database 2009-10
I. Institutional Setting
159.
Zhang P, Quinton LJ, Bagby GJ, Summer WR, and Nelson S: Interferon-gamma enhances the
pulmonary CXC chemokine response to intratracheal lipopolysaccaride challenge. J Infect Dis
187:62-69, 2003.
160.
Zhao X-J, Marrero L, Song K, Oliver P, Chin SY, Simon H, Schurr JR, Zhang Z, Thoppil D, Lee
S, Nelson S, and Kolls JK: Acute alcohol inhibits TNF-alpha processing in human monocytes by
inhibiting TNF/TACE interactions in the cell membrane. J Immunol 170:2923-2931, 2003.
161.
Bagby GJ, Stoltz DA, Zhang P, Kolls JK, Brown J, Bohm, Jr. RP, Rockar R, Purcell J, MurpheyCorb M, and Nelson S: The effect of chronic binge ethanol consumption on the primary stage of
SIV infection in rhesus macaques. Alcohol Clin Exp Res 27:495-502, 2003.
162.
Molina PE, Hoek JB, Nelson S, Guidot DM Lang CH, Wands JR, and Crawford JM:
Mechanisms of alcohol-induced tissue injury. Alcohol Clin Exp Res 27:563-575, 2003.
163.
Happel KI, Zheng M, Quinton LJ, Lockhart E, Ramsay AJ, Shellito JE, Schurr JR, Bagby GJ,
Nelson S, and Kolls JK: Cutting edge: roles of toll-like receptor 4 and IL-23 in IL-17 expression
in response to Klebsiella pneumoniae infection. J Immunol 170:4432-4436, 2003.
164.
Boe DM, Nelson S, Zhang P, Quinton L, and Bagby GJ: Alcohol-induced suppression of lung
chemokine production and the host defense response to Streptococcus pneumoniae. Alcohol Clin
Exp Res 27:1838-1845, 2003
165.
Quinton LJ, Nelson S, Zhang P, Boe DM, Happel KI, Pan W, and Bagby GJ: Selective transport
of cytokine-induced neutrophil chemoattractant from the lung to the blood facilitates pulmonary
neutrophil recruitment. Am J Physiol Lung Cell Mol Physiol 286: L465-L472, 2004.
166.
Happel KI, Bagby GJ, and Nelson S: Host defense and bacterial pneumonia. Semin Respir Crit
Care Med 25:43-52, 2004.
167.
Mason CM, Dobard E, Zhang P, and Nelson, S: Alcohol exacerbates murine pulmonary
tuberculosis. Infect Immun 72:2556-2563, 2004.
168.
Shahbazian LM, Quinton, LJ, Bagby GJ, Nelson S, Wang G, and Zhang P: Escherichia coli
pneumonia enhances granulopoiesis and the mobilization of myeloid progenitor cells into the
systemic circulation. Crit Care Med 32:1740-1746, 2004.
169.
Happel KI, Nelson S, and Summer WR: The lung in sepsis: fueling the fire. Am J Med Sci
328:230-237, 2004.
170.
Mason CM and Nelson S: Pulmonary host defenses and factors predisposing to lung infection.
Clin Chest Med 26:11-17, 2005
171.
Zhang P, Quinton LJ, Gamble L, Bagby GJ, Summer WR, and Nelson S: The granulopoietic
cytokine response and enhancement of granulopoiesis in mice during endotoxemia. Shock
23:344-352, 2005.
172.
Quinton LJ, Nelson S, Zhang P, Happel KI, Gamble L, and Bagby GJ: Effects of systemic and
local CXC chemokine administration on the ethanol-induced suppression of pulmonary
neutrophil recruitment. Alcohol Clin Exp Res 29:1198-1205, 2005.
LCME Medical Education Database 2009-10
I. Institutional Setting
173.
Happel KI, Lockhart EA, Mason CM, Poretta E, Keoshkerian E, Odden AR, Nelson S and
Ramsay AJ: Pulmonary IL-23 gene delivery increases local T cell immunity and controls growth
of Mycobacterium tuberculosis in the lungs. Infect Immun 73:5782-5788, 2005.
174.
Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE,
Bagby GJ, Nelson S, and Kolls JK: Divergent roles of IL-23 and IL-12 in host defense against
Klebsiella pneumoniae. J Exp Med 202:761-769, 2005.
175.
Song, K, Zhao XJ, Marrero L, Oliver P, Nelson S, and Kolls JK: Alcohol reversibly disrupts
TNF-alpha-TACE interactions in the cell membrane. Respir Res 6:123-131, 2005.
176.
Happel KI and Nelson S: Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc
2:428-432, 2005.
177.
Poonia B, Nelson S, Bagby GJ, Zhang P, Quinton L, and Veazey RS: Chronic alcohol
consumption results in higher simian immunodeficiency virus replication in mucosally inoculated
rhesus macaques. AIDS Res Hum Retroviruses 21:863-868, 2005.
178.
Gamble, L, Mason CM, and Nelson S: The effects of alcohol on immunity and bacterial
infection in the lung. Med Mal Infect 36: 72-77, 2006.
179.
Happel KI, Odden AR, Zhang P, Shellito JE, Bagby GJ, and Nelson S: Acute alcohol
intoxication suppresses the interleukin 23 response to Klebsiella pneumoniae infection. Alcohol
Clin Exp Res 30:1200-1207, 2006.
180.
Philipp MT, Purcell JE, Martin DS, Buck WR, Plauche GB, Ribka EP, DeNoel P, Hermand P,
Leiva LE, Bagby GJ, and Nelson S: Experimental infection of rhesus macaques with
Streptococcus pneumoniae: a possible model for vaccine assessment. J Med Primatol 35:113122, 2006.
181.
Poonia B, Nelson S, Bagby GJ, and Veazey RS: Intestinal lymphocyte subsets and turnover are
affected by chronic alcohol consumption: implications for SIV/HIV infection. J Acquir Immune
Defic Syndro 41:537-547, 2006.
182.
Bagby GJ, Zhang P, Purcell J, Didier PJ, and Nelson S: Chronic binge ethanol consumption
accelerates progression of SIV Disease. Alcohol Clin Exp Res 30:1781-1790, 2006.
183.
Molina PE, McNurlan M, Rathmacher J, Lang CH, Zambell KL, Purcell J, Bohm RP, ZhangP,
Bagby GJ, and Nelson S: Chronic alcohol accentuates nutritional, metabolic, and immune
alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res
30:2065-2078, 2006.
184.
Zhang P, Zhong Q, Bagby GJ, and Nelson S: Alcohol intoxication inhibits pulmonary S100A8
and S100A9 expression in rats challenged with intratracheal lipopolysaccharide. Alcohol Clin
Exp Res 31:113-121, 2007.
185.
Mason CM, Porretta E, Zhang P, and Nelson S: CD4+ CD25+ transforming growth factor-βproducing T cells are present in the lung in murine tuberculosis and may regulate the host
inflammatory response. Clin Exp Immunol 148:537-545, 2007.
LCME Medical Education Database 2009-10
I. Institutional Setting
186.
Happel KI, Rudner X, Quinton LJ, Movassaghi M, Clark C, Odden AR, Zhang P, Bagby GJ,
Nelson S, and Shellito JE: Acute alcohol intoxication suppresses the pulmonary ELR-negative
CXC chemokine response to lipopolysaccharide. Alcohol 41:325-333, 2007.
187.
Dufour J, Ooms TG, Phillippi-Falkenstein KM, Penney T, Doyle L, Bagby GJ, Nelson S, Veazey
RS, and Bohm RP Jr. Complications of gastric catheters implanted in rhesus macaques (Macaca
mulatta). J Am Assoc Lab Anim Sci 46: 29-34, 2007.
188.
Molina PE, Lang CH, McNurlan M, Bagby GJ, and Nelson S: Chronic alcohol accentuates
simian acquired immunodeficiency syndrome-associated wasting. Alcohol Clin Exp Res 32:138147, 2008.
189.
Zhang P, Bagby GJ, Happel KI, Raasch CE, and Nelson S: Alcohol abuse, immunosuppression,
and pulmonary infection. Current Drug Abuse Reviews 1:56-67, 2008.
190.
Siggins RW II, Zhang P, Welsh DA, LeCapitaine NJ, and Nelson S: Stem cells, phenotypic
inversion, and differentiation. Int J Clin Exp Med 1:2-21, 2008.
191.
Zhang P, Welsh DA, and Nelson S: The hematopoietic stem cell response to Escherichia Coli
bacteremia. In Press, Crit Care Med, 2008.
192.
Zhang P, Nelson S, Bagby GJ, Siggins RW II, Shellito JE, and Welsh DA: The lineage-ckit+Sca-1+ cell response to Escherichia Coli Bacteremia in Balb/c mice. Stem Cells 26:17781786, 2008.
193.
Hajishengallis G, Wang M, Bagby GJ, and Nelson S: Importance of TLR2 in early innate
immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J
Immunology 181:4141-4149, 2008.
194.
Gamble L, Bagby GJ, Quinton LJ, Happel KI, Mizgerd JP, Zhang P, and Nelson S: The systemic
and pulmonary lipopolysaccharide binding protein response to intratracheal lipopolysaccharide.
Shock 31:212-217, 2008.
195.
Walker Jr JE, Odden AR, Jeyaseelan S, Zhang P, Bagby GJ, Nelson S, and Happel KI: Ethanol
exposure impairs LPS-Induced Pulmonary LIX expression: alveolar epithelial cell dysfunction as
a consequence of acute intoxication. Published Online: Alcohol Clin Exp Res, Nov, 2008.
196.
Zhang P, Welsh DA, Siggins RW II, Bagby GJ, Raasch CE, Happel KI, and Nelson S: Acute
alcohol intoxication inhibits the Lineage-c-kit+Sca-1+ cell response to Escherichia coli
Bacteremia. J Immunology 182:1568-1576, 2009.
BOOKS/MONOGRAPHS:
1.
Contemporary Issues in Pulmonary Infections. (P. Cole, S. Nasraway, and S. Nelson., eds).
Chest: 108, 1995.
2.
Future of Sepsis Research. (R. Phillip Dellinger, Chairman). ACCP, NIAID, and NHLBI
Conference Proceedings. Division of Health and Science Policy, ACCP, 1997.
3.
Cytokines and Pulmonary Infection. Part I: Host-Pathogen Interactions in Pulmonary Infection
(S. Nelson, ed). American Thoracic Society, 1997.
LCME Medical Education Database 2009-10
I. Institutional Setting
4.
Cytokines and Pulmonary Infection. Part II: The Role of Cytokines in Systemic and Pulmonary
Medicine (S. Nelson, ed). American Thoracic Society, 1997.
5.
Cytokines and Pulmonary Infection. Part III: The Economics and Targets of New Therapies in
Pulmonary Infections. (S. Nelson, ed) American Thoracic Society, 1998.
6.
Cytokines in Pulmonary Disease. Infection and Inflammation. (S. Nelson and T. Martin, eds).
Marcel Dekker, Inc, New York, 2000.
7.
Pulmonary Host Defenses (S. Nelson and T. Standiford, eds). Sem Resp Crit Care Med Vol. 25.
Thieme, New York, 2004.
CHAPTERS:
1.
Nelson S, Summer WR, Jakab GJ: Aminophylline-induced suppression of pulmonary
antibacterial defenses. In, The Year Book of Pulmonary Disease (G.M. Green, W.C. Ball, H.A.
Menkes, J.R. Michael, S.P. Peters, P.B. Terry, M.S. Tockman, and R. Wise, eds). Year Book
Medical Publishers, Inc.,1986.
2.
Nelson S, Bagby GJ, Summer WR: Alcohol-induced suppression of tumor necrosis factor - a
potential risk factor for secondary infection in the acquired immunodeficiency syndrome. In,
Alcohol, Immunosuppression and AIDS (D. Seminara, R. Watson, and A. Pawlowski, eds). Alan
R. Liss, Inc.,1990.
3.
Nelson S: Pulmonary host defenses in burn injury. In, Respiratory Complications In Thermal
Injury (E.F. Haponik and A.M. Munster, eds). McGraw-Hill Book Company, 1990.
4.
Nelson S, Summer WR, Bagby GJ: LPS-induced inhibition of lung TNF and host defenses. In,
The Physiological and Pathological Effects of Cytokines. (C. A. Dinarello, M.J. Kluger, M.C.
Powanda and J.J. Oppenheim, eds). Wiley-Liss, Inc., 1990.
5.
Nelson S, Summer WR: The adverse effects of pharmacologic therapy on pulmonary host
defenses. In, Respiratory Disease in the Immunosuppressed Host (J. Shelhamer, P.A. Pizzo, J.E.
Parillo and H. Masur, eds). J.B. Lippincott and Company, 1991.
6.
Nelson S, Bagby G, Andresen J, Nakamura C, Shellito J, Summer WR: The effects of ethanol,
tumor necrosis factor, and granulocyte colony-stimulating factor on lung antibacterial defenses.
In, Drugs of Abuse, Immunity, and Immunodeficiency. (H. Friedman, ed.) Plenum Press, 1991.
7.
Nelson S, Mason C, Nakamura C, Bagby G: The role of tumor necrosis factor in health and
disease. In, Alcohol, Immunity and Cancer. (R. Yirmiya and A.Taylor, eds.) CRC Press, 1992.
8.
Nelson S, Diafuku R, Andresen J: Granulocyte colony-stimulating factor in infectious diseases.
In, Granulocyte Colony-Stimulating Factor in Clinical Practice. (G. Morstyn and M. Dexter,
eds). Marcel Dekker, Inc, 1993.
9.
Nelson S, Summer W: New strategies in the therapy of sepsis and pneumonia. In, Respiratory
Infections. (M. Neiderman, G. Sarosi, and J. Glassroth, eds) W.B. Saunders Company, 1994.
10.
Nelson S, Mason C, Kolls J, Summer WR: Pathophysiology of pneumonia. In, Pneumonia in the
Intensive Care Unit. (R. Wunderink, ed). W. B. Saunders Company, 1995.
LCME Medical Education Database 2009-10
I. Institutional Setting
11.
Kolls, JK, Mason CM, Nelson S: Effect of ethanol on tumor necrosis factor and cytokine
production in lung antibacterial defenses. In, Drugs of Abuse and the Immune Response. (H.
Friedman, T. Klein, and S. Specter, eds). CRC Press, 1995.
12.
Nelson S, Bagby G: Granulocyte colony-stimulating factor and modulation of inflammatory cells
in sepsis. In, The Sepsis Syndrome. (P. Dorinsky, ed). W.B. Saunders Company, 1996.
13.
Weinacker A, Nelson S: Pneumonia prevention. In, Pulmonary Secrets. (P. Parsons and J.
Heffner, eds). Hanley and Belfus, Inc, 1997.
14.
Morstyn G, Foote MA, Nelson S: Clinical benefits of improving host defences with rHuG-CSF.
In, The Molecular Basis of Cellular Defence Mechanisms. Ciba Foundation Symposium 204.
John Wiley and Sons, 1997.
15.
deBoisblanc BP, Guery B, Nelson S: Biological response modifiers and sepsis. In, Sepsis and
Multi-organ Failure: Mechanisms and Treatment Strategies (A Fein, E Abraham, R Balk, G
Bernard, R Bone, D Dantzker, and M Fink, eds). William and Wilkins, 1997.
16.
Nelson S: New interventions for pneumonia. In, Sepsis (J. Rello, ed), Kluwer Academic
Publishers, 1998.
17.
Mason C, Nelson S: Pneumonia and septic shock. In, Critical Care Pearls. (S. Sahn and J.
Heffner, eds.) Hanley and Belfus, Inc., 1997.
18.
Nelson S: Cytokine-based strategies for the treatment of pneumonia. In, Respiratory Infections in
the ICU. (A. Torres, M. El-Ebiary and M. Niederman, and Mensa, eds). Springer-Verlag, 1998.
19.
Andresen J, Movahhed H, Nelson S: Filgrastim (r-metHuG-CSF) in pneumonia. In, Filgrastim (rmetHuG-CSF) in Clinical Practice. (G. Morstyn, M Dexter and M Foote, eds). Marcel Dekker,
Inc, 1998.
20.
Dale DC, Nelson S: Use of colony-stimulating factors for treatment of neutropenia and infectious
diseases. In, The Neutrophil. (D. Gabrilovich, ed). Imperial College Press, 1999.
21.
Andresen J, Movahhed H, Nelson S: Filgrastim (r-metHuG-CSF) in pneumonia. In, Filgrastim
(r-metHuG-CSF) in Clinical Practice, 2nd Ed. (G. Morstyn, M. Dexter, and M. Foote, eds). Marcel
Dekker, Inc, 1999.
22.
Nelson S, Babgy GJ, Mason CM, Summer WR: Cytokines and the antibacterial defenses of the
lung. In, Cytokines in Pulmonary Disease. Infection and Inflammation. (S. Nelson and T.
Martin, eds). Marcel Dekker, Inc., 2000.
23.
Stoltz DA, Nelson S: Immunomodulation as a therapeutic strategy for the treatment of
pneumonia. In, Therapeutic Implications on Severe Community-Acquired Pneumonia. (J. Rello,
ed). Edika Med, 2001.
24.
Nelson S, Mason CM, Zhang P, Summer WR, Bagby GJ: Immunomodulation in sepsis. In,
Critical Care Infectious Diseases (J. Rello, J. Valles, and M. Kollef , eds). Kluwer Academic
Publishers, 2001.
25.
Weinacker A, Nelson S: Pneumonia prevention. In, Pulmonary/Respiratory Therapy Secrets. (P.
Parsons and J. Heffner, eds). Hanley and Belfus, Inc, 2001.
LCME Medical Education Database 2009-10
I. Institutional Setting
26.
Bautista AP, Bagby GJ, Nelson S, Zhang P, Bohm RP: Functional regulation in
endothelial and Kupffer cells in SIV-infected macacca mulatta following chronic alcohol administration.
In, Cells of the Hepatic Sinusoids. (DL. Knook, E. Wisse, and MJP Arthur, eds). The Kupffer Cell
Foundation, 2001.
27.
28.
Zhang P, Bagby GJ, Kolls J, Quinton LJ, Nelson S: Alcohol, infection and the lung. In,
Infectious Diseases and Substance Abuse. (Herman Friedman et al, ed). Springer US, 2005.
Quinton LJ, Dale DC, Nelson S: Use of colony-stimulating factors for treatment of neutropenia
and infectious diseases. In, The Neutrophils (D. Gabrilovich, ed). Imperial College Press, 2005.
29.
Zhang P, Mason CM, Nelson S: Phagocytes in the pulmonary host defense system. In,
Respiratory Infections (A. Torres, S. Ewig, L. Mandell, and M. Woodhead, eds). Edward Arnold
Publishers, 2006.
30.
Davis K, Weinacker A, and Nelson S: Pneumonia prevention. In, Pulmonary Respiratory Therapy
Secrets, 3rd Ed. (P. Parsons and J. Heffner, eds.). Mosby Elsevier, 2006.
AUDIOVISUAL:
1.
Nelson S: Pneumonia: Recognition and Treatment. Family Practice Vol. 34, March 24, 1986.
Audio-Digest Foundation.
2.
Nelson S: Mycoplasma Infections. Family Practice Vol. 35, April 20, 1987. Audio-Digest
Foundation.
3.
Nelson S: Community-Acquired Pneumonia. Family Practice Vol. 37, April 17, 1989.
Audio-Digest Foundation.
4.
Nelson S: Pathogenesis and Prevention of Nosocomial Pneumonia. AVM Audio Visual, Inc.,
1993.
5.
Nelson S: Prospects for Cytokine Therapy in Nosocomial Pneumonia and Sepsis. American
Thoracic Society, Convention Seminar Cassettes, 1993.
6.
Nelson S: Acute Pneumonia in the Neutropenic Patient: The Potential for Colony- Stimulating
Factors as Adjuvant Therapy. American Thoracic Society, Convention Seminar Cassettes, 1993.
7.
Nelson S: Immunomodulation of Respiratory Infections. American Thoracic Society, Convention
Seminar Cassettes, 1994.
8.
Nelson S: Respiratory Infections: New Concepts in Treatment, Prevention, and Pathogenesis.
American Thoracic Society, Convention Seminar Cassettes, 1994.
9.
Nelson S: ACCP Fellows Conference. Medical Conventions Resources, Inc., 1995.
10.
Nelson S: The Adult Patient with Cystic Fibrosis. Pulmonary Clinical Consultant, Vol. 1,
American College of Chest Physicians, 1995.
11.
Nelson S: ACCP Fellows Conference. Medical Conventions Resources, Inc., 1996.
12.
Nelson S: Audio Forum on Chronic Bronchitis. Scientific Exchange, Inc., 1997.
LCME Medical Education Database 2009-10
I. Institutional Setting
13.
Nelson S: Acute Exacerbations of Chronic Bronchitis: Diagnostic and Treatment Strategies.
Scientific Exchange, Inc., 1997.
14.
Nelson S: Innate Immunity and Pulmonary Host Defense. American Thoracic Society,
Convention Seminar Cassettes, 1998.
15.
Nelson S: ACCP Fellows Conference. Medical Conventions Resources, Inc., 1998.
ABSTRACTS:
l.
Nelson S, Summer W, and Jakab G: Aminophylline suppresses pulmonary antibacterial
defenses. Am Rev Respir Dis 127S:198, 1983.
2.
Nelson S, Summer W, and Jakab G: Aminophylline-induced inhibition of pulmonary
antibacterial phagocytic defenses. Program and abstracts of the ATS Eastern Section Meetings,
Charlottesville, Virginia.
3.
Nelson S, Laughon B, Summer W, Bartlett J, and Jakab G: A model of anaerobic pneumonia in
mice. Program and abstracts of the XXIIIrd Interscience Conference on Antimicrobial Agents
and Chemotherapy, Las Vegas, Nevada.
4.
Nelson S, Summer W, and Jakab G: Erythromycin suppresses pulmonary antibacterial defenses A potential mechanism of superinfection in the lung. Am Rev Respir Dis l29S:183, l984.
5.
White J, Nelson S, and Jakab G: Corticosteroids enhance impairment of pulmonary antibacterial
defenses following acid aspiration. Am Rev Respir Dis l29S:l83, l984.
6.
Nelson S, White J, Summer W, and Jakab G: Antibiotic efficacy against Pseudomonas
aeruginosa challenge in the immuno- compromised lung. Program and abstracts of the XXIVth
Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C.
7.
Warr G, Allegretto N, and Nelson S: Suppression of lung microbicidal activity by copper
diisopropylsalicylic acid-a superoxide dismutase - like scavenger of reactive oxygen. Program
and abstracts of the XXIVth Interscience Conference on Antimicrobial Agents and
Chemotherapy, Washington, D.C.
8.
White J, Nelson S, Jakab G, and Lanser M: Methylprednisolone impairs the bactericidal activity
of alveolar macrophages. Program and abstracts of the XVIIIth Annual Meeting of the
Association for Academic Surgery, San Antonio, Texas.
9.
Nelson S, Laughon B, Bartlett J, Summer W, and Jakab G: Characterization of the pulmonary
inflammatory response to an anaerobic bacterial challenge. Am Rev Respir Dis 131S:215, 1985.
10.
Astry C, Nelson S, Tejedor R, and Summer W: Interaction of clindamycin with in vivo
phagocytic defenses of the lung. Am Rev Respir Dis 133S:237, 1986
11.
Tejedor R, Nelson S, Astry C, and Summer W: Acute endotoxin impairs and chronic endotoxin
enhances pulmonary host defenses against Pseudomonas aeruginosa. Am Rev Respir Dis
133S:236, 1986.
LCME Medical Education Database 2009-10
I. Institutional Setting
12.
Nelson S, Tejedor R, Astry C, and Summer W: Contrasting effects of corticosteroids on systemic
and pulmonary host defenses in endotoxemia. Am Rev Respir Dis 133S:235, 1986.
13.
Astry CL, Nelson S, and Summer WR: Alveolar macrophage function with acute and chronic
alcohol. Am Rev Respir Dis 135S:267, 1987.
14.
Harris SE, Nelson S, Astry CL, and Summer WR: Endotoxin impairs pulmonary defenses
against Staphylococcus aureus. Am Rev Respir Dis 135S:267, 1987.
15.
Nelson S, Astry CL, Harris SE, and Summer WR: Endotoxin-induced impairment of pulmonary
antibacterial defenses. Am Rev Respir Dis 135S:77, 1987.
16.
Astry CL, Nelson S, and Summer WR: Effects of acute and chronic alcohol on pulmonary host
defenses. Am Rev Respir Dis 135S:34, 1987.
17.
Mouton C, Nelson S, and Karam G: The bacteriology and occurrence of beta- lactamase
production in anaerobic lung abscess. Program and Abstracts of the American College of
Physicians, New York, New York, 1988.
18.
Bainton BG, Nelson S, Chidiac C, and Summer WR: The effects of methylprednisolone and
ibuprofen on pulmonary inflammation and host defense. Am Rev Respir Dis 137S:175, 1988.
19.
Chidiac C, Nelson S, Bainton BG, and Summer WR: Effects of anti-inflammatory agents on
pulmonary host defenses suppressed by E. coli lipopolysaccharide. Am Rev Respir Dis 137S:175,
1988.
20.
Nelson S, Bagby G, and Summer W: Intratracheal lipopolysaccharide elicits tumor necrosis
factor activity in bronchoalveolar lavage fluid. Am Rev Respir Dis 137S:43, 1988.
21.
Nelson S, Bagby G, and Summer W: Alcohol suppresses lipopolysaccharide- induced tumor
necrosis factor activity and inflammation. Am Rev Respir Dis 137S:174, 1988.
22.
Bainton B, Nelson S, Chidiac C, Bagby G, and Summer WR: Methylprednisolone inhibits tumor
necrosis factor and pulmonary host defenses. Program and abstracts of the XXVIIIth Interscience
Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, CA.
23.
Nelson S, Bagby G, and Summer WR: Antibiotic-induced tumor necrosis factor during therapy
for Pseudomonas aeruginosa pneumonia. Am Rev Respir Dis 139S:582, 1989.
Chidiac C, Nelson S, Collins MS, Bainton B, and Summer WR: Hyperimmune antipseudomonas
immunoglobulin enhances host defenses in Pseduomonas aeruginosa pneumonia. Am Rev Respir
Dis 139S:32, 1989.
24.
25.
Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, and Summer W: Pentoxifylline inhibits
lipopolysaccharide-induced serum tumor necrosis factor and mortality. Am Rev Respir Dis
139S: 222, 1989.
26.
Bokulic R, Nelson S, Bagby G, Noel P, and Summer W: Inhibition of
lipopolysaccharide-induced serum tumor necrosis factor by cyclosporin A. Am Rev Respir Dis
139S:355, 1989.
LCME Medical Education Database 2009-10
I. Institutional Setting
27.
Nelson S, Noel P, Bokulic R, Bagby G, and Summer WR: Murine recombinant tumor necrosis
factor enhances host defenses against Staphylococcus aureus. Am Rev Respir Dis 139S:357,
1989.
28.
Nelson S, Bagby G, and Summer WR: Alcohol suppresses tumor necrosis factor and lung host
defenses. Alcohol Clin Exp Res 13:330, 1989.
29.
Mason CM, Dunn CW, Nelson S, Summer WR, and Dalnogare AR: Upper
gastrointestinal gram-negative bacillary colonization occurs concurrently with oropharyngeal colonization
in a rat model. Am Rev Respir Dis 141S:334, 1990.
30.
deBoisblanc BP, Jawda A, Svec F, Nelson S, and Summer WR: Effect of anabolic steroids on
diaphragmatic tension generation in a rat model of cystic fibrosis. Am Rev Respir Dis 141S:549,
1990.
31.
Nelson S, Mason C, Bagby G, Nakamura C, and Summer WR: Lipopolysaccharide-induced
inhibition of intrapulmonary tumor necrosis factor and lung antibacterial defenses. Am Rev
Respir Dis 141S:512, 1990.
32.
Nelson S, Bagby G, Nakamura C, and Summer WR: Ethanol-induced suppression of tumor
necrosis factor and pulmonary antibacterial defenses. Am Rev Respir Dis 141S:530, 1990.
33.
Nakamura C, Nelson S, Lippton H, Bagby G, and Summer WR: Contrasting effects of
misoprostol on systemic and intra-pulmonary lipopolysaccharide-induced tumor necrosis factor.
Am Rev Respir Dis 141S:131, 1990.
34.
Nelson S, Mason C, Bagby G, Andresen J, and Summer WR: Effect of murine recombinant
granulocyte-macrophage colony-stimulating factor on lipopolysaccharide-induced tumor necrosis
factor. Am Rev Respir Dis 141S:677, 1990.
35.
Nelson S, Bagby G, Andresen J, Nakamura C, and Summer WR: Granulocyte
colony-stimulating factor enhances pulmonary host defenses suppressed by alcohol. Am Rev
Respir Dis 141S:530, 1990.
36.
Nelson S, Bagby G, Plessala K, Thompson J, Wilson L, and Summer WR: Efficacy of
anti-tumor necrosis factor-alpha antibody in intravascular and peritonitis models of bacterial
infections. Am Rev Respir Dis 141S:921, 1990.
37.
Dowty BJ, Rodriguez de Turco E, Nelson S, Hagar A, and Spitzer JA: Effect of systemic
endotoxin on superoxide anion release and signal transduction in rat alveolar macrophages.
FASEB J 5:A1629, 1991.
38.
Spolarics Z, Schuler A, Lang CH, Bagby GJ, Nelson S, and Spitzer JJ: Acute upregulation of
glucose metabolism after granulocyte-macrophage colony-stimulating factor (GM-CSF)
administration. FASEB J 5:A545, 1991.
39.
Shellito JE, Sniezek MJ, Warnock M, and Nelson S: Chronic alcohol ingestion enhances host
susceptibility to Pneumocystis carinii infection in mice. Am Rev Respir Dis 143S:207, 1991.
40.
Havill AM, Andresen JW, Korach E, and Nelson S: Enhancement of endotoxin-induced lethality
in the mouse by GM-CSF. Am Rev Respir Dis 143S:236, 1991.
LCME Medical Education Database 2009-10
I. Institutional Setting
41.
Nelson S, Bagby G, and Summer W: Anti-tumor necrosis factor-alpha antibody suppresses
pulmonary antibacterial defenses. Am Rev Respir Dis 143S:393, 1991.
42.
Nelson S, Bagby G, Andresen J, Shellito J, and Summer W: Intratracheal granulocyte colonystimulating factor enhances systemic and pulmonary host defenses. Am Rev Respir Dis
143S:398, 1991.
43.
Mason CM, Bagby GJ, Summer WR, and Nelson S: Antibody to tumor necrosis factor attenuates
lipopolysaccharide-induced gram-negative bacillary oropharyngeal colonization. Am Rev Respir
Dis 143S:710, 1991.
44.
King JC, Mason CM, Onofrio J, Summer WR, and Nelson S: Granulocyte colony-stimulating
factor enhances pulmonary capillary leak following in vivo alpha-naphthylthiourea (ANTU) lung
injury. Chest 100:7S, 1991.
45.
Nelson S, Nakamura C, Andresen J, Cecchini M, Bagby G, and Summer W: Anti-granulocyte
colony-stimulating factor antibody suppresses pulmonary antibacterial defenses. Am Rev Respir
Dis 145S:13, 1992.
46.
Greenberg S, Xie J, Wang Y, Nelson S, and Summer W: Characteristics of tumor necrosis
factor-alpha suppression of nitric oxide release from pulmonary vascular endothelium. Am Rev
Respir Dis 145S:209, 1992.
47.
Shellito J, Beck J, Kolls J, and Nelson S: Alveolar macrophage release of tumor necrosis factor
during murine Pneumocystis carinii pneumonia. Am Rev Respir Dis 154S:247, 1992.
48.
Mason C, Dobard E, Summer W, and Nelson S: Granulocyte colony-stimulating factor
attenuates bacterial translocation in rats. Am Rev Respir Dis 145S:336, 1992.
Nelson S, Nakamura C, Shellito J, Bagby G, and Summer W: Intratracheal gamma-interferon
enhances pulmonary host defenses against Pseudomonas aeruginosa. Am Rev Respir Dis
145S:337, 1992.
49.
50.
Shellito J, Nelson S, and Sorensen RU: Pyocyanine, a product of Pseudomonas aeruginosa,
inhibits the release of reactive nitrogen intermediates from murine alveolar macrophages. Am
Rev Respir Dis 145S:551, 1992.
51.
Kolls J, Larson J, Deininger P, Shellito J, Nelson S, Beckerman R, and Summer W: Constitutive
expression of mRNA for tumor necrosis factor-alpha in murine alveolar macrophages. Am Rev
Respir Dis 145S:833, 1992.
52.
Bagby G, Nelson S, and Summer W: Endogenous tumor necrosis factor is a positive modulator
of pulmonary host defenses against Pseudomonas aeruginosa. Program and abstracts of the 4th
International TNF Congress, Veldhoven, The Netherlands, 1992.
53.
Malinski T, Wang Y, Xie J, Kolls J, Nelson S, Shellito J, and Summer WR ,Greenberg S: Acute
administration of ethanol releases nitric oxide from endothelium and adrenal glands but inhibits
its release from macrophages. FASEB J 7:A824, 1993.
54.
Xie J, Wang Y, Kolls S, Nelson S, and Summer WR, and Greenberg S: Ethanol induced
relaxation is mediated by release of nitric oxide and prostaglandins in pulmonary artery and vein.
FASEB J 7:A843, 1993.
LCME Medical Education Database 2009-10
I. Institutional Setting
55.
Greenberg S, LeBlanc R, Werner A, Xie J, Wang Y, Weinberg A, Kolls J, Shellito J, Nelson S,
and Summer W: Endotoxin-induced hypotension is mediated by nitric oxide from macrophages:
effect of prednisolone, aminotriazine and colony-stimulating factors. Am Rev Respir Dis
147S:99, 1993.
56.
Nelson S, Dowty B, Mason C, Bagby G, and Summer W: Gamma-interferon attenuates ethanolinduced suppression of lipopolysaccharide-stimulated tumor necrosis factor activity in lung and
serum. Am J Respir Dis 147S:203, 1993.
57.
Shellito J, D'Souza N, Nelson S, Greenberg S, and Summer W: Nitric oxide and interferoninduced enhancement of pulmonary host defenses against Pseudomonas aeruginosa. Am J
Respir Dis 147S:A203, 1993.
58.
Mason CM, Dobard E, Nelson S, and Summer W: Intraportal lipopolysaccharide is associated
with impairment of pulmonary host defense in rats. Am J Respir Dis 147S:203, 1993.
59.
deBoisblanc B, Summer WR, Mason C, Shellito J, Logan E, Bear M, Johnson S, and Nelson S:
Phase 1 trial of granulocyte-colony stimulating factor in severe community acquired pneumonia.
Am J Respir Dis 147S:204, 1993.
60.
Tutor JD, Mason C, Dobard E, Beckerman R, Summer WR, and Nelson S: Lung injury is
associated with loss of compartmentalization of alveolar tumor necrosis factor in the isolated
perfused rat lung. Am J Respir Dis 147S:730, 1993.
61.
Greenberg SS, Xie J, Kolls J, Summer WR, and Nelson S: Ethanol selectively suppresses gene
expression for inducible nitric oxide synthase II in lung phagocytes and decreases lung clearance
of K. pneumoniae. Am J Respir Crit Med 149S:A120, 1994.
62.
Mason C, Adams L, Nelson S, Summer W, and Shellito J: Mycobacterial cell wall antigens elicit
pulmonary host defense mechanisms. Am J Respir Crit Care Med 149S:A613, 1994.
63.
Nelson S, Mason C, Bagby G, and Summer WR: The contrasting effects of anti-tumor necrosis
factor antibody versus granulocyte colony-stimulating factor on pulmonary host defenses against
Candida albicans. Am J Respir Crit Care Med 149S:A872, 1994.
64.
Nelson S, Mason C, Shellito J, Bagby G, and Summer WR: The effects of gamma-interferon on
lipoarabinomannan-induced tumor necrosis factor in the lung. Am J Respir Crit Care Med
149S:A870, 1994.
65.
Xie J, Kolls J, Bagby G, Nelson S, Summer WR, Lyons R, and Greenberg SS: Endotoxin
induced stimulation of alveolar macrophage and neutrophil gene expression for nitric oxide is
independent of tumor necrosis factor. Am J Respir Crit Care Med 149S:A870, 1994.
66.
Skerrett SJ, Bagby GJ, and Nelson S: Antibody to tumor necrosis factor impairs pulmonary
clearance of Legionella pneumophila. Am J Respir Crit Care Med 149S:A871, 1994.
67.
Mandujano JF, D'Souza NB, Nelson S, Beckerman RC, Summer WR, and Shellito J: Reduction
in intensity of Pneumocystis carinii pneumonia in mice by subcutaneous administration of
granulocyte-macrophage colony-stimulating factor. Am J Respir Crit Care Med 149S:A289,
1994.
LCME Medical Education Database 2009-10
I. Institutional Setting
68.
D'Souza NB, Mandujano JF, Nelson S, Summer WR, and Shellito JE: Chronic alcohol ingestion
predisposes otherwise healthy mice to infection with Pneumocystis carinii. Alcohol Clin Exp Res
18:439, 1994.
69.
D'Souza NB, Nelson S, Summer WR, and Deaciuc IV: Alcohol-induced inhibition of alveolar
macrophage reactive nitrogen intermediates (RNI) release. Alcohol Clin Exp Res 18: 439, 1994.
70.
D'Souza NB, Nelson S, Summer WR, and Deaciuc IV: Modulation by alcohol (ETOH) of
alveolar macrophage (AM) interleukin (IL)-6 cell-surface receptors in the rat. Alcohol Clin Exp
Res 18: 439, 1994.
71.
Kolls JK, Xie J, Lei D, Greenberg S, and Nelson S: Acute exposure to ethanol blocks tumor
necrosis factor production in vivo by a post transcriptional mechanism. Alcohol Clin Exp Res
18:441, 1994.
72.
Deaciuc IV, Nelson S, and D'Souza NB: The effect of acute and chronic alcohol (ETOH)
administration to rats on tumor necrosis factor (TNF)-α cell-surface receptors of alveolar
macrophages. Alcohol Clin Exp Res 18:47A, 1994.
73.
Kolls JK, Lei D, Nelson S, Summer W, and Shellito J: Exacerbation of murine P. carinii
infection by adenoviral-mediated gene transfer of a TNF soluble receptor. Am J Respir Crit Care
Med 151S:A13, 1995.
74.
Nelson S, Bagby S, Mason C, and Summer W: Ethanol suppresses Escherichia coli-induced
plasma granulocyte colony-stimulating factor. Am J Respir Crit Care Med 151S:A14, 1995.
75.
Kolls J, Lei D, Xie J, Greenberg S, and Nelson S: Divergent effect of in vivo ethanol on
pulmonary TNF and inducible nitric oxide synthase gene expression. Am J Respir Crit Care Med
151S:A122, 1995.
76.
Rome C, Bagby G, Summer W, and Nelson S: Therapeutic efficacy of granulocyte colonystimulating factor in the treatment of Group B streptococcal sepsis in neonatal rats. Am J Respir
Crit Care Med 151S:A242, 1995.
77.
deBoisblanc B, Harris K, Bagby G, Svec F, and Nelson S: Effect of DHEA administration on
serum activity of TNF after intravenous LPS. Am J Respir Crit Care Med 151S:A242, 1995.
78.
Mason CM, Guery B, Dobard E, Summer W, and Nelson S: Keratinocyte growth factor protects
against lung injury induced by alpha-naphthylthiourea. Am J Respir Crit Care Med 151S:A345,
1995.
79.
Daifuku R, Movahhed H, Fotheringham N, Bear MB, and Nelson S: Time to resolution of
morbidity (TRM): an endpoint for assessing the clinical cure of community acquired pneumonia.
Am J Respir Crit Care Med 151S:A473, 1995.
80.
Wunderink RG, Leeper KV, Schein RMH, Nelson S, deBoisblanc B, Baker F, Fotheringham N,
and Logan E: Clinical response to filgrastim (r-metHuG-CSF) in pneumonia with severe sepsis.
Am J Respir Crit Care Med 153S:A123, 1996.
81.
Mason CM, Guery B, Dobard E, Summer W, and Nelson S: Intraportal lipopolysaccharide
impairs alveolar macrophage antibacterial defenses. Am J Respir Crit Care Med 153S:A258,
1996.
LCME Medical Education Database 2009-10
I. Institutional Setting
82.
Stoltz DA, Bagby GJ, Mason CM, and Nelson S: Intratracheal keratinocyte growth factor
preserves pulmonary antibacterial defenses in alpha-naphthylthiourea-induced lung injury. Am J
Respir Crit Care Med 153S:A258, 1996.
83.
Guery B, deBoisblanc BP, Nelson S, Dobard E, Beaucaire G, Summer W, and Mason C:
Keratinocyte growth factor protects against mechanical ventilation lung injury. Am J Respir Crit
Care Med 153S:A393, 1996.
84.
Guery B, Mason C, Dobard E, Beaucaire G, Summer W, and Nelson S: Keratinocyte growth
factor attenuates the consequences of alpha-naphthylthiourea-induced lung injury by increasing
transalveolar sodium reabsorption. Am J Respir Crit Care Med 153S:A433, 1996.
85.
McKenna PH, Nelson S, and Andresen J: Filgrastim (rhuG-CSF) enhances ciprofloxacin uptake
and bactericidal activity of human neutrophils in vitro. Am J Respir Crit Care Med 153S:A535,
1996.
86.
Nelson S, Farkas S, Fotheringham N, Ho H, Marrie T, and Movahhed H: Filgrastim in the
treatment of hospitalized patients with community acquired pneumonia (CAP). Am J Respir Crit
Care Med 153S:A535, 1996.
87.
Kolls JK, Lei D, Shellito J, Nelson S, and Summer W: Organ-specific cytokine gene therapy:
Compartmentalized activation of the alveolar macrophage by adenoviral-mediated gene transfer
of the murine interferon-gamma gene. Am J Respir Crit Care Med 153S:A764, 1996.
88.
Nelson S, Fotheringham N, and Movahhed H: Filgrastim reduces adult respiratory distress
syndrome and other serious complications in patients with multilobar pneumonia. Eur Respir J
9S:55, 1996.
89.
Zhang P, Summer WR, Bagby GJ, Stoltz DA, and Nelson S: Ethanol inhibits neutrophil β2integrin expression and phagocytosis during endotoxemia. Am J Respir Crit Care Med
155S:A292, 1997.
90.
Kolls JK, Lei D, Nelson S, Odom G, Summer WR, and Shellito JE: Adenoviral-mediated gene
transfer of the murine interferon-gamma gene prevents acquisition of P. carinii pneumonia in
CD4-depleted mice. Am J Respir Crit Care Med 155S:A458, 1997.
91.
Nelson S, Marrie T, and Movahhed H: Filgrastim (granulocyte colony-stimulating factor[GCSF]) reduces morbidity in patients with a history of chronic alcohol abuse hospitalized with
community-acquired pneumonia. Am J Respir Crit Care Med 155S:A801, 1997.
92.
Zhang P, Bagby GJ, Stoltz DA, Spitzer JA, Summer WR, and Nelson S: Modulation of the
inflammatory response by granulocyte colony-stimulating factor in rats challenged with
intrapulmonary endotoxin. Am J Respir Crit Care Med 155S:A801, 1997.
93.
Lei D, Shellito S, Nelson S, Summer WR, and Kolls JK: Organ-specific cytokine gene therapy:
attenuation of ethanol induced TNF suppression by adenoviral-mediated gene transfer of the
murine interferon-gamma gene. Am J Respir Crit Care Med 155S:A802, 1997.
94.
Mason CM, Dobard E, Summer W, Kolls JK, and Nelson S: Effect of alcohol on murine lung
interleukin (IL)-12. Am J Respir Crit Care Med 155S:A803, 1997.
LCME Medical Education Database 2009-10
I. Institutional Setting
95.
Stoltz DA, Bagby GJ, Bohm Jr. RP, Zhang P, and Nelson S: Lipopolysaccharide-induced tumor
necrosis factor-α by Rhesus monkey alveolar macrophages is suppressed by ethanol. Am J
Respir Crit Care Med 155S:A803, 1997.
96.
Mason CM, Dobard E, Summer W, Kolls J, and Nelson S: Ethanol and lung interleukin (IL)-12.
Alcohol Clin Exp Res 21:45A, 1997.
97.
Zhang P, Prakash O, Shellito JE, Stoltz DA, and Nelson S: Acute ethanol administration
suppresses endotoxin-induced β-integrin expression on PMNS in normal and HIV-1-TAT
transgenic mice. Alcohol Clin Exp Res 21:46A, 1997.
98.
Zhang P, Summer WR, Bagby GJ, Stoltz DA, and Nelson S: Acute ethanol intoxication inhibits
neutrophil β-integrin expression in endotoxin treated rats. Alcohol Clin Exp Res 21:46A, 1997.
99.
Nelson S, Stoltz DA, and Bagby G: Ethanol suppresses Escherichia coli-induced plasma
granulocyte colony-stimulating factor. Alcohol Clin Exp Res 21:46A, 1997.
100.
Zhang P, Nelson S, Summer WR, and Spitzer JA: Acute ethanol intoxication suppresses the
pulmonary inflammatory response in rats. Alcohol Clin Exp Res 21:47A, 1997.
101.
Lei D, Zhang P, Stoltz D, Ye P, Nelson S, Bagby G, Summer WR, Shellito J, and Kolls J:
Augmentation of pulmonary host defense in alcoholic rats by IFN gene therapy: overexpression
of adhesion molecule CD11b/c. Alcohol Clin Exp Res 21:82A, 1997.
102.
Lei D, Stoltz DA, Shellito J, Nelson S, Summer WR and Kolls J: Pulmonary cytokine gene
therapy: attenuation of ethanol induced TNF suppression by adenoviral-mediated gene transfer of
the murine interferon-gamma gene. Alcohol Clin Exp Res 21:82A, 1997.
103.
Mason CM, Dobard E, Summer W, and Nelson S: Effects of ethanol on bacterial and endotoxin
translocation from the gut. Alcohol Clin Exp Res 21:82A, 1997.
104.
Stoltz DA, Bagby GJ, Bohm RP Jr.,Zhang P, and Nelson S: Ethanol suppression of
lipopolysaccharide-induced tumor necrosis factor production by alveolar macrophages from
uninfected and SIV-infected asymptomatic rhesus monkeys. Alcohol Clin Exp Res 21:82A, 1997.
105.
Zhang P, Bagby GJ, Stoltz DA, Summer WR, and Nelson S: Enhancement of peritoneal
leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Am J
Respir Crit Care Med 157:A27, 1998.
106.
Mason C, Dobard E, deBoisblanc B, Guery B, Nelson S, and Summer W: Keratinocyte growth
factor, hydrostatic pulmonary edema, and lymph flow. Am J Respir Crit Care Med 157:A202,
1998.
107.
Zhang P, Spitzer JA, Summer WR, and Nelson S: Inhibition of serine/threonine protein
phosphatase enhances phagocytic activity of alveolar macrophages in rats challenged with or
without intratracheal endotoxin. Am J Respir Crit Care Med 157:A241, 1998.
108.
Zhang P, Prakash O, Shellito JE, Xie M, Stoltz DA, Bagby GJ, and Nelson S: Ethanol
intoxication suppresses endotoxin-induced β2-integrin expression on neutrophils in normal and
HIV-1-TAT transgenic mice. Am J Respir Crit Care Med 157:A864, 1998.
LCME Medical Education Database 2009-10
I. Institutional Setting
109.
Stoltz DA, Bagby GJ, Bohm RP Jr., Murphey-Corb M, Wilson LA, Zhang P, and Nelson S:
Ethanol enhances simian immunodeficiency virus (SIV) replication in rhesus monkey peripheral
blood mononuclear cells in vitro. Am J Respir Crit Care Med 157:A865, 1998.
110.
Zhang P, Bagby GJ, Summer WR and Nelson S: G-CSF does not prevent alcohol-induced
inhibition of the TNF-α and MIP-2 production in the lung in response to intratracheal endotoxin.
Alcohol Clin Exp Res 23:25A, 1999.
111.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Granulocyte colony-stimulating factor
enhances pulmonary host defense function in ethanol-intoxicated rats. Alcohol Clin Exp Res
23:1999.
112.
Mason C, Dobard E, Kolls J, and Nelson S: Effect of ethanol on murine interlelukin (IL)-12 p40
and p70 production. Alcohol Clin Exp Res 23:27A, 1999.
113.
Zhang Z, Cork J, Nelson S, and Kolls JK: Accumulated TNF-α is co-localized with the golgi
apparatus in ethanol-treated Mono Mac 6 cells. Alcohol Clin Exp Res 23:27A, 1999.
114.
Zhang Z, Stoltz DA, Nelson S, Bagby GJ, Good D, and Kolls JK: Ethanol inhibits TNF-α
receptor II shedding in peripheral blood monocytes from rhesus macagues infected with SIV.
Alcohol Clin Exp Res 23:27A, 1999.
115.
Ye P, Garvey PB, Huang W, Good DE, Zhang Z, Schwarzenberger P, Summer WR, Shellito JE,
Nelson S and Kolls JK: IL-17 increases lung immunity and improves lung host defense against
K. pneumoniae infection. Am J Respir Crit Care Med 159: A239, 1999.
116.
Welsh DA, Summer, WR, Dobard E, Nelson S, and Mason CM: Effect of keratinocyte growth
factor in ventilator induced lung injury. Am J Respir Crit Care Med 159: A479, 1999.
117.
Mason CM, Dobard E, Kolls J, and Nelson S: Ethanol and murine interleukin (IL)-12
production: role of p40 regulation. Am J Respir Crit Care Med 159:A660, 1999.
118.
Nelson S, Stoltz DA, Zhang P, and Bagby GJ: The host response to intravenous E. coli is
inhibited by anti-granulocyte colony-stimulating factor (G-CSF) antibody. Am J Respir Crit Care
Med 159:A750, 1999.
119.
Zhang P, Bagby GJ, Stoltz DA, Summer WR, and Nelson S: Granulocyte colony-stimulating
factor modulates the pulmonary host response to endotoxin in the absence and presence of
ethanol intoxication. Am J Respir Crit Care Med, 159:A753, 1999.
120.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Modulation of the pulmonary cytokine response
to endotoxin by granulocyte colony-stimulating factor. Am J Respir Crit Care Med 159:A927,
1999.
121.
Zhang P, Nelson S, Summer WR, and Bagby GJ: Effects of chronic alcohol intoxication on in
vitro T lymphocyte Ki67-Ag expression in SIV-infected rhesus macaques. Alcohol Clin Exp Res
24:19A, 2000.
122.
Kolls JK, Zheng M, Schwarzenberger P, Zhang Z, Ye P, Nelson S, and Shellito JE: Suppression
on IL-17 and pulmonary host defenses by acute ethanol. Alcohol Clin Exp Res 24:19A, 2000.
LCME Medical Education Database 2009-10
I. Institutional Setting
123.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Alcohol suppresses C-X-C chemokine
production by alveolar macrophages stimulated in vitro with endotoxin. Alcohol Clin Exp Res
24:19A, 2000.
124.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Granulocyte colony-stimulating factor
enhances neutrophil chemotaxis and attenuates alcohol-induced suppression of neutrophil
chemotaxis in vitro. Alcohol Clin Exp Res 24:20A, 2000.
125.
Zhang Z, Lancaster J, Oliver P, Nelson S and Kolls JK: Activation of TACE-mediated
ectodomain shedding in human monocytes by chronic ethanol. Alcohol Clin Exp Res 24:20A,
2000.
126.
Kolls JK, Lancaster J, Oliver P, Nelson S, and Zhang Z: Suppression of TACE-mediated
ectodomain shedding by acute ethanol. Alcohol Clin Exp Res 24:21A, 2000.
127.
Boe D, Zhang P, Nelson S, and Bagby G: Ethanol intoxication suppresses lung chemokine
production following infection with Streptococcus pneumoniae. Alcohol Clin Exp Res 24:21A,
2000.
128.
Root R, Nelson S, Dale D, Martin T, and Welch W: A multicenter, double blind, placebocontrolled study of filgrastim (R-METHUGCSF) in the treatment of patients with multilobar
community-acquired pneumonia. Am J Respir Crit Care Med 161:A91, 2000.
129.
Root R, Nelson S, Dale D, Martin T, and Welch W: Filgastrim (R-METHUGCSF) as adjunctive
therapy in the treatment of patients with pneumonia and severe sepsis: results of a placebocontrolled trial. Am J Respir Crit Care Med 161:A91, 2000.
130.
Boe DM, Zhang P, Nelson S, and Bagby GJ: Ethanol intoxication suppresses lung antibacterial
defenses against Streptococcus pneumoniae. Am J Respir Crit Care Med 161:A124, 2000.
131.
Kolls JK, Ye P, Nelson S, Summer WR, and Shellito JE: Establishment of a critical role for
CD4+ T-cells in a murine model of Streptococcus pneumoniae infection. Am J Respir Crit Care
Med 161:A216, 2000.
132.
Nelson S, Zhang P, Summer WR, and Bagby G: Granulocyte colony-stimulating factor is not
compartmentalized following an intrapulmonary bacterial challenge. Am J Respir Crit Care Med
161:A216, 2000.
133.
Welsh DA, Summer WR, Nelson S, Mason CM, and Lallier T: KGF effects expression of
alveolar epithelial cell integrins and extracellular matrix (ECM) components. Am J Respir Crit
Care Med 161:A444, 2000.
134.
Zhang, P, Holmes M, Bagby GJ, Summer WR, and Nelson S: Compartmentalization of
macrophage inflammatory protein-2, but not cytokine-induced neutrophil chemoattractant, in rats
challenged with intratracheal endotoxin. Am J Respir Crit Care Med 161:A465, 2000.
135.
Kolls JK, Zhang Z, Ye P, Shellito JE, and Nelson S: Alcohol suppresses TACE-ectodomain
shedding from monocytes: implications for pulmonary host defenses. Am J Respir Crit Care
Med 161:A588, 2000.
LCME Medical Education Database 2009-10
I. Institutional Setting
136.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Alcohol suppresses endotoxin-induced
macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant production
by alveolar macrophages. Am J Respir Crit Care Med 161:A590, 2000.
137.
Mason CM, Dobard E, and Nelson S: Effect of ethanol on infection with Mycobacterium
tuberculosis in mice. Am J Respir Crit Care Med 161:A647, 2000.
138.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Granulocyte colony-stimulating factor and
neutrophils modulate the pulmonary chemokine response. Am J Respir Crit Care Med 161:A846,
2000.
139.
Mason C, Dobard E, and Nelson S: Effect of ethanol on BCG-induced protection against murine
pulmonary tuberculosis. Alcohol Clin Exp Res 25:27A, 2001.
140.
Prakash O, Rodriguez VE, Tang ZY, Zhou P, Coleman R, Dhillon G, Shellito J, and Nelson S:
Ethanol potentiates HIV-1 Tat-induced bone marrow toxicity in transgenic mice. Alcohol Clin
Exp Res 25:27A, 2001.
141.
Bagby GJ, Brown JA, Kolls JK, Schexnayder JA, Rockar RA, and Nelson S: Chronic binge
alcohol consumption increases early viral load in SIV-infected rhesus macaques. Alcohol Clin
Exp Res 25:27A, 2001.
142.
Zhang P, Bagby GJ, Summer WR, and Nelson S: In vitro effects of alcohol on the binding of CX-C chemokines to polymorphonuclear leukocytes. Alcohol Clin Exp Res 25:29A, 2001.
143.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Acute ethanol intoxication suppresses the
systemic chemokine response in rats with endotoxemia. Alcohol Clin Exp Res 25:30A, 2001.
144.
Boé DM, Zhang P, Nelson S, and Bagby GJ: Alcohol-induced suppression of lung chemokine
production following infection with Streptococcus pneumoniae. Alcohol Clin Exp Res 25:30A,
2001.
145.
Prakash O, Tang ZY, Peng X, Zhou P, Kolls J, Shellito J, and Nelson S: Alcohol inhibits
thymidine kinase activity essential for activation of AZT (Zidovudine) to its anti-HIV form.
Alcohol Clin Exp Res 25:30A, 2001.
146.
Welsh DA, Zhang P, Mason CM, Bagby GJ, Summer WR, and Nelson S: Effect of alveolar
epithelial cells on LPS-induced TNF-α production by circulating PMN. Am J Respir Crit Care
Med 163:A274, 2001.
147.
Boé D, Zhang P, Nelson S, and Bagby GJ: Ethanol-induced suppression of lung chemokine
production in a neutropenic model of pneumococcal pneumonia. Am J Respir Crit Care Med
163:A383, 2001.
148.
Ye P, Hilton C, Zheng M, Schwarzenberger P, Nelson S, Summer WR, Shellito J, and Kolls JK:
Differences in IL-17 response against gram (-) and gram (+) bacterial lung infections. Am J
Respir Crit Care Med 163:A274, 2001.
149.
Welsh DA, Zhang P, Mason CM, Bagby GJ, Summer WR, and Nelson S: Circulating PMN
modulate LPS-induced CINC production by alveolar epithelial cells. Am J Respir Crit Care Med
163:A593, 2001.
LCME Medical Education Database 2009-10
I. Institutional Setting
150.
Mason CM, Dobard E, Shellito J, and Nelson S: CD4 lymphocyte responses to murine
pulmonary TB. Am J Respir Crit Care Med 163:A662, 2001.
151.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Contrasting chemokine responses in the lung
and systemic circulation following lipopolysaccharide challenge. Am J Respir Crit Care Med
163:A944, 2001.
152.
Holmes M, Zhang P, Nelson S, Summer WR, and Bagby GJ: Neutrophils alter the pulmonary
cytokine response to intratracheal LPS. Am J Respir Crit Care Med 163:A948, 2001.
153.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Polymorphonuclear leukocytes modulate the
systemic macrophage inflammatory protein-2 response in rats with endotoxemia. Am J Respir
Crit Care Med 163:A986, 2001.
154.
Zhang P, Bagby GJ, Purcell JE, Summer WR, and Nelson S: Neutrophil function in SIV-infected
rhesus macaques with or without chronic binge alcohol consumption. Alcohol Clin Exp Res
26:47A, 2002.
155.
Bagby GJ, Purcell JE, Zhang P, and Nelson S: Ethanol suppresses the LPS-induced TNFα
response of blood mononuclear cells obtained from SIV (-) and SIV (+) rhesus macaques.
Alcohol Clin Exp Res 26:48A, 2002.
156.
Zhang P, Quinton LJ, Bagby GJ, Summer WR, and Nelson S: Acute alcohol intoxication inhibits
interferon-ү-induced enhancement of MIP-2 response in the lung to intrapulmonary endotoxin
challenge. Alcohol Clin Exp Res 26:50A, 2002.
157.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Alcohol suppresses β2-integrin expression on
PMNs but not the binding of CXC chemokines to these immune effector cells. Alcohol Clin Exp
Res 26:50A, 2002.
158.
Kantrow SP, Marino RM, Jaligam VR, Jenkins MY, and Nelson S: Ethanol potentiates
lymphocyte death signaling. Alcohol Clin Exp Res 26:51A, 2002.
159.
Prakash O, Tang Z-Y, Peng X, Zhou P, Coleman R, and Nelson S: Ethanol inhibits human
Kaposi’s sarcoma (KS) cell-derived tumorigenesis in nude mice. Alcohol Clin Exp Res 26:58A,
2002.
160.
Winsauer PJ, Moerschbaecher JM, Gerak LR, Brauner IN Purcell JE, Bagby GJ, and Nelson S:
Alcohol unmasks SIV-induced cognitive impairments in rhesus monkeys. Alcohol Clin Exp Res
26:154A, 2002.
161.
Zhang P, Bagby GJ, Quinton LJ, Summer WR, and Nelson S: Interferon-ү enchances the
pulmonary cytokine-induced neutrophil chemoattractant response to intratracheal
lipopolysaccharide. Am J Respir Crit Care Med 165:A90, 2002.
162.
Quinton LJ, Nelson S, Zhang P, Boé DM, and Bagby GJ: The granulocyte colony-stimulating
factor response following intrapulmonary and systemic bacterial challenges. Am J Respir Crit
Care Med 165:A90, 2002.
163.
Mason CM, Dobard E, Shellito J, and Nelson S: Effect of alcohol on CD4+ lymphocytes in
murine pulmonary TB. Am J Respir Crit Care Med 165: A196, 2002.
LCME Medical Education Database 2009-10
I. Institutional Setting
164.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Endotoxemia suppresses pulmonary neutrophil
recruitment in the presence of high pulmonary chemokine levels following intratracheal
lipopolysaccharide. Am J Respir Crit Care Med 165:A816, 2002.
165.
Zhang P, Bagby GJ, Summer WR, and Nelson S: Alcohol suppresses neutrophil adhesion
molecule expression without affecting CXC chemokine binding to these cells. Am J Respir Crit
Care Med 165:A816, 2002.
166.
Zhang P, Bagby GJ, Purcell J, Veazey RS, and Nelson S: Chronic alcohol consumption
accelerates the loss of effector and central memory CD4 T-cells in SIV-infected rhesus macaques.
Alcohol Clin Exp Res 27:35A, 2003.
167.
Bagby GJ, Purcell J, Zhang P, Kolls J, and Nelson S: Chronic-binge alcohol consumption
increases viral set-point in simian immunodeficiency virus (SIV) infected macaques. Alcohol
Clin Exp Res 27:35A, 2003.
168.
Prakash O, Peng Z, Wang G, Bagby GJ, and Nelson S: Ethanol decreases thymidine kinase (TK)
activity and phosphorylation of zidovudine (ZDV) to its anti-retrovirally active ZDV-triphosphate
form. Alcohol Clin Exp Res 27:35A, 2003.
169.
Shahbazian LM, Zhang P, Quinton L, Bagby G, and Nelson S: Interferon-gamma attenuates
acute alcohol-induced suppression of bacterial clearance in mice challenged with Escherichia
coli. Alcohol Clin Exp Res 27:36A, 2003.
170.
Mason C, Dobard E, Zhang P, and Nelson S: Effect of ethanol on murine pulmonary
tuberculosis. Alcohol Clin Exp Res 27:36A, 2003.
171.
Quinton L, Zhang P, Nelson S, Summer W, and Bagby G: Acute ethanol intoxication inhibits
interferon-ү-induced enhancement of pulmonary chemokine production in response to
intratracheal endotoxin. Alcohol Clin Exp Res 27:36A, 2003.
172.
Shahbazian LM, Zhang P, Bagby G, and Nelson S: Acute alcohol intoxication inhibits
granulopoiesis induced by exogenous G-CSF in mice. Alcohol Clin Exp Res 27:37A, 2003.
173.
Happel KI, Quinton LJ, Zhang P, Bagby GJ, and Nelson S: Acute ethanol intoxication inhibits
the ELR+ and ELR-CXC chemokine response to intratracheal endotoxin. Alcohol Clin Exp Res
27:89A, 2003.
174.
Shahbazian LM, Zhang P, Quinton LJ, Bagby GJ and Nelson S: Interferon-gamma enhances
bacterial clearance in mice challenged with intravenous Escherichia coli in the absence and
presence of acute ethanol intoxication. Am J Respir Crit Care Med 167:A199, 2003.
175.
Shahbazian LM, Zhang P, Bagby GJ, and Nelson S: Inhibition of the G-CSF-induced
granulopoietic response in mice with acute alcohol intoxication. Am J Respir Crit Care Med
167:A264, 2003.
176.
Zhang P, Saluja JS, Shahbazian LM, Bagby GJ, Summer WR, and Nelson S: Endotoxemia
suppresses neutrophil chemotactic activity. Am J Respir Crit Care Med 167:A308, 2003.
177.
Quinton LJ, Nelson S, Zhang P, and Bagby GJ: Translocation of cytokine-induced neutrophil
chemoattractant, but not macrophage inflammatory protein-2 from the pulmonary compartment
into the blood. Am J Respir Crit Care Med 167:A642, 2003.
LCME Medical Education Database 2009-10
I. Institutional Setting
178.
Zhang P, Quinton LJ, Bagby GJ, Summer WR, and Nelson S: Inhibition of interferon‫ץ‬-induced enchancement of the pulmonary CINC response to intratracheal endotoxin by acute
alcohol intoxication. Am J Respir Crit Care Med 167:A643, 2003.
179.
Happel KI, Zheng M, Bagby GJ, Nelson S, Shellito JE, and Kolls, JK: Toll-like receptor 4 is
required for pulmonary expression of interleukin 17 in response to Klebsiella pneumoniae
infection. Am J Respir Crit Care Med 167:A701, 2003.
180.
Happel KI, Zheng M, Bagby GJ, Nelson S, Shellito JE, and Kolls JK: T cell production of
interleukin 17 in response to Klebsiella pneumoniae does not require cell contact. Am J Respir
Crit Care Med 167:A759, 2003.
181.
Nelson S, Zhang P, Purcell J, Rasmussen T, MacLean A, and Bagby G: The effect of
pneumococcal pneumonia on SIV replication in the pulmonary and systemic compartments. Am
J Respir Crit Care Med 169:A232, 2004.
182.
Gamble L, Zhang P, Quinton LJ, Bagby GJ, and Nelson S: Alterations in systemic and bone
marrow granulopoietic cytokine levels during endotoxemia. Am J Respir Crit Care Med 169:
A304, 2004.
183.
Zhang P, Shahbazian LM, Quinton LJ, Bagby GJ, Summer WR, and Nelson S: Enhancement of
granulopoiesis and mobilization of myeloid progenitor cells to the systemic circulation following
an intrapulmonary challenge with Escherichia coli. Am J Respir Crit Care Med 169: A559, 2004.
184.
Happel KI, Quinton LJ, Zhang P, Shellito JE, Bagby GJ, and Nelson S: Klebsiella pneumoniae
induced expression of IL-23 and IL-27 from alveolar macrophages is inhibited by acute ethanol.
Am J Respir Crit Care Med 169: A559, 2004.
185.
Gamble L, Quinton LJ, Wang G, Zhang P, Bagby GJ, and Nelson S: Primary human respiratory
epithelial cell production of cytokines in response to Klebsiella pneumoniae and the effect of
exposure to alcohol. Am J Respir Crit Care Med 169: A 564, 2004.
186.
Mason CM, Dobard E, Badewa AP, Zhang P, and Nelson S: Effect of alcohol on locoregional
lymphocytes in murine pulmonary TB. Am J Respir Crit Care Med 169: A754, 2004.
187.
Quinton LJ, Nelson S, Zhang P, Happel KI, and Bagby GJ: Systemic administration of cytokineinduced neutrophil chemoattractant attenuates alcohol-induced suppression of pulmonary host
defense. Am J Respir Crit Care Med 169: A805, 2004.
188.
Zhang P, Zhong Q, Bagby GJ, Schwarzenberger PO, Wang G, and Nelson S: Alcohol inhibits
granulocyte colony-stimulating factor induced proliferation of murine myeloid progenitor cells.
Alcohol Clin Exp Res 28 (Supplement to 5): 37A, 2004.
189.
Happel KI, Gamble L, Quinton LJ, Zhang P, Bagby GJ, and Nelson S: Klebsiella pneumoniae
induced expression of IL-23 and IL-27 by alveolar macrophages is inhibited by acute ethanol.
Alcohol Clin Exp Res 28 (Supplement to 5): 36A, 2004.
190.
Quinton LJ, Nelson S, Zhang P, Gamble L, and Bagby GJ: Intratracheal CXC chemokine
administration enhances the pulmonary neutrophil response to Klebsiella pneumoniae in rats with
acute alcohol intoxication. Alcohol Clin Exp Res 28 (Supplement to 5): 36A, 2004.
LCME Medical Education Database 2009-10
I. Institutional Setting
191.
Bagby GJ, Purcell J, Zhang P, Kolls J, and Nelson S: The longitudinal consequences of chronicbinge alcohol consumption on simian immunodeficiency virus (SIV) infected macaques. Alcohol
Clin Exp Res 28 (Supplement to 5): 38A, 2004.
192.
Gamble L, Quinton LJ, Happel KI, Zhang P, Bagby GJ, and Nelson S: The lipopolysaccharide
binding protein response to intratracheal lipopolysaccharide. Am J Respir Crit Care Med
(Abstract Issue) A70, 2005.
193.
Happel KI, Dubin PJ, Zheng M, Ghirlardi N, Nelson S, and Kolls JK: IL-23 is critical to survival
during pulmonary infection with Klebsiella pneumoniae. Am J Respir Crit Care Med (Abstract
Issue) A306, 2005.
194.
Zhang P, Zhong Q, Bagby GJ, Summer, WR and Nelson S: Inhibition of endotoxin-induced
S100A8 production in the lung by acute alcohol intoxication. Am J Respir Crit Care Med
(Abstract Issue) A367, 2005.
195.
Happel KI, Mason CM, Lockhart E, Nelson S, and Ramsay AJ: Transient IL-23 over-expression
improves early clearance of Mycobacterium tuberculosis. Am J Respir Crit Care Med (Abstract
Issue) A449, 2005.
196.
Zhang P, Quinton LJ, Gamble L, Bagby GJ, and Nelson S: The granulopoietic cytokine response
and enhancement of granulopoiesis in mice during endotoxemia. Am J Respir Crit Care Med
(Abstract Issue) A631, 2005.
197.
Mason CM, Happel KI, Porretta E, Butler R, Welsh DA, Zhang P, Shellito JE, and Nelson S:
Regulatory T cells in murine tuberculosis (TB). Proceedings of the American Thoracic Society
3:A218, 2006.
198.
Zhang P, Bagby GJ, Engel LS, and Nelson S: Alcohol up-regulates p27kip1 expression and
impairs the granulopoietic response to lung infection in mice. Alcohol Clin Exp Res 31
(Supplement to 6):219A, 2007.
199.
Zhang P, Bagby GJ, Engel LS, and Nelson S: Alcohol impairs granulocyte mobilization from
hematopoietic tissues in response to pneumococcal pneumonia. Alcohol Clin Exp Res 31
(supplement to 6):217A, 2007.
200.
Kantrow SP, Shen Z, Jagneaux T, Zhang P, and Nelson S: Neutrophils and NADPH oxidase in
lipopolysaccharide induced lung permeability. Am J Respir Crit Care Med (Abstract Issue)
A175, 2007.
201.
Happel KI, Zhang P, Bagby GJ, Dufour JP, and Nelson S: Chronic binge alcohol consumption
by rhesus macaques may alter the T-helper cell cytokine profile toward IL-17. Alcohol Clin Exp
Res 31(supplement):216A, 2007.
202.
Mason CM, Porretta E, Zhang P, Ramsay A, and Nelson S: Alcohol and foxp3+ lung T cells in
mice. Alcohol Clin Exp Res 31(supplement):219A, 2007.
203.
Nelson S and Bagby GJ: The biomedical consequences of alcohol in the simian
immunodeficiency virus (SIV) infected rhesus macaque model of HIV. Alcohol Clin Exp Res
31(supplement):262A, 2007.
LCME Medical Education Database 2009-10
I. Institutional Setting
204.
Happel KI, Zhang P, Bagby GJ, and Nelson S: Alcohol and bacterial pneumonia: impairment of
innate and adaptive immunity. Alcohol Clin Exp Res 31 (supplement):310A, 2007.
205.
Bagby GJ, Dufour J, Zhang P, and Nelson S: Bacterial pneumonia increases viral load in the
lungs of simian immunodeficiency virus infected rhesus macaques: effect of chronic alcohol
consumption. Alcohol Clin Exp Res 32 (supplement):172A, 2008.
206.
Kantrow SP, Shen Z, Zhang P, Ramsey J, and Nelson S: Acute alcohol intoxication, lung
permeability and host defense. Alcohol Clin Exp Res 32 (supplement):172A, 2008.
207.
Raasch CE, Bagby GJ, Nelson S, and Zhang P: Alcohol intoxication suppresses the Lin¯ C-Kit+
Sca-1+ cell response to pneumococcal pneumonia in mice. Alcohol Clin Exp Res 32
(supplement):173A, 2008.
208.
Thomas JS, Lacour N, Nelson S, Bagby GJ, and Amedee AM: Using the SIV-infected rheuses
macaque to examine the effects of chronic alcohol consumption on the HIV-inhibitory properties
of saliva. Alcohol Clin Exp Res 32 (supplement):173A, 2008.
209.
Zhang P, Bagby GJ, and Nelson S: Alcohol impairs G-CSF signaling in myeloid progenitor cell
proliferation. Alcohol Clin Exp Res 32 (supplement):174A, 2008.
210.
Siggins RW II, Nelson S, Welsh DA, Bagby GJ, Shellito JE, and Zhang P: Alcohol impairs the
hematopoietic stem cell response to bacteremia. Alcohol Clin Exp Res 32 (supplement):174A,
2008.
211.
Happel KI, Jeyaseelan S, Odden AR, Zhang P, Bagby GJ, and Nelson S: Acute ethanol
intoxication impairs the pulmonary LIX response to endotracheal endotoxin. Alcohol Clin Exp
Res 32 (supplement):224A, 2008.
Revised 01/27/09 KD
LCME Medical Education Database 2009-10
I. Institutional Setting
APPENDIX FOR IS-14a
LCME REPORT ON
INSTITUTIONAL SETTING
Subcommittee 14a
School of Medicine
LCME Medical Education Database 2009-10
I. Institutional Setting
Insert Appendix Material Here
(Landscape Orientaion)
LCME Medical Education Database 2009-10
I. Institutional Setting
APPENDIX FOR IS-15
LCME REPORT ON
INSTITUTIONAL SETTING
Subcommittee 15
School of Medicine
Submitted by:
James Cairo, PhD, Dean of Allied Health
LCME Medical Education Database 2009-10
I. Institutional Setting
Proposed Funding, Translational Research Initiative Grant Proposals, FY 2009
New Proposals
Funded Amount
1 – Bonny L. Dickinson, PhD and Eugene A. Woltering, MD, FACS
“Human carcinoid tumor dysregulation of dendritic cell function”
$60,000.00
2 – Tara L. Lin, MD and Yong Sung Choi, MD, PhD
“Optimizing cancer stem cell targeted therapy in ALL”
$60,000.00
3 – Sean Collins, MD and L. Joseph Su, MD
“Prevalence of metabolic syndrome in the subjects of The North
Carolina/Louisiana prostate cancer project and the association
with prostate cancer aggressiveness”
$60,000.00
4 – L. Joseph Su, MD and Jodi Kamps, PhD
“Folic acid supplementation during pregnancy and autism spectrum
disorders”
$49,000.00
5 – Yuwei Fan, PhD and Xiaoming Xu, PhD
“Novel biomimetic remineralization dental materials for early dental
caries treatment”
$38,000.00
6 – Patricia E. Molina, MD, PhD and Lisa Moreno-Walton, PhD
“Translational studies on the consequences of alcohol intoxication
on outcome from traumatic injury”
$65,000.00
7 – Erich Richter, MD, Theodore Weyand, PhD and Anne Foundas, MD
“Neuromodulation of depressive affect in Rhesus monkeys”
$60,000.00
8 – Jovanny Zabaleta, BS, MSc, PhD and Pelayo Correa, MD
“Profiles of mRNA and micro RNA in gastric pre-malignant
lesions”
$60,000.00
9 – Bennet P. deBoisblanc, MD, David Welsh, MD, Nicole LeCapitaine, PhD
“Microparticle networks in ARDS”
$65,000.00
10 – Lolie C. Yu, MD, Yan Cui, PhD, Faisal Razzaqi, MD
“Co-transfer of dendritic cell precursors and cytokine stimulation
to accelerate immune recovery following hematopoietic
stem cell transplant”
$60,000.00
11 – Donna M. Neumann, Herbert E. Kaufman, MD
“Epigenetic modifications regulation HSV-1 reactivation, efficiency,
and frequency in an ocular model of herpes simplex keratitis”
$60,000.00
12 – Jasmine Ellison, MD and William Gordon, PhD
“Modulation of inflammatory signaling in an experimental
animal model of uveitis: Potential therapeutic targets”
$65,000.00
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Supplements
Funded Amount
1 – Walter J. Lukiw, MS, PhD, Frank Culicchia, MD and Jeff Erickson, PhD.
Supplement – “Genetic regulatory mechanisms in growth and
invasiveness of glioblastoma multiforme (GBM)”
$60,000.00
2 – Kyle Happel, MD and Alistair J. Ramsay, PhD
“Immunomodulation and pneumonia in HIV infection”
(unspent FY 2008 funds: $46,775.00)
$15,000.00
3 – Paulo C. Rodriguez, PhD, John Cole, MD and Augusto C. Ochoa, MD
Supplement – “Arginase I, a molecular target for new treatment
of T cell leukemia”
$60,000.00
4 – Arnold Zea, PhD, Juzar Ali, MD, FRCP, FCCP and Carol Mason, MD
Supplement - “The role of arginase and iNOS in Mtb
growth-induced immunosuppression”
$35,000.00
5 – Jian-Guo Cui, PhD and Gabriel C. Tender, MD
Supplement – “The Role of VR1-positive neurons in central
sensitization: Neuropathic pain management”
$60,000.00
6 – Soledad M. Cortina, MD and Haydee E.P. Bazan, PhD - Renewal
Supplement - “The role of pigment epithelial-derived growth factor
(PEDF) and docosahexaenoic acid (DHA) in tear production and
corneal nerve regeneration following refractive surgery”
(start date: upon Dr. Cortina’s appointment as a faculty member)
$60,000.00
7 – Allal Ouhtit, PhD
“Dysfunction of mesenchymal stem cell CD44 signaling in
emphysema”
$50,000.00
8 - Angela M. Amedee, PhD, Rebecca Clark, MD, PhD, David Martin, MD
“Longitudinal analysis of HIV expression in women”
$60,000.00
TOTAL
LCME Medical Education Database 2009-10
$1,102,000.00
I. Institutional Setting
Academic Year _2007-2008_
Basic Science Departments Collaborations (detailed examples)
Teaching
Department of Genetics
Course name/number
Genetics
(Med)
Audience (school and
level)
1st year Medical
Students
Genetics through lifespan
(Nursing)
Nursing School
Genetics in Physical
Therapy
Molecular Biology
(INTER122/CMB-B)
PT Students
Control of Gene Expression
(INTER123/CMB-C)
1st year Graduate
students
Genetic Epidemiology &
Population Genetics
(GENET 236)
Genetics
(SPTHAUD 7225)
Practical Bioinformatics
GENET 256
Genetics/SPTHAUD7225
Graduate students
Research Methods/HMGN
795
1st year Graduate
students
Examples of collaborative arrangements
Robin McGoey, MD Medical School
Mike Marbell, MD Dept. of Peds
Paula Gregory, PhD Genetics
Gloria Giarrtano, PhD (Nursing School)
Robin McGoey, Med School
Paula Gregory, PhD Genetics
Jane Eason, PhD (Allied Health)
Paula Gregory, PhD Genetics
Andrew D. Hollenbach, Ph.D. – Course Director
(Department of Genetics)
Fern Tsien, PhD (Department of Genetics)
Tadahide Izumi, Ph.D. (Department of
Biochemistry)
Ed Grabczyk, Ph.D. (Department of Genetics)
Tomoo Iwakuma, M.D., Ph.D. (Department of
Genetics)
Andrew D. Hollenbach, Ph.D. – Course Director
(Department of Genetics)
Fern Tsien, Ph.D. (Department of Genetics)
Tomoo Iwakuma, M.D., Ph.D. (Department of
Genetics)
Diptasri Mandal, Ph.D. (Department of Genetics)
Ed Grabczyk, Ph.D. (Department of Genetics)
Paula Gregory, Ph.D. (Department of Genetics)
Diptasri Mandal, PhD (course director)
Audiology graduate
students
Graduate students
Fern Tsien, PhD (Genetics)
LSUHSC School of Allied
Health Professions
Doctor of Audiology
Fern Tsien, PhD, course director, Genetics LSUHSC
Diptasri Mandal, PhD, Genetics, LSUHSC
Chris Dvorak, MS, Genetics, Tulane HSC
Tulane Medical School
Karen Weissbecker, PhD, Course director,
Genetics, Tulane HSC
Genetics (Grabczyk, leader)
Medical students
Graduate students
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Department of Anatomy
Human Prenatal
Development
Medical Students-first
year
Medical Gross Anatomy
Medical Students-first
year
Medical Neuroscience
Medical Students-first
year
Senior Surgical Anatomy
Elective
Medical Students-4th
year
Pediatrics:
Dr. Barkemeyer; ObGyn:
Drs. Holman, Curole; Pathology: Dr. McGoey
Surgery: Drs.
Genetics: Dr. Gregory
Hollier,Paige; ENT: Drs.
McWhorther, Nuss, Pou,
Lin, Zuzukin, Valvekar;
Radiology:
Dr. Landry; Orthopedics:
Drs.Omotola,Sisco;
Emergency Medicine:
Several Residents in ER;
Ob/Gyn: Dr. Bedastani
Neurology: Drs.Deputy,England, Foundas,
Gould,Gutierrez, Tilton; Neurosurgery: Drs. Owen,
Culicchia,Dawson,Richter, Tender; Neuroscience
Center: Dr. Bazan
Surgery: Drs. Hollier,Baker, Sheahan, Wang, Paige,
Steeb, Marr, Hunt; Radiology: Dr. Chalpin;
Pathology: Drs.McGoey,Troxclair,Lipscomb,
Springer; ENT: Dr.Pou; Ob/Gyn: Drs.Brewer,
Ibeanu; Orthopedics: Dr. Murphy
Department of Pharmacology
Medical Physiology
Medical Pharmacology/
1st year medical
students
Nurse anesthetists
Graduate students
2nd year medical
students
Graduate Students
LCME Medical Education Database 2009-10
Jimmy Cairo, PhD
Ben DeBoisblanc, MD
School of Allied Health
Department of Medicine
Bob Richards – Medicine
Ben deBoisblanc – Medicine
Charles Sanders – Medicine
Deborah Fox –MIP
Jeff Hobden - MIP
James Hill – Ophthalmology
Steve Kantrow – Medicine
Paula Gregory – Genetics
Harry Gould – Neurology
Alan Kaye – Anesthesiology
Charles Cefalu – Geriatric Medicine
Kim Leblanc – Family Medicine
Victor Tuckler - Medicine
I. Institutional Setting
Academic Year _2007-2008_
Department of Biochemistry
Integrated Graduate
Curriculum (Cell Biology
& Development)
1st year graduate
students
Medical Pharmacology
1st year medical students
Medical Biochemistry
1st year medical students
The Biochemistry faculty collaborates with faculty
from other basic science departments in team
teaching this first year course for the Graduate
School of Biomedical Sciences for which Dr. Andrew
Catling is course director.
Drs. Alahari and Desai contribute lectures to this
team taught Pharmacology Department medical
course.
The course is team taught by 8 members of the
Biochemistry faculty, each of which focuses on their
particular area of expertise.
Department of Physiology
Medical Physiology 100
Nursing 8301
Medical school L1 level
Nursing grad level
Dental Physiology 1115
Dental School
1st year
Dental Hygiene 3202
Dental School
1st year
N-HLS2410
AH-OCCT 6523
Nursing School
1st year
Allied Health School
1st year
Nursing School
2nd year
N-Nursing HLSC 3410
N-Care HS 3410
Nursing School 2nd year
LCME Medical Education Database 2009-10
Physiology faculty: Levitzky, Molina, McDonough,
Harrison-Bernard, Potter, Porter, Giaimo
Jimmy Cairo – Dean Allied Health
Ben DeBoisblanc – Medicine
Warren Summer – Medicine
Juzar Ali – Medicine
Duna Penn – Pediatric Medicine
William Cefalu - Medicine
John Zamjahn – Allied health - CPS
Physiology faculty: Porter, Giaimo, Breslin, Gardner
Happel - Neurology
Emeritus professors of Physiology : Liles,
Nakamoto
Physiology faculty: Harrison-Bernard Breslin,
Gardner,
Emeritus professor of Physiology : Liles
Physiology faculty: Shepherd, Potter, Gardner
Andrew Pellett – Allied health – CPS
John Zamjahn – Allied health – CPS
Vicki Jordan - Nursing
Physiology faculty: Shepherd, Potter, Gardner,
Levitzky, Molina, McDonough, Porter
John B. Zamjahn, PhD - Allied Health - CPS
Debbie Garbee, PhD- Nursing
Vickie Jordan, PhD, CRNA – Nursing
Phyllis Peterson, PhD– Nursing
Demetrius Porche, Dean Nursing School
Miroslav Sarac, PhD
- Xavier University
Albert J. Swafford, PhD - Our Lady of Lake
Physiology faculty: Shepherd, Potter, Gardner,
Levitzky, Molina, McDonough, Porter
John B. Zamjahn, PhD - Allied Health - CPS
I. Institutional Setting
Academic Year _2007-2008_
Medical School 1st year
Debbie Garbee, PhD- Nursing
Vickie Jordan, PhD, CRNA – Nursing
Phyllis Peterson, PhD– Nursing
Demetrius Porche, Dean Nursing School
Miroslav Sarac, PhD
- Xavier University
Albert J. Swafford, PhD - Our Lady of Lake
Physiology faculty: Shepherd, Potter, Gardner,
Levitzky, Molina, McDonough, Porter, HarrisonBernard, Bagby
Dan Kapusta – Pharmacology
Paula Gregory – Genetics
Richard Tracy – Pathology
Hamilton Farris – Neuroscience
Physiology Faculty : Molina
Graduate School
Physiology Faculty : Potter
Graduate School
Physiology faculty: Molina, Bagby
Ping Zhang – Medicine
Levitzky, McDonough
G-INT132
Graduate school
1st year
G-INT 132 (AH DPT)
M-Medical Spanish
PHSY220a
G-INTER217 History and
Philosophy of Medical
Research
G Special Topics PHYS 281
PAR
Science and Practice of
Medicine 100 (DXR)
Medical School
1st year
2nd year
Department of Microbiology
Medical Microbiology
2nd year medical
students
Microbiology Dental
Hygiene [3201course]
1st year dental hygiene
students
Advanced Bacteriology
Graduate Students
Microbiology (Hobden, Director)
Microbiology (Johnston)
Molecular Biology of
Eukaryotic Pathgins
(MIP231)
Medical Pharmacology
Graduate Students
Microbiology (Sturtevant, Director)
Dental School (Palmer)
Pediatrics (Cutler, Fox, Wang)
Microbiology (Koochekpour, Hobden)
Medical students
LCME Medical Education Database 2009-10
James Thompson, PhD, Director - Microbiology
Bonny Dickinson PhD
Children’s Hospital
Julio Figueroa, MD
Department of Medicine
Dipon Dixit, PhD
Pennington Center
Tom Gillis, PhD
Hansen’s Center
Mike Hagensee,MD,PhD Department of Medicine
David Martin, MD
Department of Medicine
Lee Engel, PhD,MD
Department of Medicine
Toby Rodriguez,PhD
School of Dentistry
JoAnne Maffei,MD
Department of Medicine
William Cassidy,MD
Department of Medicine
Charles Sanders,MD
Department of Medicine
Microbiology (Johnston, Director)
Dental School (Palmer)
I. Institutional Setting
Academic Year _2007-2008_
Research
Department of Genetics
Activity/project
RCEEP Grant BOR
LGTRC
The Role of
phosphorylation in the
development of the
solid muscle tumor
alveolar
Rhabdomyosarcoma,
Junior investigator on
the Cancer Genetics
COBRE award
Determination of
Genetic Susceptibility to
Lung Cancer
Genetic
Characterization of
Prostate Cancer
Analysis of
Endometriosis
Candidate Genes
Mechanisms
contributing to frataxin
deficiency, RO1, NINDSfunded
The roles of MTBP in
osteosarcoma
metastasis
Characterization of
multipotent
mesenchymal stem cells
from the bone marrow
of rhesus macaques
Departments or schools involved
Tulane HSC (Hamou)( Weiner)( Delafontaine)
LSU HSC- Medical (Nelson)
Genetics (Gregory)
Pediatrics (Pincus)
Tulane HSC
LSUHSC-Genetics (Gregory)
Gene Therapy (Ramsay)
Tulane Medical School – Epidemiology (Deininger,PI)
Epidemiology (Engel)
Microbiology (Scandurro)
LSUHSC – Genetics ( Keats, Co-PI)
Genetics ( Hollenbach)
Genetics (Iwakuma)
Washington University, St. Louis, Missouri;
Mayo Clinic, Rochester, Minnesota
University of Cincinnati, Cincinnati, Ohio
University of Colorado, Denver, Colorado
Karmanos Cancer Institute, Detroit, Michigan
University of Toledo College of Medicine,Toledo, Ohio
Saccomanno Research Institute, Grand Junction, Colorado
National Human Genome Research Institute
M. D. Anderson Cancer Center, Houston
National Cancer Institute, Bethesda, Maryland, USA
National Human Genome Research Institute
Department of Genetics/Tulane University School of Medicine
Department of Medicine and Urology/Tulane Medical School
MD Anderson Cancer Center, Houston
Department o Microbiology/Ponce School of Medicine, Puerto Rico
Genetics, LSUHSC (Grabczyk, PI)
Genetics, LSUHSC (Iwakuma, PI)
Genetics, LSUHSC (Tsien,)
Tulane Primate Center (Bunnell, PI)
Genetics, LSUHSC (Tsien)
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Center for Acadiana
Genetics and Hereditary
Health Care (CAGHHC)
Crosstalk between IL7Rα signaling and p53
pathway in maintaining
chromosomal stability
during thymopoiesis and
preventing
lymphomagenesis
The roles of MTBP in
osteosarcoma
metastasis
The role of mutant p53
in the properties of
osteosarcoma stem cells
DNA Damage-Response
Defects and Prostate
Cancer Susceptibility
The Role of AXIN2 in
Colorectal Cancer
Development
CD8 T-CELLS AND Host
Defense against P.
carinii Pneumonia
IL-23/IL-17 and Lung
Host Defense
Host Defense against
HIV-related pulmonary
infections
Alcohol, ROS, and
Macrophage Epigenetics
LSUHSC (Keats and Kolls, PIs)
LSUHSC (Tsien)
Tulane HSC (Andersson)
Nicholls State University,Thibodeaux LA ( Doucet)
Gene Therapy (Yan Cui, PI)
Genetics (Tsien)
Genetics ( Iwakuma; Liu)
Orthopedics (S Heinrich)
Bioinformatics ( Velasco-Gonzalez),
Pathology ( Ruiz)
Genetics (Iwakuma; Liu)
Orthopedics (Heinrich)
Bioinformatics (Velasco-Gonzalez),
Pathology (Ruiz)
Microbiology & Cancer Center (Koochekpour)
Genetics ( Liu)
Genetics & Cell Biology (Wessely)
Genetics (Liu)
Animal care (Birke)
Genetics (Kolls, PI)
Medicine (Shellito)
Genetics (Kolls, PI)
Medicine (Happel)
Genetics (Kolls Project 2)
Medicine (Shellito Project 1)
Gene Therapy (Ramsay Project 3)
Genetics (Kolls, PI)
Physiology (Bagby)
Physiology (Zhang)
Medicine (Happel)
Department of Pharmacology
Seminar series
Physiology/Pharmacology
Journal Club
Physiology/Pharmacology
Cardiovascular Center
Seminar program
(COBRE)
Medical Student
Summer Research
Pharmacology, Physiology, Pathology, Biochemistry, Surgery
Basic Science and Clinical Science Depts. and the 1st year Medical Students
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Medical Student Honors
program
THC impact on SIV
progression RO1, NIDAfunded
“Mentoring in
Cardiovascular Biology”,
COBRE Grant, NI
Basic Science and Clinical Science Depts. and Medical Students
Physiology (Molina, PI)
Pharmacology (Winsauer, Varner)
Microbiology (Amedee)
Animal Care (Birke)
Pathology (Zieske, Troxclair)
Pharmacology : (Kapusta, PI, Varner, Cormier, Lazartigue, Songu-Mize, Guidry,
Wu, Wainford, Worthylake, Boulares, Filipeanu)
Physiology: (Molina, Breslin, Harrison-Bernard, Gardner)
Biochemistry: (Claycomb)
Pathology: (Strong, Troxlair)
Surgery: (Bazan)
Department of Biochemistry
Bioinformatics and
Xiaogeng Feng MS, our Bioinformatics Specialist, collaborates with a number of
statistics
investigators from Biochemistry and other departments in the School of
Medicine on bioinformatic projects involving protein and gene sequence
analysis in addition to software development.
Structural biology
Drs. Chiu and Worthylake individually collaborate with a number of
investigators from the School of Medicine on projects to determine the
structure of specific proteins including: Ben Kelly (MIP), Sunyoung Kim
(Biochemistry), Ed Wojcik (Biochemistry), Sunyoung Kim (Biochemistry), Suresh
Alahari (Biochemistry), and Andrew Catling (Pharmacology). These
collaborations have resulted to date in two submitted grant applications (Kelly
and Catling).
Cancer and neurological Dr. Desai is collaborating with Augusto Ochoa (Cancer Center) and J. Rao
disorders
(Ochsner Foundation Clinic) on the role of ISG15 in cancer progression and
Parkinson’s disease, respectively.
Cancer research
Dr. Alahari collaborates with several investigators on the etiology of breast
cancer: Robin McGoey (Pathology), Donald Mercante (Biostatistics), Andrew
Catling (Pharmacology), Becky Worthylake (Pharmacology), Tomoo Iwakooma
(Genetics)
Department of Physiology
Seminar series
Physiology/Pharmacology
Journal Club
Physiology/Pharmacology
Cardiovascular Center
Physiology, Pharmacology, Pathology, Biochemistry, Surgery
Seminar program
(COBRE)
Medical Student
Basic Science and Clinical Science Depts. and the 1st year Medical Students
Summer Research
Medical Student Honors Basic Science and Clinical Science Depts. and Medical Students
program
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
THC impact on SIV
progression RO1, NIDAfunded
“Mentoring in
Cardiovascular Biology”,
COBRE Grant, NI
Regulation of Coronary
Collateral Growth in
Metabolic Syndrome
Physiology (Molina, PI)
Pharmacology (Winsauer, Varner)
Microbiology (Amedee)
Animal Care (Birke)
Pathology (Zieske, Troxclair)
Physiology: (Molina, Breslin, Harrison-Bernard, Gardner)
Pharmacology : (Kapusta, PI, Varner, Cormier, Lazartigue, Songu-Mize, Guidry,
Wu, Wainford, Worthylake, Boulares, Filipeanu)
Biochemistry: (Claycomb)
Pathology: (Strong, Troxlair)
Surgery: (Bazan)
University South Alabama
LSU HSC- Physiology (Potter)
Department of Microbiology
Longitudinal Analysis of
HIV Expression in
Women – Translational
Research Initiative
Mucosal Cell Mediated
Immunity in Vaginal
Candidiasis, R01, NIAID
Microbiology (Amedee, PI)
Medicine/Infectious Disease (Martin, Mentor)
Tulane/Dept of Medicine (Clark, Clinician)
Mechanisms of Herpes
Virus Proteins in
Hijacking and Subverting
Host and Cellular
Response Pathways –
BOR LEQSF
Endocervical Chlamydia
Trachomatis Infection; is
there evidence of
persistence? –
Translational Research
Initiative
Gulf South STI/Topical
Microbicide Cooperative
Research Center – U19,
NIAID, Project 1
Signaling Complexes and
the 14-3-3 Protein in
Candida, R01, NIAID
Microbiology (Foster, PI)
Gene Therapy (Ramsay)
Pharmacology (Cormier)
South Louisiana
Institute for Infectious
Disease Research – BOR,
RCEEP
Microbiology and School of Dentistry (Fidel, PI)
Microbiology (Quayle, PI)
Pathology (Ruiz, Strong)
Medicine/Infectious Disease (Martin)
OB/GYN (Dildy, Nolan)
UTHSC, Molecular Sciences (Belland)
Microbiology (Quayle, PI – Project 1)
Medicine/Infectious Disease (Martin)
University of Missouri (Schust)
Microbiology (Sturtevant, PI)
School of Dentistry (Palmer, Fidel)
Pediatrics (Cutler)
UTHSC (Lorenz)
Microbiology and School of Dentistry (Fidel, PI)
Medicine/Infectious Disease (Martin, Co-PI, Hagensee)
TUHSC, Microbiology (Clements, Co-PI)
Microbiology (Hobden, Luftig, Quayle, Shen, Amedee, Zhong)
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Dental School COBRE,
NCRR
Research Institute at
Children’s Hospital
COBRE, NCRR
Discovering New AntiLeishmania Therapies by
Targeting Leishmania
Signaling Pathways
Required for Virulence,
DOD
Development and
Evaluation of Student
Competency Measures
Alcohol Research Center
THC impact on SIV
progression RO1, NIDAfunded
Antibody Affinity
Maturation
Bacterial Keratitis
Bacterial Biofils on
Artificial hip and knee
joints
Anatomy and School of Dentistry (Lallier)
Office of Technology Development (Ceulemans)
Gene Therapy (Ramsay)
Pediatrics (Cutler, Pincus, Pishardy, Ferris, Penn)
Medicine/Pulmonary (Shellito)
Opthalmology (Hill)
School of Dentistry (Wen)
School of Dentistry (Fidel, PI)
Microbiology (Sturtevant, Luftig - both as mentors)
Pediatrics (Cutler, PI)
Microbiology (Sturtevant, Co-PI and Mentor)
Microbiology (Kelly, PI)
Biochemistry (Chiu
Microbiology (Thompson – PI)
Office of Medical Education and Research
Medicine/Pulmonary (Nelson – PI)
Microbiology (Amedee)
Physiology (Molina, PI)
Microbiology (Amedee)
Pediatrics (Pincus – PI)
Microbiology (Aiyar)
Microbiology (Hobden)
LSU Ag Center (Liu)
Microbiology (Hobden)
Orthopedics (Vinod)
Service
Department of Genetics
Strategic Planning,
Communications
workgroup
Physiology (Molina, leader)
Pathology (Venuti)
Genetics (Hollenbach)
OB/Gyn (Brewer)
Anatomy (McClugage)
Psychiatry (Osofsky)
Neuroscience Center (Bazan)
LSU Alumni (Klein)
LSU Foundation
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Strategic Planning
Faculty Development
Workgroup
Med School
Curriculum
Committee
LSUHSC Committee on
Women’s Affairs
LSUHSC Faculty
Assembly
Graduate Advisory
Council
Neurosurgery (Richter)
Pharmocology
Path (McGoey)
Phys. (Levitsky)
Biochemistry
Int. Med (Launders)
Genetics (Gregory)
Anatomy ( Schwartz)
Physiology (Levitsky; McDonough)
Family Medicine (Le Blanc)
Neurosurgery (Richter)
OB/GYN
Genetics (Gregory)
Genetics (Gregory, Tsien)
Medicine (McLean, Sanders, Clark, Subramaniam, Besch, Kumari, Hebert,
Murphey-LaVoie, Cui)
Anatomy (Delcarpio)
Pediatrics (Velez, Yu, Olister, Albrecht, Rivera, Lo-Blais, Sadowska-Krowicki,
Mangat)
Pharmacology (Songu-Mize, Worthylake)
Neurology (Gutierrez)
Ophthalmology (Jacob, Canavier)
OB/Gyn (Chau, Truehill, Holman)
Pathology (Espinosa)
MIP (Amadee, Luftig)
BioChemistry (Huh)
Med/Peds (McDermott)
Psychiatry (Many)
Cell/Bio (Venuti)
Dean’s Office (Letourneau)
Various clinical and basic research faculty representatives for each department
within LSUHSC
Genetics (Hollenbach, Andrew)
School of Medicine
LSUHSC Graduate School
Biochemistry (Alahari, Haas, Kim)
MIP (Amedee, Hobden)
Physiology (Bagby, Levitzky, McDonough)
Pharmacology (Catling, Nichols, Songu-Mize)
Neuroscience (Erikson)
Biostatistics (Fang, Mercante)
Anatomy (Lallier, Mize, Venuti, Weyand)
Pathology (Sakamuro, Scheer)
Neuroscience (Erikson)
VC for Academic Affairs (Moers)
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Curriculum Committee
Council on Professional
Conduct
Institutional Biosafety
Committee
Area Health Education
Centers (AHEC)
Member of the junior
faculty mentoring
committee in Stanley S.
Scott Cancer Center,
LSUHSC
Member of the Tissue
Utilization Review
Committee in LCRC
Graduate School
Chairperson (Mandal)
Biostatistics (Mercante)
Physiology (Molina)
Pharmacology (Songu-Mize)
Anatomy (Weyend)
Genetics (Mandal)
School of Medicine
Chancellor (Gardner)
Med (Herbert, Wilcox)
Med/Pul (Kantrow, Mason)
Anat/Cell (Lallier, Whiworth)
Phys iology (Levitzky)
Dean/Anat (McClugage)
Pediatrics (Lo-Blais)
Med/Id (Taylor)
Microbiology, Immunology & Parasitology (Thompson, leader)
Biochemistry (Alahari)
Pharmacology (Catling)
Genetics (Grabczyk)
Opthalmology (Jacob)
Environmental Health & Safety (Pourciau, Troxler)
LSUHSC (Tsien)
Tulane HSC (Anderson)
Nicholls State University,Thibodeaux LA (Doucet)
Cancer Center (Ochoa)
Genetics (Liu)
Cancer Center (Paz)
Genetics (Liu)
Department of Pharmacology
Strategic Planning,
Physiology (Molina, leader)
Communications
Pathology (Venuti)
workgroup
Genetics (Hollenbach)
OB/Gyn (Brewer, Holman)
Anatomy (McClugage)
Psychiatry (Osofsky)
Neuroscience Center (Bazan)
LSU Alumni (Klein)
LSU Foundation
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Department of Biochemistry
Strategic Planning,
Physiology (Molina, leader)
Communications
Pathology (Venuti)
workgroup
Genetics (Hollenbach)
OB/Gyn (Brewer, Holman)
Anatomy (McClugage)
Psychiatry (Osofsky)
Neuroscience Center (Bazan)
LSU Alumni (Klein)
LSU Foundation
Department of Physiology
Strategic Planning,
Physiology (Molina, leader)
Communications
Pathology (Venuti)
workgroup
Genetics (Hollenbach)
OB/Gyn (Brewer)
Anatomy (McClugage)
Psychiatry (Osofsky)
Neuroscience Center (Bazan)
LSU Alumni (Klein)
LSU Foundation
Strategic Planning
Neurosurgery (Richter)
Faculty Development
Pharmocology
Workgroup
Path (McGoey)
Phys. (Levitsky)
Biochemistry
Int. Med (Launders)
Genetics (Gregory)
Med School
Anatomy ( Schwartz)
Curriculum
Physiology (Levitsky; McDonough)
Committee
Family Medicine (Le Blanc)
Neurosurgery (Richter)
OB/GYN
Genetics (Gregory)
Graduate Advisory
School of Medicine
Council
LSUHSC Graduate School
Biochemistry (Alahari, Haas, Kim)
MIP (Amedee, Hobden)
Physiology (Bagby, Levitzky, McDonough)
Pharmacology (Catling, Nichols, Songu-Mize)
Neuroscience (Erikson)
Biostatistics (Fang, Mercante)
Anatomy (Lallier, Mize, Venuti, Weyand)
Pathology (Sakamuro, Scheer)
Neuroscience (Erikson)
VC for Academic Affairs (Moers)
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
Curriculum Committee
Council on Professional
Conduct
LSUHSC Faculty
Assembly
IACUC
ACAC
Search for Head of
Pathology
Graduate School
Chairperson (Mandal)
Biostatistics (Mercante)
Physiology (Molina)
Pharmacology (Songu-Mize)
Anatomy (Weyend)
Genetics (Mandal)
School of Medicine
Chancellor (Gardner)
Med (Herbert, Wilcox)
Med/Pul (Kantrow, Mason)
Anat/Cell (Lallier, Whiworth)
Phys iology (Levitzky)
Dean/Anat (McClugage)
Pediatrics (Lo-Blais)
Med/Id (Taylor)
Various clinical and basic research faculty representatives for each department
within LSUHSC
Physiology (Porter, Bagby, Levitzky)
Physiology (Bagby, Molina)
Physiology (Bagby, Molina)
Physiology ( Molina)
Department of Microbiology
Faculty Assembly
Microbiology (Sturtevant, MIP representative)
Strategic Planning:
Gene Therapy (Ramsay – Chair)
Research and Core
Microbiology (Kelly, Foster, Aiyar)
Facilities
Radiation Safety
Microbiology (Koochekpour, Aiyar – members)
Committee
Institutional Biosafety
Microbiology (Thompson – Chair)
Committee
Teaching Academy
Microbiology (Thompson – Chair)
Scholarship Committee
Faculty Senate
Microbiology (Amedee – Member)
Constitution and Bylaws Microbiology (Amedee – member)
Committee (Faculty
Senate)
Graduate Advisory
Microbiology (Amedee, Hobden – members)
Council
Postdoctoral Fellow
Microbiology (Amedee – member)
Committee (Graduate
Advisory Council)
Pharmacology Chair
Microbiology (Amedee – member)
Search Committee
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
N.O. Public School
Outreach Program
(Graduate School)
Research Enhancement
Fund Committee
LCME Prep Committee
Microbiology (Amedee – participant)
Pre-Clinical Promotions
Committee
Microbiology (Hobden)
Microbiology (Aiyar)
Microbiology (Hobden)
LCME Medical Education Database 2009-10
I. Institutional Setting
Academic Year _2007-2008_
END OF SECTION I
LCME Medical Education Database 2009-10
I. Institutional Setting